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ABSTRACT 
 
Heterotrimeric G proteins, composed of alpha, beta and gamma subunits, are a major 
group of signaling molecules in eukaryotic organisms. There is lack of direct 
biophysical and structural data for the plant heterotrimer unlike its mammalian 
counterparts. 
Heterotrimeric G protein subunits from Arabidopsis were cloned and purified. The 
alpha subunit, GPA1 was purified from Pichia, with a GTP binding ratio of 0.3 mole 
GTP/ mole protein. The recombinant beta (AGB1) and gamma (AGG1 and AGG2) 
subunits were isolated from E.coli and preliminary purification strategies were 
optimized. This is to our knowledge, the first study to report recombinant production of 
a plant beta subunit and in vitro dimerization of purified AGB1-AGG2 subunits. 
GPA1 was purified in two different biophysical states, as characterized by UV-
spectroscopy, dynamic light scattering, circular dichroism spectropolarimetry and mass 
spectrometry. The stable oligomeric form had higher GTP hydrolysis activity and a 
GDP binding ratio of 1.4 mole GDP/mole protein. Indirect biophysical evidence points 
to interaction of GPA1 with receptor mimetic compounds, membrane fractions of yeast 
 v 
cells and the recombinant AGB1-AGG2 dimer. This is to our knowledge, the first study 
showing the expression and purification of the plant alpha subunit from a eukaryotic 
expression system and its detailed biophysical characterization. 
Small angle solution X-ray scattering (SAXS) measurements verified the oligomeric 
nature of the protein, which was stabilized via detergent micelles. The detergent content 
was verified by proton nuclear magnetic resonance spectroscopy. SAXS patterns were 
consistent with dimeric protein complexing with micelles. Rigid body modeling was 
used for further modeling. 
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ÖZET 
Heterotrimerik G proteinleri alfa, beta ve gamma altbirimlerinden oluşan ve ökaryot 
organizmalarda bulunan sinyal iletim molekülleridir. Memeli heterotrimerinin 
biyofiziksel ve yapısal özellikleri üzerine kapsamlı incelemeler olmasına rağmen bitki 
proteinleri üzerine çalışmalar sayılıdır. 
Bu çalışma kapsamında, Arabidopsis heterotrimerik G protein altbirimleri klonlandı ve 
saflaştırıldı. Pichia hücrelerinden saflaştırılan alfa altbiriminde (GPA1) bir mol proteine 
0.3 mol GTP bağlandığı gösterildi. Rekombinant beta (AGB1) ve gama (AGG1 ve 
AGG2) altbirimleri E.coli hücrelerinde üretildi ve ilk saflaştırma aşamaları optimize 
edildi. Bu tez bitki beta altbiriminin rekombinant olarak üretilmesi ve saflaştırılmış 
AGB1-AGG2 etkileşimini gösteren ilk çalışmadır. 
GPA1 proteinin iki farklı biyofiziksel formda saflaştırıldığı UV spektroskopisi, dinamik 
ışık saçılımı, dairesel dikroizm spektroskopisi ve kütle spektrometrisi ile gösterildi. 
Kararlı oligomerik formun GTP hidroliz aktivitesi daha yüksek ve GDP bağlama oranı 
da 1.4 mol GDP/mol protein’dir. Biyofiziksel bulgular GPA1 proteinin reseptör benzeri 
bileşikler, maya hücrelerinin zar kesimleri ve rekombinant AGB1-AGG2 dimeri ile 
etkileştiğini dolaylı olarak göstermiştir. Bu tez, bitki alfa altbiriminin bir ökaryot 
ekspresyon sistemi kullanılarak saflaştırılması ve detaylı biyofiziksel karakterizasyonu 
üzerine ilk çalışmadır. 
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Küçük açı X-ışını saçılımı (SAXS) ölçümleri oligomerik proteinin deterjan miselleriyle 
birarada saflaştırıldığını göstermiştir. Deterjan misellerinin miktarı proton nükleer 
magnetik rezonans spektroskopisi ile tespit edildi. SAXS sonuçları GPA1 proteinin 
dimerik protein-misel kompleksi halinde olduğunu gösterdi. Yapısal modeller katı cisim 
modellemesi kullanılarak hesaplandı. 
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CHAPTER 1 
1 ITRODUCTIO 
 Heterotrimeric G proteins are mediators that transmit the external signals via 
receptor molecules to effector molecules and play a crucial role in signal transduction in 
mammalian, plant and lower eukaryotic cells. The mammalian heterotrimeric G proteins 
are composed of three subunits, α, β and γ. The α subunit by binding /dissociation from 
βγ dimer, transmits signals from receptor to effector molecules. Availability of high-
resolution structural data led to a comprehensive understanding of the mechanism of 
signaling in mammalian systems. The α subunits have posttranslational lipid 
modifications which allow them to attach to the plasma membrane and interact with the 
hydrophobic regions of the receptor. Following receptor activation heterotrimer 
dissociation or loosening occurs and the α subunit and the βγ dimer interact with 
downstream effector molecules to transmit the signal. The α subunit can bind and 
hydrolyze GTP and this enzymatic activity serves as an on/off switch for the 
heterotrimeric signaling cycle. 
 There are 16 Gα genes in the human genome, which encode 21 known Gα 
proteins of molecular mass ranging from 39 to 52 kDa. These proteins can be divided 
into four major classes based on sequence similarity: Gα (s /olf), Gα (i1/i2/i3/o/t-rod / t-
cone /gust /z), Gα (q / 11 / 14 / 16) and Gα (12 / 13). Despite the high number of Gα 
subunits there are up to date only 6 Gβ and 14 Gγ subunits identified in humans. There 
are, however, more than 800 genes encoding for GPCRs only in the human genome. 
Each Gα has a distinct function, the specificity determined by the poorly conserved C-
terminal receptor-binding domain. The signaling diversity in mammalian systems 
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probably results from this specific GPCR- Gα coupling. The heterotrimeric G proteins 
are involved in various signaling mechanisms including visual perception (Gt-rod), 
olfactory system (Golf), nervous system (Gi/o/z), taste (Ggust) and many others. The 
signaling specifity may not be directly related to Gβγ, since most β and γ isoforms are 
functionally interchangeable with each other and different Gβγ can interact with the 
same Gα. Still not all βγ or heterotrimer combinations occur; for example Gβ1γ1 
always couples to Gt (transducin) and functions in rhodopsin directed light dependent 
signaling [1]. 
 Plant heterotrimeric G proteins are identified in several higher plants. The plant 
heterotrimer was shown to be involved in signaling pathways directing cell and plant 
growth, development and differentiation, ion channel regulation and drought tolerance 
and biotic stress resistance. These processes are mediated by several plant hormones. 
Plants have one or two isoforms of Gα subunit as opposed to the high number in 
mammalian systems. Similarly there is only one Gβ and two Gγ isoforms identified in 
different plants [2].  
 Studies revealed the presence of the three subunits in the A. thaliana genome. The 
G protein α subunit, GPA1 was first to be isolated [3] followed by the β- subunit AGB1 
[4] and the two γ-subunits; AGG1, AGG2 [5, 6]. 
 Current research on plant heterotrimeric G proteins is mainly focused on null 
mutant / overexpression studies performed in model organisms, i.e. A. thaliana and O. 
sativa. These studies provide information about the pathways involving the 
heterotrimeric G proteins, however, the mechanism of G protein activation via signaling 
molecules and mechanisms of interactions with different partners in pathways remain 
unknown. Current literature is especially poor from the perspective of structural 
analyses on the plant heterotrimeric G-proteins, whereas for the mammalian 
counterparts, such studies have contributed unique insights to understanding of their 
functional roles. Structural characterization of the plant heterotrimer and the individual 
subunits would reveal the level of similarity with the mammalian complexes and may 
allow prediction of the nature of interactions of the proteins with up/down stream 
signaling components.  
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 The overall aim of this work is to understand the structural constraints of the 
heterotrimeric G protein signaling mechanism(s) in plant species. To achieve this 
objective, the corresponding genes from the model plant A.thaliana are cloned in 
different expression systems. The specific aims can be summarized as: 
 Recombinant expression of A.thaliana heterotrimeric G protein subunits. 
 Purification of recombinant GPA1. 
 Characterization of the GDP / GTP binding and GTPase activity of recombinant 
GPA1 by UV spectrophotometry and radioactive assays. 
 Biophysical characterization of GPA1 by Western analysis, receptor mimetics 
interaction, 1H NMR and MALDI-TOF. 
 Structural characterization of GPA1 by CD, DLS and SAXS. 
 Purification of AGB1 and AGG1/2. 
 Reconstitution of the plant heterotrimer. 
 GPA1 was expressed as a C-terminal myc epitope and 6 his fusion using Pichia 
pastoris from a genome integrated expression construct that leads to intracellular 
production of recombinant protein [7]. The presence of Gα or Gβγ is not yet identified 
in P.pastoris but is reported from other yeast including S.cerevisiae [8]. P.pastoris is 
shown to perform co-and post-translational lipid modifications myristoylation and 
palmitoylation [9].  
 In this study, GPA1 was isolated with or without the presence of detergents using 
his-tag affinity chromatography with yields of 10 or 20 mg/L culture, respectively. The 
protein was further purified by either anion exchange or size exclusion chromatography. 
Purified recombinant protein was routinely analyzed by using UV spectrophotometry 
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and circular dichroism (CD) spectropolarimetry and western detection to assure protein 
quality, monodispersity and size were analyzed by dynamic light scattering (DLS). 
Anion exchange resulted in separation of two biophysically different forms of GPA1; 
one an oligomeric but stable form, the other one a heterogenous mixture with 
monomeric sized particles and prone to both aggregation and degradation. In contrast, 
gel filtration column purified GPA1, on the other hand, appeared to be homogeneous 
with a molecular mass higher than that expected from the monomer. NMR analysis 
showed that this protein was purified together with detergent/lipid micelles. It was 
shown that all three forms of GPA1 had comparable GTP binding and hydrolysis 
activity. The oligomeric form had higher tendency to bind GDP. CD measurements 
indicated helical secondary structure elements resembling that observed in the native 
proteins. Attempts to collect small angle solution X-ray scattering (SAXS) data from the 
anion exchange purified forms of GPA1 were not successful. SAXS measurements from 
the gel filtration purified protein were consistent with the presence of high molecular 
mass structures, which may be oligomeric GPA1 alone or protein-micelle complexes 
(PMC). The molecular mass was estimated to be about 2.5 fold of GPA1.  
 Mass spectrometry analyses were different for the oligomeric and monomeric 
forms. The N-terminus of the monomeric form did not contain any lipid modifications, 
whereas the 6 N-terminal amino acids could not be detected at all for the oligomeric 
GPA1. Furthermore the trypsin digestion patterns were different, the lysines in the 
putative nucleotide and receptor binding domains of oligomeric GPA1 were not 
digested. The recombinant protein was expressed in cytosolic fractions and was also 
present in membrane fractions of P.pastoris. The interaction of oligomeric GPA1 with 
receptor mimetic compounds was shown by CD analysis. 
 AGB1 and AGG1/2 could not be expressed in P.pastoris (data not shown). Hence, 
the genes were inserted into different E.coli expression vectors and several strains were 
screened for protein production. AGB1 expression was very low in each case and 
AGG1 was expressed in inclusion body fractions. AGG2 was expressed in soluble 
fractions and initial purification strategy was optimized with yield approximately 1-4 
mg/150 ml culture. 
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 The interaction of AGB1 and AGG2 was shown by a non-denaturing SDS-PAGE-
Western detection strategy. Interaction of GPA1 with partially purified β and γ subunits 
was demonstrated by PAGE analysis. This interaction appeared to reverse the 
aggregation observed for GPA1 after storage and protected from degradation. 
 These results show that the biophysical properties of the oligomeric form and the 
PMC form of GPA1 are similar and correspond to a stable state which may resemble the 
membrane-bound form of native GPA1. These studies highlight the tendency of GPA1 
to form complexes. It appears that meaningful studies directed to develop an 
understanding of the signaling mechanism in plants would require additonally the 
presence of the βγ dimer. Purification of the plant β and γ subunits for reconstitution of 
the recombinant heterotrimer is being investigated. 
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CHAPTER 2 
2 BACKGROUD 
2.1 The Mammalian Heterotrimer 
 Heterotrimeric G proteins are mediators that transmit external signals arriving at 
receptor molecules to effector molecules and play a crucial role in signal transduction in 
mammalian and plant systems.  
 Most information on heterotrimeric G-proteins is from studies on the mammalian 
complex. The mammalian heterotrimeric G proteins are composed of three subunits; α, 
β and γ. The Gα subunit is the site of GTP binding and GTPase activity and β and  γ 
subunits remain as a tight complex during the signal transduction process. In the general 
mechanism of signal transmission from receptor to effector molecules the state of 
association of the α subunit with the βγ dimer acts as a switch (Figure 2.1). Signal 
transduction occurs via G-protein coupled receptors (GPCRs) which are identified as 7 
TM domain proteins in mammals; the extracellular amino-terminal extension 
determining the ligand specificity [10]. Activation of the GPCR upon ligand binding 
leads to an interaction with the membrane bound Gα inside the cell. This interaction, 
occurring between the cytoplasmic loop of the receptor and the amino- and carboxy- 
terminal domains of Gα catalyses the nucleotide exchange. The nucleotide exchange, 
GDP to GTP, releases Gα from Gβγ, allowing both the Gα and Gβγ  to interact with 
their downstream effector molecules. Gβ, released from Gα, remains strictly bound to 
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the γ subunit, which anchors the heterotrimer/dimer to the lipid bilayer via a lipid 
modification at its carboxy terminus. The intrinsic GTPase activity of Gα eventually 
results in GTP hydrolysis and in the re-formation of the heterotrimer. RGS (Regulator 
of G protein signaling) proteins, which are GTPase activating factors (in the case of Gα 
GAPs), bind to Gα and accelerate the rate of GTP hydrolysis to GDP, shortening the 
lifetime of Gα’s active, GTP-bound state. GAPs lead to reduced signal strength and/or 
accelerated termination of the signal after ligand removal from the GPCR [11]. There 
are other regulatory proteins which have GDI (guanine nucleotide dissociation 
inhibitor) activity, these associate with the Gα subunits in their GDP bound state 
preventing GDP release, one of them being the Gβγ dimer itself [12]. 
  
Figure 2.1 The classical model for receptor mediated G protein activation [13]. 
R: GPCR, R*: activated GPCR. 
 
2.2 Structure- function relations of heterotrimeric G proteins 
 It is well known that key structural domains regulate the function of the 
heterotrimeric G proteins complex. All three subunits have characteristic functional 
regions conserved among structurally characterized mammalian proteins. There are 
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experimentally–determined structures for two different mammalian G protein 
heterotrimers, a 2.0 Å structure of the heterotrimer Gt-α (bovine) /Gi-α (rat) chimera 
(expressed in E.coli), Gi-β1γ1 (isolated from bovine rod outer segment) PDB accession 
code 1GOT [14] and a 2.3 Å structure of the Gi-α1 (rat, expressed in E.coli), Gi-β1 
(bovine), Gi-γ2 (C68S) (bovine, coexpressed with Gβ in insect cells) PDB accession 
code 1GP2 [15].  
 
 
Figure 2.2: 2.0 A° structure of the heterotrimeric complex 1GOT. 
Gt α/ Gi α (green) chimera and the Gβ (yellow) Gγ (brown in a and pink in b) subunits 
GDP in magenta, and the switch I-III regions are colored in cyan. Residues 216-294 of 
bovine Gt α replaced with residues 220-298 of rat  Gi α, expressed in E.coli. G βγ 
dimer isolated from photolysed bovine retinal rod segments. a: Ribbon drawing of the 
complex b: Rotated 70° about the horizontal axis compared with the view in a [14]. 
 
 The mammalian α subunit has two domains; one with an α helical secondary 
structure which buries the nucleotide in the core of the protein  and the other a ras 
(GTPase) domain, where nucleotide binding and hydrolysis occurs [16]. Structure of 
transducin (isolated from bovine rod) bound to GTPγS (a non hydrolyzable analog of 
GTP), 1TND [17], revealed many important features for GTP binding and hydrolysis, 
including the active site arginine and glutamine residues. These residues were later 
shown to have a key function in GTP hydrolysis and mutating these abolishes 
hydrolysis creating constitutively active Gα [18]. Many other crystal structures at 
different resolutions and with different ligands and/or effectors; the AlF4
--GDP bound 
 9 
Gα  (GTP hydrolysis transition state), GTPγS stabilized Gα and RGS bound Gα [19-
21] also contributed to the understanding of Gα structure and function. GTPase domain 
contains the GTP/GDP binding site, the Mg+2-binding domain, the threonine and 
glycine residues needed for GTP hydrolysis, the covalently attached lipid anchoring the 
subunit to the bilayer and sites for binding receptors, effector molecules, and the βγ 
subunit. 
 The Gβ subunits have a molecular mass of approximately 36 kDa, all share 7 
WD-40 repeats and thus fold in to a 7 blade β-propeller structure. The γ subunits are 
disordered helical coils and interact with beta subunits through an N-terminal coiled-
coil. Upon this interaction the γ subunit makes extensive contacts all along the base of β 
and this interaction is not dissociable except under denaturing conditions [22]. These 
structural features are conserved in both the heterotrimer and the dimer form (PDB 
accession code 1TBG [23]) and the conformation of free dimer is identical to that in the 
heterotrimer. The amino acid sequences of β1-β4 are highly homologous (~80%), β5 is 
less similar and was shown to interact with some RGS proteins which have Gγ similar 
(GGL) domains [1].  
 The mammalian Gγ subunits are small proteins with molecular mass around 7-8 
kDa. The overall sequence homology among Gγ’s is lower as compared to Gα and Gβ, 
and these are grouped according to their C-terminus amino acid sequence. The Gγ 
subunits with identical C-terminus sequence interact with the same receptor, thus this 
sequence also plays a role in heterotrimer-receptor specifity [24]. 
 The crystals of Gβγ (1TBG) or the heterotrimer 1GOT were produced from 
proteins isolated from bovine rod outer segments. The β and γ subunits were also 
produced with in vitro translation [25] or using baculovirus expression systems [26]. 
These studies contribute to understanding some important biochemical properties of 
both the individual subunits and the dimer itself. Gβ is not stable without the presence 
of its dimerizing partner and forms high molecular mass aggregates. Co-expression /co-
translation is not required, however, for dimerization of β and γ. Trypsin proteolysis 
was used to detect dimerization as shown by the discrete pattern of purified bovine 
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brain Gβγ [27]. The Gβ1 subunit has only one site available for tryptic digestion in the 
dimer form (Arg-129) which results in 2 fragments of size ~25 and 14 kDa [28]. 
 The high resolution crystal structures for transducin in heterotrimeric and GTPγS 
bound forms reveal some conformational differences which may result in heterotrimer 
dissociation. The Gβγ dimer binds to a hydrophobic pocket present in Gα -GDP. GTP 
binding to Gα removes the hydrophobic pocket and reduces the affinity of Gα for the 
Gβγ  dimer. In the GDP bound heterotrimeric form 1GOT [14], the Gβ interface is 
mainly formed by the exposed hydrophobic amino acid residues and switch regions are 
flexible allowing the interaction. In the GTPγS bound Gt crystal structure; 1TND [17], 
these hydrophobic amino acids side chains are rather buried inside and basic and polar 
amino acids are located at the interface. The key structural rearrangement upon 
activation occurs in the backbone loops of Gα which act as switches depending on the 
bound nucleotide. Switches position themselves depending on whether GDP or GTP 
occupies the nucleotide binding site. When GDP is bound, the switches orient to permit 
tight association of Gα to the β subunit, but upon GTP binding, these switches reorient 
such that the Gα / Gβγ interaction is disrupted permitting a slightly different interaction 
at the same interface with membrane-localized enzyme, i.e. effectors. Switch I is a loop 
connecting helix α4 to strand β6, switch II, corresponds to the loop preceding the α2 
helix, and the helix itself and switch III corresponds to the loop that connects helix α3 to 
strand β5 (Figure 2.2a). Almost the entire length of the switch II region is buried in the 
contact with β subunit and also forms the binding site for the γ phosphate of GTP. Both 
the switch II and the amino-terminal parts of Gα are dynamic components of GTP 
hydrolysis. Upon GTP-hydrolysis, the switch II helix rotates approximately 120o, 
exposing the hydrophobic residues, including Trp-211, to interact with complementary 
nonpolar pockets in the β subunit. The same rotation also creates two ionic interactions 
between the α and β subunit [29]. Conformational changes within switch II region are 
coordinated with a complementary shift of the switch I peptide that ultimately traps 
GDP in the catalytic site of α subunit. Switch I also contributes an oxygen ligand to the 
Mg+2 in the GTP bound state [19]. The structural changes occurring in switch I and II 
are directly due to GTP binding, whereas switch III does not have a binding site for 
GTP. Switch III indirectly undergoes structural rearrangements by responding to the 
changes occurring in switch II and this coupling was shown to play a role in effector 
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activation [30]. The N-terminal helical region is exposed only in the GDP bound form, 
which is another interaction site for the dimer. The N terminal helical region of Gα is 
ordered by its interaction with the beta-propeller domain of Gβ (Figure 2.2b). These 
data support the classical view of heterotrimer dissociation upon receptor activation. 
Recently, an alternative mechanism for heterotrimeric G protein activity involving 
subunit structural rearrangement rather than dissociation was also suggested for Gi 
family based on FRET analyses [31]. Several biochemical data suggest that subunit 
dissociation may not be necessary for effector interaction after nucleotide exchange 
[32]. It is argued that the mode of activation may depend on the type of receptor and 
alpha subunit; for example dissociation is a more favorable mechanism in case of 
transducin-Gβ1γ1 heterotrimer due to the requirement of movement of transducin from 
rod outer segments to other cellular compartments in order to respond to varying light 
sources [33]. 
 The mammalian Gα subunits share high sequence homology especially for the 
amino acids in the GTPase domain; P binding loop (GXGESGKS), Mg+2-binding 
domain (RXXTXGI and DXXG) and guanine ring binding motifs (NKXD and TCAT). 
The helical domain is, however, not conserved and this divergence might be the reason 
of interaction with different effectors [18]. 
 The GTP binding activity of mammalian G protein α subunits have been 
established through both radioactive assays [34] and intrinsic fluorescence 
measurements [35-37]. The radioactive assay allows direct measurement of the amount 
of bound radioactive GTPγS, whereas intrinsic fluorescence measurements rely on the 
conformational change that occurs in switch II. GTP binding assays not only reveal the 
kinetic properties of the individual subunit but also give valuable information about the 
effect of other proteins; activators, GDIs and other interactor proteins. These studies 
showed that the dissociation of bound GDP is the rate-limiting step for GTP binding 
and the requirement for a cation, especially Mg+2 for irreversible binding to GTPγS. In 
the absence of Mg+2 GTPγS binding is freely reversible and GDP binding is largely 
unaffected [38]. The GTPase activity of each mammalian Gα was shown to be different, 
with in vitro kcat values (first order reaction rate constant); Gαs 3.5 min 
-1 and Gαi 1.8-
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2.4 min -1at 20 °C, Gαq 0.8 min -1, Gα12 0.2 min 
-1, and the lowest for Gαz 0.05 min -1at 
30 °C [18]. 
 Circular dichroism was also used to investigate the effect of bound nucleotide on 
recombinant (E.coli) Gαi and no significant spectral change was observed in the 
presence of GDP or non-hydrolyzable GTP analog [39]. Yet receptor activation was 
shown to decrease the helical content of non-myristoylated Gαi and this maybe 
explained by the interaction of helical Gα C terminus with the receptor upon activation 
[40]. Similarly conformational changes are also expected to take place also in the 
helical N-terminal region. Furthermore CD was used as a tool for verification of the 
intactness of the recombinant Gα subunits [41]. 
 The N-terminus amino acids were either cleaved in order to obtain crystal quality 
protein or these amino acids were not visible in the electron density maps. Structural 
features of N-terminus are not clear in crystal structures of Gα transducin (27 and 26 
amino acids missing for 1TND and 1TAG respectively, protein isolated from bovine 
rod) or Gαi1 (33 amino acids missing; 1GIA, 1GIL, 1GFI; recombinant rat Gαi 
expressed in E.coli, [19]). Although the N-terminus of Gα is more ordered in the 
heterotrimeric state, still 5 and 4 amino acids are missing in 1GOT and 1GP2 crystal 
structures respectively. 
 The N-terminus of Gα plays significant role when membrane, receptor and Gβγ 
interactions are considered. The mammalian alpha subunits all have at least one lipid 
modification at the immediate N-terminus that would facilitate to locate the heterotrimer 
in close contact to receptor, which is in the plasma membrane (PM). The presence of 
hydrophobic fatty acids increases the overall hydrophobicity of the proteins.  
 Gαi (αi1, αi2, αi3, αo, αz, αt) family members are myristoylated as the result of 
co-translational addition of the saturated 14-C fatty acid myristate to the glycine residue 
by a stable amide bond at the new N-termini following the removal of the initiator 
methionine. The addition of myristate also depends on the 4th residue following glycine, 
which has to be either a serine or threonine for the myristoylation to occur. This residue 
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is a serine in case of Gαi family members. Mutating the glycine residue results in 
cytosolic Gαi which can not bind to PM. All Gα families except Gαt and Gαgust are 
posttranslationally modified by the addition of 16-C fatty acid palmitate attached 
through a reversible thioester linkage to cysteine residue(s) [42]. The palmitoylation site 
is one (or more) cysteine residue(s) in the N terminal 20 amino acid region [33], with 
the exception of Gαs which was recently shown to have two palmitate moieties at 
glycine 2 and cysteine 3 [43]. 
 Palmitoylation site is the cysteine following the myristoylated glycine for Gαi 
family members and requires presence of myristic acid and/or the Gβγ dimer. The 
presence of Gβγ is enough for palmitoylation to occur for the myristoylation mutants 
(G2A) of Gαi and Gαz, and the heterotrimeric form was shown to be a better substrate 
for palmitoylation for Gαi and Gαs [44]. This suggests that palmitoylation occurs after 
membrane attachment of Gα by its increased hydrophobicity, either through the 
myristic acid or the hydrophobic Gβγ [42]. On the other hand the mutating the 3rd 
cysteine of Gαo results in high amount of cytosolic protein, even though the protein is 
myristoylated [45]. Thus the presence of myristate is a transient hydrophobic anchor 
that allows the protein to be placed near the PM, where palmitoylation may take place 
and the more hydrophobic palmitate anchors the protein more strongly to the PM.  
 Palmitate is attached through a reversible covalent bond and the 
palmitoylation/depalmitoylation cycle contributes to the dynamic nature of Gα 
activation and oligomerization. The GDP bound form of myristoylated Gαo was shown 
by native continuous gel electrophoresis; to be in oligomeric form (dimer, trimer, 
tetramer and pentamer), which was disintegrated to monomers upon GTPγS binding and 
addition of Lubrol-PX. In vitro palmitoylation resulted in a stable oligomeric form, 
which was not completely reversed by the addition of GTPγS. Furthermore the 
palmitoylated Gαo had lower GTPγS binding [46]. Depalmitoylation was shown to 
occur upon agonist stimulation of receptor for Gαo [47] and Gαs [48, 49]. 
Palmitoylation was also shown to effect protein-protein interactions; palmitoylated Gαs 
had higher affinity to Gβγ and Gβγ protected GDP-Gαs from depalmitoylation but not 
GTPγS-Gαs [50] and palmitoylated Gαz and Gαi1 had lower affinity to RGS proteins 
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[51]. It is clear that this reversible lipid modification affects the functioning of Gα 
subunits, yet the exact mechanism of this cycle is unclear; is palmitoylation favored by 
interaction with Gβγ (or does palmitoylation favors Gβγ interaction), by returning to 
GDP bound form by GTP hydrolysis or by recruitment to the PM with GDP bound 
heterotrimeric form (if Gα was ever translocated to cytosol). The precise order of events 
in this cycle will clarify the different observations for various Gα subunits localization 
(internalization) upon activation considering that palmitoylation may take place in any 
cellular membrane, PM and although at a lower extent at Golgi or endoplasmic 
reticulum (ER) [18]. 
 The overall hydrophobicity of Gβγ is already high and furthermore the γ subunits 
are prenylated. 20-C isoprenoid group geranyl geranyl or 15-C isoprenoid farnesyl is 
posttranslationally attached through a stable thioether linkage to a cysteine in the so 
called CAAX motif in the C terminus of Gγ subunits, where A represent an aliphatic 
amino acid residue. The last amino acid X of CAAX box determines the isoprenoid to 
be attached, farnesyl in case of serine or methionine and geranyl geranyl in case of 
leucine. Gγ1,9,11 are farnesylated and remaining Gγ subunits are geranyl geranylated. 
Prenylation occurs in the cytosol followed by Gβγ dimerization, and then the dimer is 
translocated to ER where AAX amino acids are cleaved off and the new C-terminus is 
carboxyl methylated. Prenylation is not required for the formation of the Gβγ dimer as 
shown by limited proteolysis [52]; but dimerization was shown to be necessary for 
proteolytic cleavage and methylation of the Gγ C –terminus [33].  
 Prenylation of Gγ increases the affinity of dimer to Gα [52] and allows its 
attachment to the PM. Cysteine mutant studies show that without prenylation the dimer 
is not attached to the PM even in the presence of the Gα subunit [53]. Some Gβγ dimers 
were shown to be localized to inner cellular membranes upon heterotrimer interaction, 
to Golgi complex Gγ1,9,11 rapidly and Gγ5,10 slowly and to ER, Gγ13. The activated 
dimers of Gγ2,3,4,7,8,12 stay attached to PM [54].  
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 The presence of both the lipid modifications and the Gβγ assure Gα membrane 
attachment and thus receptor proximity. The exact mode of membrane attachment and 
the effect of fatty acids on the structure of the heterotrimer is not known.  
 There is no crystal structure of a heterotrimer with myristoylated and 
palmitoylated Gα. Especially an understanding of the effect of myristate on the Gα- Gβ 
interface will be crucial, ie does myristate directly interact with Gβ or does it allow a 
favorable conformation of Gα to bind Gβγ. In a recent study of Gαt in living cells, a 
very small fraction of the myristoylation deficient protein was shown to be localized to 
PM and interact with Gβγ, but had severely reduced GTPase activity in vivo [55]. There 
are studies investigating the dynamics of the N-terminus helix by use of site directed 
fluorescent labelling and EPR. The N-terminal helix solvent exposed residues of Gαi 
that are placed on Gβγ interface (as judged from the Gβγ bound crystal structure) were 
mutated to cysteine either in the presence or absence of myristate. In the non 
myristoylated protein the N-terminus is more solvent exposed in the GDP bound form 
and is placed in a more hydrophobic environment in GTP or GDP-AlF4
-
 bound form 
[56]. On the other hand myristoylated cysteine labeled N-terminus was more immobile 
in the hydrophobic environment and the immobility was not significantly altered in 
conformations with different nucleotides [57]. Both studies verified that N-terminus was 
present as a more ordered helix in the presence of Gβγ. The presence of Gβγ may have a 
stabilizing effect on the N-terminus helix of Gα which becomes a disordered random 
coil in the absence of Gβγ (either by dissociation or by increased distance). There may 
be a binding pocket on GPA1 where the disordered N-terminus helix is hidden by 
hydrophobic interactions, which are stronger in the presence of myristate. 
 The mode of membrane attachment is another important issue in heterotrimeric G 
protein cycle. The Gαi/s subunits were shown to prefer lamellar membrane structures, 
whereas the heterotrimeric Gαi prefers non-lamellar hexagonal structures [33]. The 
presence of Gβγ was shown to be the driving force of the heterotrimer to be recruited to 
nonlamellar phase [58]. The α helical transmembrane peptides can induce formation of 
nonlamellar membrane structures, thus GPCR may have a similar effect [33]. A recent 
study gives insight to the membrane-heterotrimer interaction by use of electron 
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microscopy. The transducin-Gβγ heterotrimer was crystallized on the surface of a 2–D 
lipid bilayer and the results show that the membrane interacting portion of the protein is 
only the 2% of the total heterotrimer surface. The crystal structure fit on the surface 
reveals that the membrane interacting residues are from Gαt β2-β3 loop and its N-
terminal helix [59]. Still the absence of receptor (rhodopsin would be in this case) and 
the missing portions of N- and C-terminal helices of Gα in the heterotrimer crystal 
structure limits further conclusion. 
 All GPCRs has 7 transmembrane alpha helices with an extracellular N-terminus, 
an intracellular C-terminus and 3 interhelical loops on each side of the membrane. The 
only crystal resolution native structure up to date is that of rhodopsin and this structure 
revealed that the C-terminal helix had an eighth α-helix and a fourth intracellular loop 
which is a palmitoylation site [60]. The attemps to crystallize other receptors failed and 
only engineered receptors could be crystallized [61]. Much information about the 
receptor-heterotrimer interaction is from rhodopsin (1GZM)-transducin-Gβ1γ1 (1GOT) 
complex. 
 
 
Figure 2.3: The models for rhodopsin-transducin heterotrimer complex. 
A: Superimposed models of 1GZM and 1GOT. B: The superimposed models of inactive 
rhodopsin dimmers (1GZM packed into unit cell constraints from atomic force 
microscopy data) [62] and 1GOT. Figure taken from [18]. 
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 Both the Gα and Gβγ dimer binds to receptor; the later through the C-terminal 
region of Gγ [16]. The receptor interacting sites on Gα were shown with different 
biochemical approaches and were found to be C-terminus, N-terminal helix and the α4 / 
β6 loop which are all distant from the nucleotide pocket. There is some evidence 
highlighting the movement of α5 helix, switch I and swicth II regions upon receptor 
activation, yet the mechanism how GDP release can be achieved with such distant 
interaction sites is unknown [63]. A mechanism for liganded receptor enhancement of 
the GDP release from Gα subunit was recently suggested and points out the importance 
of α5 helix. This helical region connects the C terminus receptor binding region to the 
nucleotide binding pocket. Upon receptor binding structural changes occur in α5 helix 
simultaneously with GDP release [64]. 
 The classical view of receptor-heterotrimer interaction is the “collision coupling” 
model in which only the activated receptor can couple with the heterotrimer. Dark 
(inactive) rhodopsin was also shown to bind Gαt, but the affinity of activated receptor is 
much higher. Similarly Gαi co-purified with α2 adregenic receptor and the unactivated 
δ-opoid receptor can bind to Gαo. The presence of GTPγS did not cause dissociation in 
the later case, which may be explained by the presence of a receptor-Gα(GDP)Gβγ 
complex. All these data support the presence of a precoupled system; the receptor is 
already bound to the heterotrimer prior to activation [63] as given in Figure 2.3A. The 
recent findings suggest that GPCRs can dimerize [65] as supported by the findings from 
atomic force microscopy analysis of inactive rhodopsin (Figure 2.3B), but there is also 
opposing data suggesting that only monomeric receptors are active [66].  
 The receptor-heterotrimer specifity is another important issue in understanding 
heterotrimeric G protein function. There is high number of GPCRs in mammalian 
systems, yet every receptor does not activate every heterotrimer. There is evidence that 
the Gα subunits have receptor specifity, especially in C-terminus; chimeric Gαq protein 
with C-terminus replaced with that of Gαi results in activation by the receptor specific 
to Gαi but the effector specifity is that of Gαq. The C-terminal 5-7 amino acids of Gα 
are disordered in the heterotrimeric G protein crystal structures, which were shown to 
be interacting with receptor using a peptide screen approach [67]. On the other hand 
receptors activating the same Gα subunits have very low sequence homology and not 
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much is known about if there is a receptor-specific sequence for selecting the 
heterotrimer isoform (s) [63]. 
 The primary effectors of heterotrimeric G proteins are either attached to PM or 
transmembrane proteins such as phospholipase C, adenyl cyclase (AC) and ion channels 
[59]. The crystal structures for effector complexes for different Gα subunits all reveal a 
localized hydrophobic effector-binding surface on Gα which is structurally conserved 
among different Gα subunits. The hydrophobic residues inserted into a pocket formed 
between switch II and α-3 helix; α2/β4 and α3/β5 loops were shown to be involved in 
effector specifity. The involvement of N-terminus and myristoylation of Gαi in effector 
binding was also shown. The number of effectors identified is low as compared to the 
possible heterotrimer combinations, some Gα subunits were shown to interact with only 
one effector and others with many effectors. The numbers of effectors are expected to 
be high since even highly homologous Gα subunits interact with different effectors. 
Some effectors were shown to increase the GTP hydrolysis rate of their respective Gα 
subunits; PLCβ1 for Gαq and PDEγ for Gαt. Thus, these effectors can act as GAPs and 
control the duration of the signal in which they are involved. A specific  family of GAPs 
are called RGS due to their conserved RGS domain which forms a bundle of nine α-
helices which is the binding site to Gα switch regions [18]. The binding of RGS to 
switch regions was shown to stabilize the transition state conformation and thus 
increase GTP hydrolysis rate. The transition state was mimicked with the presence of 
AlF4
- ion, which increases RGS binding [21]. The structural constraints of Gα N-
terminal helix interaction with the RGS are not identified, yet it was shown that the 
presence of myristoylation increased the affinity of Gα (z/i) to RGS proteins whereas 
palmitoylation decreased [18]. 
 The Gβγ dimer also interacts with effector molecules including PLCβ, AC, β-
adrenergic receptor kinase, MAP kinase pathway components, K+ and Ca +2 channels, 
crystal structures are available for some of them. The Gβγ interacts with these effector 
molecules and Gα using a similar mechanism but different residues are involved for 
interactions with known effectors. Most of the interaction is through the central 
structure around the cavity formed by blades. The Gβγ dimer has effector specifitiy 
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similar to Gα different Gβγ subunits interact with different effector molecules. The 
specifity is considered to be mainly due the hydrophobicity and tight structural 
constrains of Gβ and also the involvement of lipid moiety on the Gγ was shown. [18] 
 Recently new signaling components functioning in heterotrimeric signal 
transduction pathway were identified, which are non-receptor GEF proteins. These 
soluble proteins (AGS1, Ric8A) act as receptors and promote GDP release /GTP 
binding to Gαi/q. The involvement of Gα subunits in cell division was shown to be 
receptor independent and Ric-8 was shown to prefer the GDP bound state and increase 
GTPγS binding in C.elegans [68]. There are also GDI proteins that act on Gαi family to 
prevent GDP release by their conserved GoLoco domain to help formation of a salt 
bridge between the P-loop and switch I [69]. This salt bridge is also observed in the 
heterotrimer structure and locks GDP inside Gα. These proteins are suggested to 
promote Gα dissociation from heterotrimer without nucleotide release/exchange [33].  
2.3 The plant heterotrimeric G proteins 
 In plants studies revealed the presence of the three subunits in the A. thaliana and 
Oryza sativa (rice) genomes; Gα; GPA1 [3] and RGA1 [70], Gβ; AGB1 [4] and RGB1 
[71], and finally the two Gγ; AGG1, AGG2 [5, 6] and RGG1, RGG2 [72], respectively. 
For other cereals, α subunits were identified from Triticum aestivum; TaGA1, TaGA2 
[73], Hordeum vulgare (accession: AF267485.2) and β subunits from Triticum 
avestivum (accession: BAC10503) and Zea mays, ZGB1 [4]. Sequence homologies 
show that plant G proteins contain the functional domains seen in mammalian 
counterparts. Recombinant expression studies show that plant Gα subunits can bind 
specifically to GTP and have GTPase activity [74-77].  
 The signaling pathways involving heterotrimeric G proteins in A.thaliana were 
shown mainly by analyses on mutant plants. The phenotypic differences in the absence 
or with the overexpression of the subunits are well characterized for A. thaliana and 
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O.sativa [78]. These studies  point to involvement of G proteins in important plant 
processes such as regulation of ion channels (stomotal regulation and drought stress), 
cell division, seed germination, plant growth and development and pathogen response 
which are regulated by plant hormones abscisic acid (ABA), auxin, brassinolide, 
gibberellin [78-81], ethylene, salisylic acid and jasmonic acid [82]. Many other 
signaling pathways including; light [73, 83], sphingolipid [84], oxidative stress response 
to ozone [85] and response to metal toxicity [86] also appear to be mediated by plant 
heterotrimeric G proteins. Furthermore the presence of heterotrimeric G protein 
subunits in diverse plant species highlights their importance in plant systems [2]. 
2.3.1 GPA1 
 GPA1 is detected in all organs and cell types, being most abundant in vegetative 
tissues including leaves and roots, less in floral stems and least in floral buds and floral 
meristems [87]. Results of localization studies of Gα are consistent with the classical 
heterotrimer model where the protein immunolocalizes at the PM and ER membrane 
[88]. 
 GPA1 is encoded by a 1149 bp gene resulting in a protein of 383 amino acids, 
corresponding to a molecular mass of 44,482 Da. GPA1 is 36% identical to rat Gαi1-3 
and bovine rod transducin (Gαt) at the amino acid level [3]. 
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Figure 2.4: Unrooted tree from CLUSTALW alignment of all human Gα and GPA1.  
  GPA1 is more similar to Gi and Gt family. 
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Figure 2.5: CLUSTALW alignment of human Gαi family members and GPA1. 
Completely conserved (blue), identical (green) and conserved domains (bold face) are 
shown. Important residues are numbered and indicated in text. 
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 Multiple alignment with all human Gα shows that GPA1 is most similar to Gαi 
family (Figure 2.4). The heterotrimeric Gα specific residues and motifs are conserved in 
GPA1 (Figure 2.5); palmitoylated cysteine (2), Gβγ contact sites (3), P-loop (4), RGS 
contact site (5) and nucleotide binding residues (7). The critical residues for GTP 
hydrolyis are also identical in GPA1, arginine and glutamine (6). Considering the 
conserved residues GPA1 is most similar to Gαi subfamily and similarity results from 
the Gαi subfamily specific N-terminus myristoylation motif; glycine (1) and serine (1), 
GoLoco binding residues (9) and within this subfamily the absence of the carboxy-
terminal cysteine (8) is unique to only Gαz, which is known to play a role in cell 
proliferation and death via its control of potassium channels [89]. The evolutionary 
connection between plant and mammalian Gα was investigated using bioinformatic 
tools and plant Gα is found to be descended from Gαo which was predicted to be the 
Gα ancestor [90]. All residues of GoLoco motif are not conserved in GPA1, which is a 
good indicator that plants have different effector proteins possessing GDI activity. 
Switch regions and putative receptor binding sites are underlined in Figure 2.5 and these 
are not fully conserved as expected. 
 There is limited literature on recombinant expression of plant Gα subunits. 
Cloning of GPA1 has been reported by Wise et al., [76] and GPA1 was produced from 
E.coli in the presence of an arginine tRNA encoding plasmid with a yield of 1-2 mg per 
L culture. The recombinant protein bound 0.3 mol GTPγS / mol protein with an 
apparent Kd of 0.34 nM assuming one binding site. Recombinant RGA1 was produced 
from E.coli and there are two significantly different kcat values reported; 0.44 min-1 
[75] and 0.0075 min -1 [74]. The first kcat was calculated from the apparent binding 
constant (0.36 nM) and Mg+2 was not required for GTP binding [75]. In another study 
GPA1 was expressed with an N-terminus 6 his tag in E.coli and purified protein had a 
very high GTP binding rate, 1.4 min-1 and 14.4 min -1 as shown by radioactive and 
fluorescent GTPγS probes respectively. The kcat was reported to be 0.12 min-1 and the 
bound GTPγS was 0.91 mol GTPγS/ mol protein and GPA1 was shown to prefer GTPγS 
over GDP in a 5 minute nucleotide competition assay. According to these values the 
authors suggest that GPA1 has higher affinity to GTP over GDP and is found mostly as 
GTP bound due to its low GTPase activity [77].  
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 RGA1 with mutations at active site arginine (R191L) or glutamine (Q223L) were 
shown to be GTPase dead (constituvely active) but they retained GTP binding ability 
[91]. Q222L mutant of GPA1 was also shown to be constitutively active. [92]. Total 
protein was isolated from Arabidopsis seedlings, native, overexpressing GPA1 and 
overexpressing Q222L GPA1 and applied to gel filtration column. The fractions were 
detected with α-GPA1 antibody and most of the protein was eluted as oligomers with 
molecular mass higher than 45kDa; even for the constituvely active form [93]. This may 
imply that GPA1 forms oligomers in vivo, with other proteins and/or itself.  
 There is no direct experimental evidence showing GPA1 or any other plant Gα is 
myristoylated or palmitoylated upto date. As indirect evidence, a peptide consisting of 
the N-terminal 8 residues of GPA1 was synthesized and 2nd amino acid glycine was 
shown to be N- myristoylated by A.thaliana myristoyl transferase (AtNMT1) by an in 
vitro spectroscopic assay [94]. The putative lipid modifications sites; G2 and C5 were 
mutated and CFP (Cyan Fluorescent Protein) fusion single or double mutants were 
localized both on PM and cytosol, G2 mutants being more cytosolic. In the same study 
the Q222L mutant was localized to PM similar to GPA1 [95]. These results imply that 
GPA1 has sites for both myristoylation and another molecule (not proved to be 
palmitate) which increase the proteins affinity to PM.  
2.3.2 AGB1 and AGG1/AGG2 
 AGB1 is encoded by a 1134 bp gene resulting in a protein with 377 amino acids; 
~41 kDa. AGB1 contains the WD-40 domains and share 45% identity with mammalian 
Gβ subunits (Figure 2.6 ). 
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Figure 2.6: CLUSTALW alignment of human and arabidopsis Gβ protein sequences. 
Completely conserved (blue), identical (green) and WD repeats (bold face) are shown. 
Residues numbered are involved in contacts with Gγ (1), Gα switch regions (2) and Gα 
N-terminus; highlighted residues are similar but not identical to human residues. 
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 Arabidopsis Gγ subunits AGG1 (98–aa, 10. 8 kDa) and AGG2 (100-aa, 11.1 kDa) 
both contain structural features conserved in all known G protein γ subunits; including a 
prenyl binding site a (CAAX) box on their C-terminus. AGG1 and AGG2 have 47% 
amino acid sequence identity and both proteins have ~50 % sequence similarity to 
human Gγ (Figure 2.7). 
 
 
Figure 2.7: CLUSTALW alignment of human gamma subunits, AGG1 and AGG2. 
The residues involved in hydrophobic contacts with Gβ are numbered with 1 and arrow 
shows residue involved in hydrogen bonding with Gβ. The prenylated cysteine and the 
following AAX are numbered with 3. The unusual C of AGG2 is numbered 2.  
 
 AGG1 and AGG2 have the CAAX motif in their C-termini, which could be sites 
for prenylation. In vitro geranyl geranylation confirmed that both proteins are 
prenylated and mutating the cysteine prevented the modification. Furthermore cysteine 
95 of AGG2 (directly upstream of prenylation site) was proposed to be a target for 
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palmitoylation; as both mutating this residue and incubating with a palmitoylation 
inhibitor resulted in cytosolic localization of YFP fusions in tobacco leaves [96]. 
 Both AGG1 and AGG2 were identified from yeast two hybrid screens using 
AGB1 as bait. In vitro interaction was confirmed between AGB1 (in vitro translated and 
radioactively labeled) and AGG1/AGG2 (GST fused) by the presence of radiaoactivity 
after purification from glutathione beads. However in these papers analysis of GST 
fusion proteins neither by SDS-PAGE nor western blots is shown [5, 6]. 
 The tobacco Gβ was shown to be localized on PM and was also detected in 
purified nucleus fractions [97], AGB1-CFP fusion was detected in both intracellular 
membrane and plasma membrane fractions of Arabidopsis leaves [98]. YFP-AGG1 was 
localized to PM in Arabidopsis protoplasts in both the presence and absence (agb1 null 
mutant line) of AGB1, whereas YFP-AGB1 was localized to both PM and cytosol. 
AGB1 was completely localized to PM when AGG1 was coexpressed on the same 
expression vector. FRET results show that AGB1 and AGG1 interact on PM [99]. In 
another study YFP-AGG1 was localized on both PM and Golgi, whereas YFP-AGG2 
was completely localized to PM in cowpea protoplasts. The number of CFP-AGB1 
expressing cells was higher when either Gγ was coexpressed and C95S mutant YFP-
AGG2 was shown to interact with CFP-AGB1 by FRET [95]. All these results support 
that Gβ and Gγ can interact, before lipid modification and the dimer is translocated to 
PM. 
 Promoter::GUS analysis was done for AGB1, which exhibited ubiquitous 
expression in vegetative organs, and expression in stamens, stigma and the abscission 
zone of the floral organs. AGG1 expression was in apical meristem, leaves, mature 
roots, the abscission zone of the floral organs and stamens; and AGG2 was detected in 
vegetative organs, including meristematic tissues, leaves and the roots [100]. Quantative 
PCR analysis showed that both GPA1 and AGB1 has higher levels of expression in 
roots as compared to shoots in A. thaliana seedlings[79]. 
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2.3.3 Signaling Components 
 Although mammalian heterotrimeric G proteins are well characterized, studies on 
plant systems are limited. Recently two important heterotrimeric G protein signaling 
components were identified. The search for 7 TM domain proteins in A. thaliana 
genome resulted in only two proteins, a putative plant GPCR protein, G-Coupled 
Receptor1 (GCR1) and an unusual Regulator of G-protein Signaling protein (AtRGS1). 
The function of GCR1 as a G protein coupled receptor was suggested based on the 
evidence of in vitro interaction of the G protein α subunit with the receptor [101]. 
Studies with mutant plants reveal that GCR may have both heterotrimer dependent and 
independent functions [102]. A ligand for GCR1 could not be identified yet. The unique 
regulator of G protein signaling protein, AtRGS1, was shown to interact with 
Arabidopsis GPA1, to accelerate its intrinsic GTPase activity, and thereby modulate cell 
proliferation [83]. Furthermore AtRGS1 was shown to be involved in sugar and ABA 
signaling in seed germination [103] whereas GCR1 was shown to be involved in cell 
cycle [104, 105], brassinosteroids and gibberellins [102] and ABA signaling in seed 
germination [106].  
 AtRGS1 was shown to physically interact with GPA1 by in vitro GST pull down 
assay, with higher affinity to AlF4
-
 bound form than both GDP and GTPγS bound forms. 
For this the C-terminal RGS box of AtRGS1 was produced as an N-terminal GST 
fusion in E.coli, and low amount of protein was reported to be soluble [107]. The 
presence of GST-RGS increased the GTPase activity of GPA1. AtRGS1 was also 
shown to interact with both GPA1 and Q222L GPA1 in yeast complementation assays. 
The full length AtRGS1 fused with GFP was shown to be localized on PM of 
Arabidopsis protoplasts [83] and the interaction was also shown with FRET in 
Arabidopsis root PM [77]. 
 Two interesting Arabidopsis proteins were recently identified, which were named 
as GTG1 and GTG2. These proteins are localized in plasma membrane, have predicted 
8-10 transmembrane domains and have GTP binding / hydrolysis activity, with a higher 
preference to GDP than GTP. The involvements of GTG1 and GTG2 in ABA signaling 
was shown with mutant studies and in vitro binding assays and thus are proposed to be 
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ABA receptors. Furthermore constituvely active (GTPase deficient) GPA1 was shown 
to interact and reduce GTPase activity of these proteins [92]. 
 Although RGS and GTG1/2 have predicted transmembrane domains, these 
proteins are not directly verified to be receptors. The presence of receptor and regulator 
proteins raises the possibility that the mechanism of action of the heterotrimer in plants 
is similar to that observed in mammalian system, but it is obvious that there are 
additional mechanisms significantly different from the mammalian systems, which may 
be heterotrimer independent. 
 There are a limited number of possible effectors identified in plants. One of them 
is phospholipase D (PLD) and was shown to be activated during ABA inhibition of 
stomatal inwardly rectifying K+ channels in Vicia faba guard cells and barley aleurone 
[108, 109]. PLD in membrane preparations from barley aleurone is stimulated by ABA 
also in vitro, and GTPγS, an activator of G protein α subunit, was shown to mimic the 
effect of ABA on PLD. Thus PLD activation by ABA probably involves the active G 
protein as an essential component in barley aleurones [110].This raises the possibility 
that PLDα1 can be a GAP and this was supported by the increased GTPase activity of 
GPA1 in the presence of PLD [111]. The other putative effectors are Atpirin1, 
prephenate dehydratase (a cytosolic enzyme involved in regulation of the shikimate 
pathway), and THF1 (a protein located in plastid membranes) [112]. 
 
2.4 The plant heterotrimer 
 The A. thaliana heterotrimer structure was modeled by Ullah et al., [113] using 
the high resolution structure 1GOT as template for homology modeling. A similar 
structure at the Gα/Gβ interface and the Gβγ dimer structure of the model and the 
crystal structure (Figure 2.8) suggest that plant heterotrimeric G protein exists and 
activation by nucleotide exchange may follow the mammalian pattern by means of 
subunit binding/dissociation. 
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Figure 2.8: 1GOT (A) and the homology modeled Arabidopsis complex (B) [113]. 
      The α, β and γ subunits colored blue, purple and gold, respectively. 
 
 There are various reports that suggest interaction of subunits both in vivo and in 
vitro. GPA1 and AGB1 was shown to interact by yeast complementation assay [114], 
GPA1 was shown to interact with dimer, but not with individual subunits in FRET 
assays and GPA1 did not co-immuno-precipitate with AGG1 in the absence of AGB1 
[99]. The heterotrimer and subunits were found to be in large complexes with a 
molecular mass higher than that of estimated for heterotrimer in Arabidopsis PM 
fractions using a native –SDS-PAGE-western detection approach. GPA1 antibody 
reacted with complexes of variable size, but dominantly there were two bands, one with 
a very high molecular mass (HMM) and the smallest which could be representing the 
monomeric mass. The addition of GTPγS to PM fractions resulted in a decrease in the 
amount of HMM but did not result in a complete dissocation into a monomeric form. 
Similarly AGB1 was found in HMM using a CFP antibody in CFP-AGB1 expressing 
leaves [99]. The exact mass of those HMM complexes and assumed monomers are not 
known since the first electrophoretic separation was done on Native-PAGE. A similar 
study was done with rice leaf plasma membranes, the solubilized PM proteins were 
applied to a gel filtration column and the fractions were analyzed with rice subunit 
specific antibodies. All there subunits were detected in fractions with mass 400-700 
kDa, but RGB1, RGG1 and RGG2 were more in fractions with size 60-200 kDa. 
Addition of GTPγS both during PM isolation and gel filtration resulted in elution of all 
subunits in complexes with mass with 100-200 kDa and RGB1, RGG1/2 isolated from 
null rga mutant  rice had a similar pattern. When the GTPase deficient Q223L mutant 
RGA was introduced on null rga background, all subunits were again found in HMM 
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complexes although the amount was lower as compared to that of wild type rice. These 
results suggest that heterotrimer forms in plants together with yet unidentified proteins 
and subunit dissociation may not be the case for plant heterotrimeric G proteins. The 
observation of plant Gα being localized with other proteins even in the constituvely 
active form may suggest that effector interactions also take place in plant membrane.  
 Plants have reduced numbers of each heterotrimeric G protein component 
identified until now. The number of Gα, Gβ and Gγ will not be increased as rice and 
Arabidopsis genomes do not have any other putative isoforms. There may be other 
signaling proteins substituting the heterotrimer or the plants can manage with this low 
complexity of specifity. The heterotrimeric G proteins in mammalian systems function 
in several pathways and mainly these pathways lead to response to light (vision), odour 
and taste perception or are involved in neural transmission and muscle contraction. 
Mammalian systems have a diverse set of genes/proteins that work specifically in each 
tissue. Plant systems, on the other hand, have less overall complexity in terms of tissue 
types, cell communication and signaling. The diverse pathways that heterotrimeric G 
proteins are involved in mammalian systems can be converted to plants by two general 
mechanisms, hormone perception and regulation of ion channels. Although we may not 
yet have enough information about the complexity of plant signal transduction 
pathways, hormone sensing (ABA, auxin, GA, ethylene, JA) and ion channel regulation 
(stomatal regulation, pathogen response) can be regulated by a simpler repertoire of 
heterotrimeric G proteins, without the necessity of subunit specificity. The tissue 
specific behavior of GPA1 and AGB1 with response to same hormone/signal was 
shown especially in regulation of ion channels and cell division [81]. This may imply 
that the response of signaling is more dependent on the tissue specific effectors and not 
the heterotrimer subunits. 
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2.5 Biophysical Approach 
2.5.1 Circular Dichorism Spectropolarimetry 
 Circular Dichroism measures the difference in absorbance of right and left 
circularly polarized light. The spectra are a combination of optical absorption (electric 
dipole moment) and asymmetry (magnetic dipole moment) and thus secondary structure 
elements have signature absorbances in CD spectra. CD is especially sensitive for α 
helical secondary structure. α helices have two distinct minima at 208 nm and 222 nm, 
and a maximum at 192 nm. Spectra of disordered structures have a minima ~200 nm 
and β-sheets have a minima at 217 nm which is very broad and a maxima at 193 nm 
(Figure 2.9). The far–UV region (180-230 nm) absorption is related to backbone 
conformational changes and the near-UV region is dominated by the absorption of 
aromatic amino acid side chains. The far-UV region is important for analysing 
secondary structure features, but below ~200 nm buffer components significantly 
contribute to signal which prevents a clear characterization [115]. The CD data is 
represented as ellipticity (θ) instead of absorbance. Protein concentration and cuvette 
path length are important parameters that affect ellipticity so these are also included in 
data processing and final data is represented as mean residue ellipticity, with units deg 
cm2 dmol-1. A polypeptide composed of only α helical secondary structure will give a 
mean residue ellipticity of ~-30.000 deg cm2 dmol-1 at 222 nm, so a protein will have 
less ellipticity with a higher value [116]. A simple way of estimating the α helices is the 
ratio of intensities of two negative bands, θ208 nm/ θ222 nm , which should be ~1 for mainly 
helical proteins. This ratio becomes < 1 for peptides with coiled-coil interactions and is 
> 1 if α-helical secondary structure formation occurs [117]. The near UV absorption 
gives information about the tertiary structure of the protein, as the conformations 
(asymmetry) of aromatic side chains depend on their local environment. Phenylalanine, 
tyrosine and tryptophan has absorption around 250-260 nm, 270-280 nm and 280-300 
nm respectively (Figure 2.10), yet the signals from Tyr and Trp may overlap [116]. 
Unfolding results in disruption of the local environment and thus the asymmetry of 
these aromatic residues and CD signals are greatly reduced /lost. Molten globule or 
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partially folded structures display very weak / no signals at near-UV region, although 
the far-UV spectra is not generally affected. Thus, the presence of near UV signals is a 
good indicator that protein retained a well defined tertiary fold. The near-UV CD 
spectra is sensitive to small changes in overall structure resulting from solvent 
conditions or protein-protein interactions [115]. Near- UV CD mean residue ellipticities 
for the aromatic amino acid side chains should be generally lower than 200 deg cm2 
dmol-1 [116]. 
 
 
Figure 2.9: Far-UV CD spectral analysis of secondary structural elements. 
α-helix (−−), anti-parallel β sheet (− −), type 1 β turn (⋅⋅⋅⋅⋅), extended 
31-helix (++) and irregular structure (- - - -), figure taken from [116]. 
  
 
Figure 2.10: The near UV CD spectrum for type II dehydroquinase from 
Streptomyces coelicolor. Figure taken from [116]. 
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2.5.2 The use and detection of detergents in membrane protein purification 
 The use of detergents is essential for solubilization integral membrane or 
transmembrane protein solubility and stability, but the presence of detergents generally 
lead to experimental difficulties. The main reason to use a detergent during a membrane 
attached/integrated protein is to try to mimic the physical properties of the membrane 
bilayer where protein structure is maintained [118]. It is important to verify the 
functional activity and structural integrity of proteins in the presence of detergents. 
Non-ionic detergents with medium / long alkyl chains are generally the choice, since 
zwitterionic detergents tend to denature proteins [119]. The detergent concentration 
used is an important parameter to be optimized, to ensure complete solubility of protein 
a concentration higher than critical micelle concentration (cmc) of the detergent should 
be used. Above cmc, the detergent will form micelles and in turn result in the formation 
of protein micelle complex (PMC). It is important to find the optimal concentration 
since use of very high amount of detergent can lead to removal of essential lipid moities 
from the protein and protein aggregation. Addition of phospholipids was shown to 
improve the stability of PMC in some cases. Above cmc the micellar-monomeric form 
equlibrium will be reached and the amount of free monomer will be constant. The cmc 
of a detergent may be effected by temperature and ionic strength of the buffers used so 
requires careful inspection. Aggregation number refers to the number of detergent 
molecules in the detergent micelle and depends on the molecular mass of the 
monomeric form of the detergent. Detergents with high aggregation number will result 
in formation of high molecular mass PMC and thus will interfere with the experimental 
procedures that are used for protein size measurements [118]. The mode of detergent-
protein binding depends on the nature of both components, detergents tend to form a 
prolate monolayer ring around the transmembrane region of TM proteins whereas a 
micellar binding mode is assumed for less hydrophobic proteins that are integrated into 
membrane with small regions [119]. 
 The presence of detergent micelles in protein solution can be experimentally 
verified by different techniques, fourier transform infrared spectroscopy (FT-IR), thin 
layer chromatography and nuclear magnetic resonance (NMR). 1H proton NMR was 
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shown to be a powerful tool to monitor the presence and the amount of detergent that 
remains after protein purification procedures [120].  
2.5.3 Small Angle Solution X-ray Scattering 
 Small angle solution X-ray scattering (SAXS) results fom the contrast of electron 
density of a macromolecular solution distributed isotropically in a solvent with uniform 
electron density. The macromolecules in solution scatter the incident beam at an angle 
2θ (scattering angle) and the intensity of the scattered beam, I(s) is proportional to the 
concentration of the molecules. In a monodisperse solution the intensity will reflect the 
scattering from a single particle averaged over all directions. The concentration of the 
molecule determines the magnitude of the signal. SAXS provides information about the 
molecular mass (MM), radius of gyration (Rg), hydrated volume and maximum 
intramolecular distance (Dmax) [121].  
 Low resolution (1-2 nm) structural models can be built from SAXS data by fitting 
the electron density information into dummy residues ab initio . The availability of high 
resolution structural models (X ray crystallography atomic models) makes it possible to 
combine information about subunits of a multidomain protein or to determine the 
physiological oligomeric state of a protein in solution. For this the scattering from 
atomic models are calculated using a software (CRYSOL) and the resulting scattering is 
fitted on the experimental scattering (SAXS data) using a simulated annealing software 
(SASREF). SAXS data can also be used to model the missing portions of an atomic 
model [121]. 
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CHAPTER 3 
3 MATERIALS AD METHODS 
3.1 Materials 
3.1.1 Chemicals 
 Chemicals that are used are listed in Appendix A. 
3.1.2 Molecular biology kits 
 Molecular biology kits that are used for DNA isolation, gel extraction, DNA 
cleanup/desalting, cloning /expression, protein purification, protein quantification and 
biophysical characterization are listed in Appendix B. 
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3.1.3 Other materials  
 Details of materials including, cells, plasmids, DNA markers, protein markers, 
purification media, enzymes and enzyme buffers are listed in Appendix C. Maps of 
plasmids are given in Appendix E. 
3.1.4 Equipment 
 Equipment used for general laboratory procedures are listed in Appendix D. 
3.1.5 Genes 
 The genes were amplified from plasmids purchased from TAIR. The details of 
plasmids are given in Table 3.1. 
 
Table 3.1 Plasmids purchased from TAIR 
Target 
gene Vector Resistance Source Accession 
Vector 
size, bp 
Gene 
size, bp 
Total 
size, bp 
AGB1 
lambda 
ZipLox amp DH10B 162P20 4307 1134 5441 
AGG1 pUNI51 kan PIR1 U82042 2551 297 2848 
AGG2 pUNI51 kan PIR1 U84515 2551 303 2854 
3.1.6 Buffers and solutions 
 Standard buffers and solutions used in cloning and molecular manipulations were 
prepared according to the protocols in Sambrook et al., 2000 [122]. 
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3.1.7 Culture medium 
a. Escherichia coli 
 LB Broth (Lenox L broth) containing tryptone, yeast extract and NaCl from 
Sigma (L-3022) was used for liquid culture of bacteria. 20 g of LB Broth was used for 
preparation of 1 L liquid medium. The liquid medium was autoclaved at 1210 C for 15 
min. before using. Ampicillin at a final concentration of 100 µg/ml was added to liquid 
medium for selection. 
 LB Agar (Luria Bertani, Miller) containing tryptone, yeast extract, NaCl and agar 
from Sigma (L-3147) were used for preparation of solid medium for the growth of 
bacteria. 40 g of LB Agar was used for preparation of 1 L of solid medium. The 
appropriate amount of LB Agar is dissolved in a corresponding amount of deionized 
water for autoclaving at 1210 C for 15 min. Autoclaved medium was poured to Petri 
plates (~20 ml/plate) after cooling down to room temperature. Ampicillin at a final 
concentration of 100 µg/ml was added when antibiotic selection was required. 
b. Pichia pastoris 
 YPD was used for liquid culture of yeast. The medium contains 1% yeast extract, 
2% peptone and 2 % dextrose. Yeast extract and peptone were dissolved in water and 
autoclaved at 1210 C for 15 min. Sterile dextrose was added before use. Zeocin, at a final 
concentration of 100 µg/ml was added when antibiotic selection was required. 
 BMGY, buffered complex glycerol medium, was used for biomass generation 
before induction of expression. This medium contains 1% yeast extract, 2% peptone, 
100 mM potassium phosphate, pH 6.0, 1.34% YNB (yeast nitrogen base), 4 10-5 % 
biotin and 1% glycerol. Yeast extract and peptone were dissolved in water and 
autoclaved at 1210 C for 15 min. Other components were separately either autoclaved or 
filter sterilized and added to the yeast extract and peptone mixture. 
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 BMMY, buffered complex methanol medium, was used for induction of 
recombinant proteins. This medium is similar to BMGY, except that there is 1 % 
methanol instead of 1% glycerol. 
 YPD agar was used for growth of yeast on solid media. The medium contains 1% 
yeast extract, 2% peptone, 2% agar-agar and 2 % dextrose. Yeast extract and peptone 
was dissolved in water, agar was added and autoclaved at 1210 C for 15 min. After 
cooling below 600 C sterile dextrose and zeocin at a final concentration of 100 µg/ml, 
when necessary, was added and medium was poured to Petri plates (~20 ml/plate). 
3.1.8 Sequencing 
 Sequencing service was commercially provided by SEQLAB (Germany), 
TOPLAB (Germany), Iontek (Turkey) and an in-house sequencer was also used. 
3.2 Methods 
3.2.1 Culture growth 
a. Escherichia coli 
 E. coli cells were grown overnight (12-16h) at 37 °C shaking at 300 rpm in LB 
Broth (Lenox L broth) prior to any application. LB Agar (Miller’s LB agar) solid media 
was used as unselective and selective solid medium for bacterial growth at 37 °C. The 
protocols of Sambrook et al., [122] were used for liquid and solid culture growth as well 
as other applications including competent cell preparation and preparation of  glycerol 
stocks. 
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b. Pichia pastoris 
 P. pastoris cells were grown overnight at 30 °C shaking at 250 rpm in YPD 
medium for general purposes. For biomass generation they were grown in BMGY 
medium for 48 hours before induction. Induction was performed in baffled flasks for 48 
hours using BMMY medium, with 1 % methanol addition at the 6th and 24th hour. 
3.2.2 PCR 
 Reaction volumes and final concentrations of PCR components were based on 
manufacturer’s recommendations (Fermentas). Annealing temperatures of primers were 
estimated according to manufacturer instructions (Fermentas). 
a. Template Isolation 
 Plasmids from TAIR were isolated with Qiaprep® Spin Miniprep Kit (250) 
according to the manufacturer’s instructions (QIAGEN). 
b. Amplification  
PCR amplifications of AGB1 and AGG1 were carried out using the thermal cycle 
conditions given in Table 3.2. 
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Table 3.2: Thermal cycle conditions for AGB1, AGG1 and AGG2. 
Gene Vector 
Initial  
denat. Cycle (30) 
Final  
elongation 
  94 °C denaturation annealing elongation 72 °C 
AGB1 pGEX-4T-2 3 min 94o C 1 min 
65 °C 1min 
5.5 °C gradient 72 °C 1min 10 min 
AGG1 pGEX-4T-2 3 min 94o C 1 min 
65 °C 1min 
5.5 °C gradient 72 °C 1min 10 min 
AGB1 pQE-80L 2 min 94o C 1 min 58 °C 1 min 72 °C 2 min 7 min 
AGG2 pQE-80L 3 min 94o C 1 min 53 °C 1 min  72 °C 1min 10 min 
 
 PCR products were purified directly with Qiaquick® PCR Purification Kit (250) 
(QIAGEN). 
3.2.3 Cloning 
 General molecular biology were done according to Sambrook et al., [122]. 
a. Cloning using pGEX-4T-2 
 10 µl of each PCR product and 400 ng of pGEX-4T-2 vector were double digested 
with the enzymes EcoRI and XhoI as recommended by the manufacturer (Fermentas). 
The digested PCR products and the vector were precipitated together with ethanol. The 
precipitated pellets were resuspended in water, T4 DNA ligase and ligation buffer as 
recommended by the manufacturer (Fermentas).  
b. Cloning using pQE-80L 
 20 µl of AGG2 and 5µl of AGB1 PCR product and 2000 ng of pQE-80-L vector 
were double digested with the enzymes BamHI and KpnI as recommended by the 
manufacturer (Fermentas). The linearized vector was cleaned by phenol extraction and 
dephosphorylated using Shrimp Alkaline Phosphatase according to the manufacturer’s 
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protocol (Fermentas). The digested PCR products and the vector were precipitated with 
ethanol and ligation was done as given in previous section. 
3.2.4 Transformation 
 The ligation products were introduced into chemically competent E.coli TOP10F’ 
cells. Briefly, 50 µl of competent cells were mixed with different volumes of the 
ligation products, the mixtures were incubated on ice for 30 minutes followed by heat 
shock, 2 minutes at 42 °C. Warm LB medium (800 µl) was added to the cells which 
were grown at 37 °C for 1 hour with shaking. Finally, cells were plated on selective LB 
agar containing 100 µg/ml ampicillin. The positive colonies appeared after overnight 
growth at 37 °C. 
3.2.5 Agarose gel electrophoresis 
 1 X TAE (40 mM Tris-acetate and 1 mM EDTA pH 8.0) buffer was used for 
preparation of 1% agarose gels. Gels were run at constant voltage (100 mV) for 45 
minutes. DNA was visualized by including 0.005% ethidium bromide in the gel during 
its preparation. 
3.2.6 Verification and Sequencing 
 Colonies grown on selective medium were analyzed by colony PCR using gene 
specific primers. Plasmids were isolated from the PCR verified colonies and sent for 
sequencing.  
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3.2.7 Expression screen for GST-AGB1 and GST-AGG1 
 The verified constructs were isolated from TOP10F’ cells and introduced into 
BL21(DE3) and BL21(DE3)RIPL expression cells. Cells were induced with different 
concentrations of IPTG at an optical density of ~0.6 and grown at different temperatures 
for optimization of expression. Samples of 1.5 ml volume were taken at different time 
points to monitor growth and analyzed by SDS-PAGE analyses as described below. 
 
a. Cell lysis for cytoplasmic soluble protein  
 Cell pellets were resuspended in 25 µl lysis buffer (1 mg/ml lysozyme, 25 mM 
Tris-HCl pH 8.5, 10 mM EDTA and 50 mM glucose). An equal volume of triton buffer 
I (25 mM DTT, 100 mM NaCl, 200 mM MgCl2 and 0.8 % Triton X-100) was added to 
well-resuspended pellets. Solubilized cells were centrifuged for 10 minutes at 13,000 
rpm in a microfuge at 4 °C. Supernatants were taken to a clean tube and mixed with 
SDS loading dye to be analyzed on SDS-polyacrylamide gels. Insoluble pellets were 
stored for inclusion body solubilization. 
 
b. Solubilization of Inclusion Bodies 
 Insoluble pellets were resuspended in Triton Buffer II (50 mM Tris HCl, pH 8.0, 
10 mM EDTA, 100 mM NaCl and 0.5 % Triton X-100) and incubated for 5 minutes at 
room temperature. The resuspended pellets were centrifuged at 4˚C, 13,200 rpm for 15 
minutes. Supernatants were stored in fresh tubes and are referred to as cell lysate 2. The 
pellet was resuspended in 100 µl Inclusion-body Solubilization Buffer I (50 mM Tris 
HCl, pH 8.0, 1mM EDTA, 100 mM NaCl, 8 M urea and 0.1 mM PMSF). The solution 
was incubated at room temperature for 1 hour and 900 µl of Inclusion-body 
Solubilization Buffer II (50mM KH2PO4, 1mM EDTA, 50mM NaCl) were added after 
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incubation. After 30 minutes of incubation at room temperature, the pH of the solution 
was decreased to 8 by addition of 12M HCl. After another 30 minutes of incubation at 
room temperature, the solution was pelleted at room temperature, 13200 rpm for 15 
minutes. The supernatant, urea soluble inclusion body fraction was stored in fresh tubes. 
The pellet is the urea insoluble inclusion body fraction. Samples were analyzed on SDS-
polyacrylamide gels. 
3.2.8 Expression screen for RGS-his-AGB1 and RGS-his-AGG2 
 The verified constructs were isolated from TOP10F’ cells and introduced into 
TOP10 and Rosetta 2 (DE3) cells. These were screened for recombinant protein 
expression at different temperatures and with different IPTG concentrations. Protein 
expression at different time points was monitored by SDS-PAGE with coomassie 
staining and western blot detection. Cell lysis for expression screening was carried out 
as described above under “Cell lysis for cytoplasmic soluble protein” 
3.2.9 Large Scale Expression from E.coli cultures 
 Cells were grown in LB medium with 100 µg/ml ampicillin at 37 °C for 16-18 
hours and inoculated into fresh medium with ampicillin to give a final OD600 of ~0.2. 
Fresh cultures were grown at the indicated temperature and IPTG was added at OD600 
~0.6. After harvesting, the pellets were stored at -80 °C until purification. 
3.2.10 Purification of recombinant AGB1 and AGG2 
 The compositions of buffers are given in chapter 4.8 for ease of following the 
results. During all purification procedures Complete EDTA free protease inhibitor 
Cocktail tablets (EFPI) (Roche) were included in lysis buffers (1 tablet (50X)/50 ml).  
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a. Batch Affinity Purification 
 All steps were performed at +4 ° C. Cells were rapidly thawed and resuspended in 
lysis buffer, at a ratio of 5 ml buffer / 100 ml culture. Resuspended cells were lysed by 
sonication with a cycle of 8 seconds pulse and 9 seconds pause. Total sonication time 
was 4-10 minutes depending on the lysate volume. In order to solubilize the 
membranes, lysate was incubated with 1% Triton X-100 for 30 minutes with continuous 
rotation. Lysate was cleared from cell debris by high speed centrifugation, 30 minutes at 
30,000g and supernatant was transferred to a fresh tube. Cleared lysate was equilibrated 
with purification buffer if necessary. 
 Ni-NTA- agarose was washed with water and equilibrated with purification buffer 
before binding. Briefly the resin slurry was loaded to a 15 ml conical tube and 
centrifuged at 900g for 5 minutes. Supernatant was discarded and resin was resuspended 
in an equal volume of water. After incubation for 5 minutes with continuous rotation, 
centrifugation was repeated. The same procedure was followed with purification buffer 
and the resin was resuspended in purification buffer after the final centrifugation step. 
 Cleared lysate was combined with resin in a 50 ml conical tube and incubated for 
60 minutes with continuous rotation for binding. Solution was centrifuged at 900g for 5 
minutes; the supernatant was saved as flow-through and resin was washed as described 
below. An equal volume of wash buffer was added to the resin and the slurry was 
loaded onto a 10 ml plastic column. Resin was washed 4 times with gravity using wash 
buffer. The wash buffer was made by addition of imidazole to purification buffer as 
indicated. An equal volume of elution buffer was loaded onto the column and proteins 
were eluted. The amount of imidazole in the elution buffers is indicated.  
b. Column Affinity Purification 
 Cells were lysed as described in batch affinity purification. All column 
purifications were performed using an AKTA Prime system (GE Healthcare) and 
HisTrap HP, 5 ml column (GE Healthcare). The column was pre-equilibrated with 
binding buffer and clear lysate was loaded onto it at a flow rate of 3 ml/min. The 
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column was washed with wash buffer using 8 column volumes (CV) and a linear 
gradient elution was done in 6 CV. Flow rates for wash and elution steps are indicated 
for each experiment in the results section.  
3.2.11 Large Scale Expression of GPA1-myc-his 
 The following procedure was adapted after several optimization trials, with details 
given in Chapter 4.1.  
 BMGY medium was inoculated with a single colony from a fresh YPD plate. 
Cells were grown until the culture reached an OD600 of 10 / ml. They were then 
inoculated into fresh BMGY medium and grown for 24 hours more. Harvested cells 
were resuspended in BMMY medium with a starting OD600 of ~10 / ml and 1% 
methanol was added at the 6th and 24th hour to maintain induction. Cells were harvested 
48 hours after induction and the pellets were stored at -80 °C until purification. 
3.2.12 Purification of recombinant GPA1 
a.  Affinity purification 
 Cells were lysed and cleared lysate was obtained at 4 °C as described below. 
According to our results P. pastoris was more efficiently lysed with zirconia beads (Bio 
Spec Products) than with glass beads but the efficiency of lysis was reduced after the 
beads were re-used 3 to 4 times (data not shown). Furthermore cell lysis in 250 ml 
chambers was less efficient than in 50 ml chambers in the Bead Beater (Bio Spec) cell 
breaker. Cell density was another parameter that affects lysis efficiency, the optimum 
ratio was found to be 72 for OD600 of cells/ lysis buffer volume. 
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• Column Affinity purification 
 The compositions of buffers are given in chapter 4.2.1 for ease of following the 
results. During all purification procedures Complete EDTA free protease inhibitor 
Cocktail tablets (EFPI) (Roche) were included in lysis buffers (1 tablet (50X)/ 50 ml). 
 Cells were rapidly thawed and resuspended in lysis buffer, at a ratio of 10 ml 
buffer / g pellet. All steps were performed at 4 ° C. Resuspended cells were lysed by 
beating with 0.5 mm diameter glass beads, with a cycle of 30 seconds beat and 30 
seconds pause, for 3 times, followed by 30 seconds beat and 1 minute pause for 4 times. 
Beating was done using a Bio Spec Bead Beater keeping the cells on ice throughout the 
procedure. Lysate was cleared from cell debris by high speed centrifugation, 10 minutes 
at 22,000g and supernatant was transferred to a fresh tube. 
 All column purifications were performed using an AKTA Prime system (GE 
Healthcare) and HisTrap HP, 5 ml GE Healthcare), column; pre-equilibrated with 
binding buffer. Cleared lysate was loaded onto the column and the column was washed 
for 8 CV using a peristaltic pump at a flow rate of 1 ml/min in the cold room. Flowrate 
and volume of elution are indicated in results section for each experiment. 
 
• Batch Affinity purification 
 Cells were rapidly thawed and resuspended in lysis buffer (50mM TrisHCl, pH 
8.0, 10mM MgCl2, 1mM EDTA, 5% glycerol, 2mM PMSF and EFPI), at a ratio of 10 
ml buffer /g pellet. All steps were performed at +4 ° C. Resuspended cells were lysed by 
beating using the Bio Spec bead beater as described above. Lysate was cleared from cell 
debris by high speed centrifugation, 30 minutes at 22,000g and supernatant was 
transferred to a fresh tube. The cleared lysate was equilibrated with purification buffer 
by incubating 5 minutes with 10X purification buffer (500 mM Tris-HCl, pH 8.0, 3 M 
NaCl, 100 mM BME, 1 mM PMSF, 20 mM MgCl2 and 200 µM GDP). The amounts of 
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imidazole were optimized throughout the experiments and the concentrations are given 
in Chapter 4.2.2. 
 Where necessary the membrane fraction was solubilized using a mixture of 
detergents. The pellet obtained after high speed centrifugation was resuspended in 10 ml 
lysis buffer, with fresh PMSF supplemented. The resuspension was centrifuged at 
13,000 rpm for 30 minutes and supernatant was discarded. The pellet was resuspended 
in 5 ml of TBS-5 % Triton X-100 and allowed shaking to aid solubilization. Finally, 2.5 
ml of TBS with 0.1% Lubrol PX, 0.1 % NP-40 and 1 mM DTT was added for complete 
solubilization of the membrane fraction. 
 Ni-NTA agarose was washed with water and equilibrated with purification buffer 
before binding as described in section 3.2.10. Cleared lysate was combined with resin in 
a 50 ml conical tube and incubated for 60 minutes under continuous rotation for 
binding. The solution was centrifuged at 900 g for 5 minutes; supernatant was saved as 
flow through and resin was washed as described below. An equal volume of wash 
buffer was added to the resin and the slurry was loaded to a 10 ml plastic column. The 
resin was washed with gravity for four times with two resin volume of wash buffer. 
Imidazole was added to purification buffer to make wash buffer, where indicated. 
Elution buffer was loaded onto the column and protein was eluted by gravity. The 
volume and imidazole amount of elution buffers and incubation time with elution buffer 
are indicated in Chapter 4.2.2. 
 
• Batch Affinity purification with detergent 
 Detergent type and concentration for individual purifications are indicated in 
Chapter 4.2.3. Cells were rapidly thawed and resuspended in lysis buffer (50mM 
TrisHCl, pH 8.0, 10mM MgCl2, 1mM EDTA, 5% glycerol, 2mM PMSF, EFPI, 50 µM 
GDP and detergent), at a ratio of 200 ml buffer per 20 g pellet. Resuspended cells were 
re-pelleted at 5086g for 15 minutes and the pellet was resuspended in 100 ml lysis 
buffer. All steps were performed at 4 ° C. Lysis was performed by beating as described 
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above, except with 0.5 mm diameter zirconia beads. Lysate was cleared from cell debris 
by high speed centrifugation for 30 minutes at 23,000g and the supernatant was 
transferred to a fresh tube. Cleared lysate was equilibrated by incubating 5 minutes with 
10X purification buffer (500 mM Tris-HCl, pH 8.0, 3 M NaCl, 100 mM BME, 1 mM 
PMSF, 50 mM MgCl2, 500 µM GDP, 200 mM imidazole and detergent). The wash 
buffer composition was 1X PB and elution buffer was composed of 1X PB with a final 
imidazole concentration of 300 mM.  
 Procedures for washing and equilibrating Ni-NTA agarose and binding were also 
carried as described above for the purification without detergent using 20 ml plastic 
column. Elution was repeated with 10 ml and 5 ml elution buffer respectively, making 
10 ml of E1 and E2 and 5 ml of E3. Ni-affinity elutions were either directly 
concentrated and/or buffer exchanged or stored at -20 ºC with 10 % glycerol until use. 
b. Concentrators: 
 Initially an Ultracel YM-30 membrane (Millipore) was used to reduce the volume 
of the protein solution, but the presence of glycerol in the sample resulted in protein 
loss. Vivaspin 20 Polyethersulfone Membrane 30,000 MWCO (Sartorius) concentrators 
did not result in any protein loss. Briefly concentrators were pre-rinsed with water and 
washed with anion exchange start or gel filtration buffer by centrifugation for 10 
minutes at 5000g. Ni-affinity purified GPA1 was concentrated by centrifugation at 
5000g until the desired volume was reached. Proteins were concentrated at 4 ºC using a 
Bioshield Windshielded Swinging Bucket Rotor (Thermo Scientific). 
 
c. Desalting: 
 Desalting was done at room temperature using a HiPrep™ 26/10 Desalting 
column (GE Healthcare) following the manufacturer’s instructions and the fractions 
were stored on ice until further use. 
 50 
d. Dialysis: 
 Dialysis was done in cellulose ester dialysis tubing; MWCO: 12,000-14,000 
(Cellu•Sep® T3 Membranes). Dialysis membranes were pre-equilibrated by boiling in 
distilled water and incubating in dialysis buffer at +4 ºC for several hours. Dialysis was 
done against 250 ml of buffer for a total of 3 hours with a buffer change with 1 hour 
intervals. Fresh 1 mM PMSF and 1 mM DTT were added to each buffer; where 
indicated. Dialysis was done overnight against 1 L, when the buffer was changed from 
Tris HCl to HEPES. 
 
e. Anion Exchange 
 Ni-affinity purified GPA1 samples were combined and centrifuged at 5000 rpm 
for 15 minutes at 4 °C. The elution pool was buffer exchanged to 50 mM TrisHCl, pH 
8.0; using either a desalting column or dialysis before loading onto an anion exchange 
column. Samples were concentrated using a concentrator unit prior to buffer exchange 
where indicated. 
 A Q Trap HP, 5 ml, anion exchange column was washed with NaCl elution buffer 
(50 mM Tris HCl, pH 8.0, 700 mM NaCl) and equilibrated with start buffer (50 mM 
Tris HCl, pH 8.0). A 50 ml Super loop (GE Healthcare) was also washed with start 
buffer, before filling in the sample. After loading, the column was washed at a flow rate 
of 3 ml/min with start buffer until the absorbance stabilized (~40 ml + sample volume). 
A linear gradient (0-700 mM NaCl in 25 ml) was applied for elution. 
 
f.  Size Exclusion chromatography 
 Ni-affinity purified GPA1 samples were combined and centrifuged at 5000 rpm 
for 15 minutes at 4 °C. The elution pool was concentrated using a concentrator unit. The 
buffer was exchanged where indicated using a desalting column. The concentrated 
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sample was centrifuged at 14,000 g for 10 minutes at +4 °C and loaded onto a gel 
filtration column (Sephacryl -200 HR or Sephacryl-300 HR) through a 2 ml loop. The 
compositions of the gel filtration buffers and flow rates are indicated in chapter 4.4. Gel 
filtration column calibrations were done as described by the manufacturer (GE 
Healtcare). 
3.2.13 SDS-PAGE 
 SDS-polyacrylamide gels (10%, 12% or 15%) were prepared according to 
Laemmli [123]. Samples of 20 µl, were prepared with SDS loading dye, boiled at 95 °C 
for 3 minutes and unless stated otherwise 10 µl were loaded into the wells. 2X, 3X or 
6X SDS loading dye was used depending on sample concentration. Non-denatured 
samples were prepared with 6X native loading dye and heat treated if indicated. Gels 
were run at constant current, 20mA, for 45-90 minutes depending on the acrylamide 
concentration. 1X Tris-Glycine-SDS (sodium dodecyl sulfate) buffer was used for 
polyacrylamide gel electrophoresis. Buffer contains 1.51 g. Tris base, 9.4g. Glycine and 
2.5 ml of 20% SDS in 500 ml. 
3.2.14 ative-PAGE /TCA Stain 
 Native polyacrylamide gels (3% stacking-8% separating) were prepared without 
SDS and gels were run in 1X Tris-Glycine buffer at constant volt; 80mV for 2 hours. 
Samples for native-PAGE were prepared with loading dye without reducing agent and 
were directly loaded without heat treatment. Gels were run with 80 mV for 2 hours. Gel 
was fixed in 12.5% TCA (trichloroacetic acid) for overnight. Next day fresch TCA was 
put on the gel and gel was photographed against a dark background. 
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3.2.15 Western blotting 
 SDS-polyacrylamide gels (10%, 12% or 15%) were blotted on PVDF membranes 
at 25 mA constant current for 2 hours at room temperature in transfer buffer (14.41 g. 
Tris base, 3.028 g. Glycine and 200 ml methanol in 1 L.). Blotted membranes were 
blocked with Qiagen blocking solution on an orbital shaker for 1 hour and incubated 
with an appropriate HRP conjugated antibody for 1 hour at room temperature. The 
membranes were treated with Pierce ECL Western Blotting Substrates (Pierce, Thermo 
Scientific) after washing with TBS-Tween and resulting signals were analyzed on CL-
XPosure Film (Pierce, Thermo Scientific). 
3.2.16 Protein Concentration Determination 
a. Bradford Assay 
 Bradford assay was performed with Bio-Rad Protein Assay Dye Reagent as 
described by the manufacturer (Bio-Rad). The measurements were done at 595 nm 
using a Microplate Reader (Bio-Rad). The BSA standards were prepared fresh in 
sample buffer and standard curves were plotted to determine the concentration as a 
linear function of absorbance. 
 
b. Spectrophotometric Determination 
 The absorbance of the samples was measured in the range 200-310 nm using a 
Schimadzu, UV-3150 spectrophotometer. Unless otherwise stated in all measurements 
the reference buffer used was the same buffer that protein was eluted in or dialyzed 
against. Absorbance values at 260 and 280 nm were used to estimate protein 
concentration as described by Layne et al., [124] by the following equations; 
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Eqn 4.1: mg/ml= (1.55xA280)-(0.76xA260) 
Eqn 4.2: mg/ml=0.92xA280 
 Extinction coefficient was estimated as 0.92 from amino acid sequence of GPA1-
myc-his using ExPASy Proteomics Server (http://www.expasy.ch). 
 The absorbance at 254 nm is used as an indirect estimate of GDP content of the 
protein samples [38]. The absorbance at 290 nm and the light scattering ≥ 300 nm is 
monitored to detect aggregates [125]. Presence of aggregates may result in a non zero 
baseline due to the light scattering from those particles. 
 The molarity calculations were done assuming all protein is GPA1 with molecular 
mass 48 kDa. This overestimates the concentration for Ni-affinity purified GPA1. 
3.2.17 GTP Binding Assay 
 The GTP binding of GPA1 was analyzed using 35GTPγS (GE Healthcare) binding 
experiments [126]. The buffers used are; 
Protein Dilution Solution: 20 mM HEPES, 8.0, 1 mM EDTA, 1 mM DTT, 50 µM GDP, 
0.1 % Lubrol. 
GTPγS Binding Solution (2X): 100 mM HEPES, 8.0, 120 mM MgCl2, 4 mM EDTA, 
400 mM NaCl, 4 mM DTT, 4 µM GTPγS, 2 µl 35GTPγS ( 250.000 cpm / µl). 
35SGTPγS Dilution Solution: 20 mM Na-HEPES, 8.0, 1 mM EDTA, 1 mM DTT, 0.1 % 
Lubrol. 
Filtering Solution: 20 mM Tris-HCl, pH 8.0, 100 mM NaCl, 25 mM MgCl2. 
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 Protein samples were prepared in protein dilution solution in 30 µl. 30 µl of 
GTPγS Binding Solution (2X) was added. 100 µM of nucleotides were added for 
competition assays. The reaction was incubated at 30 °C for 60 minutes. The reaction 
was stopped with the addition of 2 ml of ice-cold filtering solution. The solution was 
applied to nitrocellulose membranes and were washed using a vacumm filtration unit 
with 8 ml of filtering solution. Nitrocellulose membranes were left at 70 °C for 20 
minutes and were resuspended in 2 ml scintillation liquid (Perkin Elmer). The 
radioactivity was measured as counts per minute (CPM) with a scintillation counter. 
 The specific activity (Ci/mol) of 35GTPγS was calculated from a decay table and 
the dilution factor. The amount of bound GTPγS was calculated according to the 
formula: 
pmole GTPγS=(CPM x 100)/ (2,22 x %counter efficiency x specific activity) 
3.2.18 GTPase activity Assay 
 The GTP hydrolysis activity of GPA1 was analyzed using 32P-GTP (Izotop) by 
measuring the amount of released 32P [35]. Protein samples were prepared in assay 
buffer at the appropriate dilution and equilibrated at room temperature. Assay buffer 
was composed of 50 mM HEPES, pH 8.0, 1 mM EDTA, 1 mM DTT, 10 mM MgCl2 
and 0.1% Lubrol-PX. The reaction started with the addition of indicated amount of 32P-
GTP at room temperature. Each reaction, 60 µl, was stopped by the addition of 750 µl 
ice-cold 5% activated charcoal solution at the indicated time points. The unbound 32P-
GTP precipitated by centrifugation at 2000g for 15 minutes. 400 µl of supernatant was 
added to 2 ml of scintillation liquid (Perkin Elmer) and released radioactivity was 
measured as counts per minute (CPM) for 5 minutes using a scintillation counter. The 
CPM values were corrected by subtracting CPM of reaction without protein and with 
32P-GTP.  
 55 
3.2.19 Biophysical characterization 
a. Analysis of GDP Content 
 In order to analyze protein quality, GDP binding was measured [38]. Purified 
recombinant GPA1 samples (400 µl) were boiled for 3 minutes and applied to micro 
concentrator units (Vivaspin 600), with MWCO of 10 or 30 kDa. The protein was 
separated from buffer and GDP by centrifugation at 12,000g for 15 minutes. The 
original sample tube was washed with 400 µl of water and further applied to the micro 
concentrator unit. Centrifugation was repeated and the filtrate analyzed for GDP amount 
with a UV-vis spectrophotometer (Schimadzu, UV-3150). 
b. Dynamic Light Scattering 
 Dynamic light scattering measurements were performed to monitor the 
homogeneity and the oligomeric state of the protein preparations. Protein samples were 
equilibrated to room temperature and measurements were recorded using a Nano-ZS 
(Malvern Ins.).  
 Scattering intensity is observed due to the Brownian motion of the molecules and 
particles in solution and fluctuations in the scattering intensity are dependent on the size 
of the particles. Heterogeneities in the size of proteins can be detected even at low 
concentrations. Results are obtained as intensity, volume fraction and number 
distribution. Among these the size distribution with respect to intensity is the most 
sensitive to presence of large particles in solution. Size distribution by intensity and 
number reveal the largest and the smallest particles in the solution, respectively. In the 
results section measurements are shown with alternative representations depending on 
the aim of the experiment. 
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c. Circular Dichroism  
 Circular Dichroism measurements were primarily conducted to analyze helical 
content and folding status of the recombinant proteins. 
 The CD measurements were done using JASCO J-810 CD Spectrometer with 300 
µl sample in 1 mm path length cuvette at room temperature. Measurements were done at 
standard sensitivity, with continuous scanning of speed 100 nm/min, 1 second response, 
0.05 nm data pitch and 1 nm band width. Three accumulations were collected for each 
sample.  
 The effects of receptor mimetic compounds were also analyzed by comparing the 
helical content of the protein [40]. These measurements were done using 1 mm path 
length at standard sensitivity, with continuous scanning speed of 50 nm/min, 8 second 
response, 0.2 nm data pitch and 1 nm bandwidth.  
Ellipticity was calculated from milidegrees using [127]; 
θ (deg cm2 dmol -1)=(milidegrees X mean residue weight) / (path length (mm) X protein 
concentration (mg/ml))  
 Mean residue weight of a protein is calculated by dividing the molecular mass by 
number of amino acids - 1. GPA1 mean residue weight is 116.573. 
 
d. Mass spectrometry 
 Mass spectrometry analysis was commercially provided by TOPLAB (Germany). 
Buffer exchange was done using C18 ZipTip, C4 ZipTip or by dilution. Cysteines were 
modified with iodoacetamide. Samples were digested with trypsin and MALDI-TOF 
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MS was done in DHBS (2, 5 Dihydroxybenzoic acid: 2 Hydroxy-5 methoxy-benzoic 
acid 9:1) matrix. 
e. MR  
 NMR measurements were performed on Varian Unity Inova 500 MHz using a 500 
MHz 1H-19F (15N-31P) 5 mm PFG Switchable Probe. The samples were labeled with 
10% deuterium using D2O. The 1H NMR measurements were performed after solvent 
(H2O) saturation. The NMR measurements were mainly conducted to characterize the 
detergent content of protein samples. 
f. SAXS  
 SAXS measurements were performed at EMBL, DESY; X-33 beam line using a 
2D Mar345 Image Plate detector. The X-33 beamline is located at DORIS III storage 
ring of the Deutches Elektronen Synchrotron (DESY) in Hamburg. Scattering patterns 
were recorded in the range of momentum transfer 0.15 < s< 3.5 nm -1 (s = 4πsinθ /λ, 
where 2θ is the scattering angle and λ the X-ray wavelength, 0.15 nm). All preliminary 
data analysis were done using ATSAS program package [128]. 
 SAXS data can be used to obtain the overall shape and size of macromolecules. 
The data is represented as logarithm of the intensity of scattered radiation against the 
momemtum transfer, s. 
 At small angles the logarithm of the intensity can be plotted as a function of the 
square of the scattering vector (Guinier approximation). For a monodisperse solution 
this yields a straight line with intercept proportional to the molecular mass and slope 
proportional to the radius of gyration. 
ln (I) = ln(I(0))-s2Rg2 /3 
The Guinier plot is valid for globular particles for sRg <1.3  
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 For protein solutions a known protein (e.g. BSA) can be used as molar mass 
reference in SAXS data collection and analysis. I(0) values calculated from the Guinier 
plot of BSA are proportional to its molecular mass and the molar mass of sample with 
known concentration (c) can be calculated by:  
MM sample = (I(0) sample/csample) * (cBSA*MMBSA / I(0)BSA) 
 Intensity measurements are dependent on beam line conditions, so BSA 
measurements should be made for each set of samples. BSA is prepared in 20 mM 
HEPES, pH 8.0, 150 mM NaCl and 1 mM DTT with a concentration of ~5 mg/ml. 
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CHAPTER 4 
4 RESULTS 
4.1 Optimization of Expression of GPA1 
 The gene encoding GPA1 was cloned into the pPICZC vector in frame with the C-
terminal myc epitope and a his-tag. The pPICZC-GPA1 construct was integrated into 
the genome of Pichia pastoris GS115 cells [7]. The expression is induced with 
methanol through the AOX promoter upstream of the GPA1 coding region. The 
recombinant protein has an estimated molecular mass of 48219 Da (amino acid 
sequence provided in Appendix I). 
 Expression of recombinant GPA1 was optimized by varying the medium 
composition, induction conditions and the time of induction. Cell growth was followed 
by measuring optical density of cells and the amount of protein was monitored with 
small scale purification trials. Results are summarized in Figure 4.1 to Figure 4.7. 
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Figure 4.1 Growth of GS115 cells expressing GPA1 in MMH or BMMY. 
0.5 % methanol was added to the medium at 24-hour intervals at the points shown 
above. 
 
 Cells grow to higher cell density in BMMY medium than in MMH, which does 
not contain yeast extract and peptone (Figure 4.1). 
time (h)
0 20 40 60 80
A
bs
or
ba
nc
e 
60
0 
nm
 (
A
U
)
0
10
20
30
pPICZC/GPA1
pPICZC/LacZ
pPICZC
 
Figure 4.2: Comparison of growth of GS115 cells with the empty vector (pPICZC), the 
LacZ gene (pPICZC-LacZ) and the GPA1 gene (pPICZC-GPA1). 
BMMY medium contained 0.5 % methanol. Methanol (0.5 % final) was added to the 
medium at 24 hour intervals as in Figure 4.1. 
 
 Growth of P. pastoris was investigated under induction condition and as 
illustrated in Figure 4.2 expression of recombinant GPA1 did not have any negative 
effect on cell growth. 
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Figure 4.3: Comparison of growth of GS115 cells expressing GPA1 in BMMY medium 
after induction with 0.5 % (---) or 1 % (−) methanol. 
Methanol was added at 24th hour. Both cultures were 120 ml in 1L flasks. 
 
 Induction with 1% methanol yielded a higher cell density than 0.5% methanol 
(Figure 4.3), but protein expression was still very low (data not shown). The initial cell 
density before induction was increased from 1 to 10 which resulted in both higher cell 
density and amount of recombinant GPA1 synthesized after induction. In order to 
increase the starting cell density, cells were grown in BMGY medium for 48 hours with 
a change of fresh medium after 24 hours. 
 Following this, the time points at which 1% methanol was added to maintain 
induction were varied. In the initial trials cells were grown 24 hours in BMMY medium 
and methanol was given at different times of induction as summarized below. 
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Figure 4.4: Pellet weight as function of methanol induction time. 
1% methanol was supplemented at the indicated time of induction Cultures were grown 
in baffled flasks for 24 hours. 
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Figure 4.5: Optical densities of cell cultures as a function of methanol addition time. 
Methanol was given at 5th (−⋅⋅−), 6th (−) or 10th (---) hour of induction. Cultures were 
grown in 100 ml BMMY in baffled flasks for 24 hours. 
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Figure 4.6: Affinity (HisTrap™ HP column) purified GPA1 amount as function of 
methanol addition time. 
1% methanol was supplemented at the indicated time of induction. Cultures were grown 
in baffled flasks for 24 hours before induction. 
 
 Time points for methanol replenishment after induction affected cell growth as 
shown by pellet weight (Figure 4.4) and optical densities (Figure 4.5). Addition after 10 
hours results in high cell growth but also reduces recombinant protein expression 
(Figure 4.6). Optimal time for methanol addition was selected at 6 hours after induction. 
 Under the conditions above the yield of recombinant GPA1 was still not sufficient 
to complete biophysical assays. To increase the yield, the total induction time and the 
volume were increased. The induction time was optimized for a total of 48 hours growth 
(Figure 4.7 and Figure 4.8). 
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Figure 4.7: Comparison of pellet weight for cultures with methanol addition at 24 hours 
and at 6th and 24th hours after induction. 
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Figure 4.8: Amount of Ni-affinity purified GPA1 as function of the methanol addition 
time. 
 
 The optimized conditions correspond to addition of 1% methanol to induced 
cultures after 6 and 24 hours during the 48 hour induction period (Figure 4.9). After 48 
hours of induction cells reached the stationary phase in the flask growth conditions (data 
not shown). 
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Figure 4.9: Growth of GPA1-GS115 cells in induction medium. 
Methanol was supplemented at 6 and 24 hours after induction. 
 
4.2 ickel-Affinity Purification of GPA1 
4.2.1 Small scale purifications: HisTrap™ HP 
 Recombinant GPA1 was expressed with a histidine-tag to facilitate purification 
and labeling, and a nickel-affinity matrix was used as the first chromatography step. 
Lysis and purification procedures were optimized using small-scale (150-200 ml) 
cultures and a 5 ml HisTrap™ HP column (GE Healthcare). P.pastoris was induced for 
24 hours, with methanol given after 6 hours. Buffers and some parameters for two 
procedures that gave best results are summarized in Table 4.1. Results of these 
procedures are given below for comparison with results of large-scale purifications that 
will be described separately. 
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Table 4.1: Purification Conditions for GPA1 HisTrap™ HP Affinity.  
Prep Buffers Elution 
 Lysis Purification Buffer (PB) Gradient/Step Flow rate 
1.NaPO4 / 0.3 M NaCl          
(200 ml / 6 hour methanol) 
50 mM Na-PO4 pH 7.4, 5% glycerol, 1 
mM EDTA, 2 mM PMSF ,EFPI 
20 mM Na-PO4, pH 7.4 
0.3 M NaCl 
Gradient:0-500 mM 
imidazole in PB, 5 CV 
1 ml/min 
2.Tris HCl/0.3 M NaCl                            
(175 ml / 6 hour methanol) 
100 mM Tris HCl, pH 7.4, 5% glycerol,                                           
1mM EDTA, 2 mM PMSF, EFPI 
40 mM Tris-HCl, pH 7.4 
0.3 M NaCl 
Gradient:0-500 mM 
imidazole in PB, 5 CV         
1 ml/min 
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1: a-PO4 / 0.3 M aCl 
 Bound protein eluted from the column in 3 peaks with the 0-500 mM imidazole 
gradient (Figure 4.10). According to the result of SDS-PAGE analysis in Figure 4.11, 
the first two peaks contained the two major contaminants, one at 80 kDa and the other at 
40 kDa, that bind to the Ni-affinity matrix. GPA1 eluted close to the end of the gradient 
and its separation from the contaminants was satisfactory.  
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Figure 4.10: Elution of GPA1 from HisTrap™ HP column. 
Linear gradient of imidazole was from 0 to 500 mM (- - -) in NaPO4 buffer. Flow rate 
was 1 ml/min for 5 CV (25 ml) and 1 ml fractions were collected. 
 
 
 
Figure 4.11: 12% SDS-PAGE analysis of HisTrap™ HP fractions. 
A:Lane 1: Protein ladder ®,  lane 2: cell lysate (CL), lane 3: flow through (FT), lane 4: 
wash, lanes 5-7: peak 1 fractions eluted at 4-7 ml. B: Lane 1: Protein ladder ®, lanes 2-
4: peak 2 fractions eluted at 16-18 ml, lanes 5-9: peak 3 fractions eluted at 21-25 ml. 
Samples were prepared with 2X SDS loading dye. 
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 The GPA1 yield determined by Bradford assay was 3.2 mg from 200 ml culture. 
 
2: Tris HCl /0.3 M aCl 
 As the last parameter for optimization, the buffer was changed from Na-PO4 to 
Tris-HCl in order to avoid interference in functional assays.  
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Figure 4.12: Elution of GPA1 from HisTrap™ HP column. 
Linear gradient of imidazole was from 0 to 500 mM (- - -) in Tris buffer. Flow rate was 
1 ml/min for 5 CV (25 ml) and 1 ml fractions were collected. 
 
 
Figure 4.13: 12% SDS-PAGE analysis of HisTrap™ HP fractions. 
A:Lane 1: Protein ladder ®, lanes 2-5: peak 3 fractions eluted at 21-24 ml, lanes 6-7: 
peak 4 fractions eluted at 28-29 ml, lanes 9-10: peak 5 fractions eluted at 34-35 ml. 
Samples were prepared with 2X SDS loading dye. 
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 Separation was better and GPA1 appeared to be more resistant to proteolytic 
attack in Na-PO4 buffer but in large-scale purifications Tris- buffers were used to avoid 
interference with functional assays. 
4.2.2 Large Scale GPA1 Purification 
 The large volume and viscosity of yeast cell lysate prevented the use of a 
HisTrap™ HP, 5ml, affinity column for large scale purification from 48 hour induced 
cultures. Purification with Probond TM Resin (Invitrogen) was investigated, but due to 
the low binding capacity yields were very low (data not shown) and Ni-NTA Agarose 
(Qiagen) was used in batch affinity purifications. As mentioned above Tris-buffers were 
used in purifications and some additives were included in buffers to improve storage 
and protein stability. The buffers used for GPA1 Ni-affinity purification are given in 
Chapter 3.2. 
 Based on the optimization results obtained from small scale purifications further 
conditions for P. pastoris induction and matrix-binding, wash and elution steps were 
investigated.  
  GPA1 was bound to the Ni-NTA agarose in the presence of 20 mM imidazole 
and remained bound through washes with the same buffer. Proteins bound to Ni-NTA 
agarose were eluted with step gradients at 100 mM, 150 mM, 200 mM, 250 mM and 
300 mM imidazole in batch mode. GPA1 eluted in all fractions up to 300 mM imidazole 
from Ni-NTA agarose. 
 SDS-PAGE analysis shown in Figure 4.14 gives the results of elution with 200 
mM and 300 mM imidazole. In both cases GPA1 eluted together with the contaminants 
at about 90 kDa, 80 kDa and another one just below 40 kDa.  
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Figure 4.14: 12% SDS-PAGE analysis of Ni-affinity fractions. 
Lane 1: Protein ladder ®, lane 2: CL, lane 3:FT, lanes 4-6: wash 2-4, lane 7: Elution 
with 200 mM imidazole, lane 8: Elution with 300 mM imidazole. Samples were 
prepared with 6X SDS loading dye. 
 
 Protein concentration in elution fractions was determined by Bradford assay based 
on standard curves obtained for BSA with 200 mM and 300 mM imidazole (data not 
shown). Results showed that similar amounts of protein, about 0.3 mg/ml, were eluted 
from the matrix for the two concentrations of imidazole. The total yield of protein was 
3.6 mg GPA1 purified from a 300 ml culture, where 1% methanol was added after  24 
hours during a of 48 hours induction.  
 For the standard procedure elution was carried out with 300 mM imidazole in 
three consecutive steps (E1: 5 ml, E2: 3 ml and E3:2 ml). For further analyses these 
eluates were pooled and although the total yield of protein was variable in general it was 
about 3-5 mg protein from 300 ml cultures. 
 UV spectrum of GPA1 eluted at 300 mM imidazole shown in Figure 4.15 displays 
a shoulder extending from about 250 nm to 280 due to the presence of bound nucleotide 
in the protein. This feature of the UV spectrum was investigated further by 
measurements against buffers containing different additives in the following sections. 
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Figure 4.15: Comparison of UV spectra of Ni-affinity elutions; E1 and E2. 
 GPA1 samples precipitated when stored overnight at +4 ºC in elution buffer. 
Storage at -20 ºC did not result in any precipitation or protein degradation as shown in 
Figure 4.16. 
 
 
Figure 4.16: Western analysis of Ni-affinity elutions after storage at -20 °C. 
 Lane 1 E1, lane 2:E3. Detection was done with 1:20,000 anti-myc-HRP. 
 Results of Dynamic Light Scattering (DLS) measurements shown in Figure 4.17 
indicated that GPA1 was purified from Ni-affinity in oligomeric form. In DLS size 
distribution of particles in solution is determined according to the scattered intensity. 
This can also be converted to a volume and number distribution. Intensity distribution is 
1             2 
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sensitive to the presence of large particles in solution whereas as volume and number 
distribution also detects the smaller particles. The dominating species in Ni-affinity 
eluted GPA1 solutions appears to have a diameter of about 85-100 nm according to 
DLS measurements. Larger particles in intensity plot correspond to elution buffer 
scattering (data not shown). 
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Figure 4.17: DLS, size distributions by intensity (A) and number (B) of Ni-affinity 
GPA1. 
Fraction was eluted with 300 mM imidazole. 
 
• Buffer Exchange 
 Following partial purification of GPA1 fractions by Ni-affinity, optimum 
conditions for buffer exchange and for storage were investigated. Buffers were 
exchanged using either a HiPrep™ 26/10 Desalting column (GE Healtcare) or by 
dialysis against 50 mM TrisHCl, pH 8.0 buffer.  
 
• Dialysis 
 In a preparation where the yield of the affinity step was 4.5 mg protein (in 9 ml) 
the elution pool was dialyzed against 50 mM Tris HCl, pH 8.0. Concentration 
estimations given in Table 4.2 showed that the dialysis procedure did not result in any 
protein loss.  
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Table 4.2: Absorbance values and concentration estimates after affinity and dialysis. 
The calculations were done either considering the presence of nucleotides (eqn 4.1) or 
using theoretical extinction coefficient (eqn 4.2). 
 Absorbance (AU) 
Concentration 
(mg/ml) 
Total 
Volume Yield A254/A280 
Sample 254 nm 260 nm 280 nm 310 nm eqn 1 eqn 2 ml mg  
Affinity 
pool 0.689 0.698 0.637 0.350 0.456 0.586 9.5 4.336 1.082 
Dialyzed 
pool 0.726 0.718 0.645 0.329 0.454 0.593 9 4.086 1.125 
 
 Protein concentrations were estimated using equation 4.1, which takes into 
account the presence of bound nucleotide, since GPA1 was expected to be purified with 
bound GDP. Estimations of concentrations based on theoretical extinction coefficient 
from equation 4.2 were higher, due to the significant absorption of GDP at 280 nm. In 
routine calculations, protein concentrations were determined using eqn. 4.1. The ratio of 
A254/A280, also shown in Table 4.2 can be used as an indicator of the amount of GDP in 
protein solution, either bound or free. When the buffer exchange was carried out by 
dialysis after the affinity step this ratio did not change significantly. 
wavelength (nm)
240 250 260 270 280 290 300
A
bs
or
ba
nc
e 
(A
U
)
0,3
0,4
0,5
0,6
0,7
0,8
0,9
Ni-NTA E1
Ni-NTA E2
Pool after dialysis
 
Figure 4.18: Comparison of UV spectra of Ni-affinity elutions; before and after dialysis.  
  Absorbance of nucleotide (triangle) and aggregated protein (star) are shown. 
 
 A comparison of the UV spectra of the affinity elutions and the pool after dialysis 
shown in Figure 4.18 indicated that the sample contained aggregates after dialysis, 
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indicated by a shoulder starting at 290 nm and extending to the light scattering region 
[125]. 
 Dialyzed samples were stored in the presence of different additives (Table 4.3) at 
-20 °C in order to investigate the optimum storage conditions. 
Table 4.3: Absorbance values and concentration estimates of GPA1 with additives.  
The calculations were done considering either the presence of nucleotides (eqn 1) or 
using theoretical extinction coefficient (eqn 2). 
 Absorbance (AU) 
Concentration 
(mg/ml) A254/A280 
Sample 254 nm 260 nm 280 nm eqn 1 eqn 2  
Dialyzed pool 0.726 0.718 0.645 0.454 0.593 1.125 
S1 0.561 0.557 0.494 0.342 0.454 1.135 
S2, 10µM GDP 0.408 0.416 0.388 0.285 0.356 1.051 
S5, 10µM GDP and  
10 % glycerol 0.541 0.545 0.505 0.368 0.464 1.071 
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Figure 4.19: Comparison of fresh and -20 ºC stored samples with different additives.  
Presence of aggregated protein (star) shown. 
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 Samples stored without additive or with both GDP and glycerol had spectra 
similar to that of fresh protein and concentration values indicated that there was little 
protein loss. On the other hand storage with only GDP resulted in protein further 
aggregation (Figure 4.19). 
 
  
Figure 4.20: 12% SDS-PAGE (A) and Western (B) analysis of Ni-affinity elutions. 
A:Lane 1: Protein MW marker ®, lane 2: E1 (2 fold diluted), lane 3: E2, lane 4: E3 and 
lane 5: dialyzed pool. B: Lane 1: E1, lane 2:E3, lane 3:S1, lane 4: S5. Detection was 
done with 1:20,000 anti-myc-HRP. Gel samples were prepared immediately after 
dialysis and with 6X SDS loading dye. 
 Results of SDS-PAGE analysis shown in Figure 4.20 reveal that dialysed protein 
was prone to degradation (degradation product shown with arrows). Samples in the 
imidazole buffer did not show degradation although they were stored at -20 °C for 7 
days. Furthermore, several freeze-thaw cycles did not result in protein degradation in 
imidazole elution buffer. DLS results obtained with dialyzed pool showed particle size 
distributions similar to those before the dialysis (data not shown). 
 
• Desalting 
 The imidazole buffer of affinity purified GPA1 (total of 9 mg) was exchanged 
with 50 mM Tris-HCl pH 8.0 using a HiPrep™ 26/10 desalting column (Figure 4.21). 
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Figure 4.21: A: HiPrep™ 26/10 Desalting chromatogram. B: 12% SDS-PAGE analysis. 
A: The elution pool was desalted against 50 mM TrisHCl, pH 8.0 at 3 ml/min. B: Lane 
1: PMW, lane 2: E1, lane 3: E3, lane 4:desalted pool. Samples were prepared with 6X 
SDS loading dye. 
 
Table 4.4: The absorbance values after Ni-affinity and desalting. 
 Absorbance (AU) A254/A280 
sample 254 nm 260 nm 280 nm  
E1 1.335 1.415 1.436 0.929 
E2 0.663 0.687 0.634 1.045 
E3 0.428 0.435 0.328 1.304 
pool 0.983 1.022 0.934 1.052 
desalted 
pool 0.767 0.733 0.63 1.217 
 
 The desalted pool was stored at -80 ºC with 20 µM GDP, 10% glycerol and 0.1 
mM PMSF. Fresh and stored samples were analyzed to investigate the effect of storage 
on protein stability and preservation of the bound nucleotide. 
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Figure 4.22: Comparison of UV-Vis spectra of desalting column load and desalted pool. 
Absorbance of nucleotide (triangle) and aggregated protein (star) are shown. 
 
 After desalting the GPA1 spectrum displayed a pronounced maximum at 280 nm 
accompanied by a second small peak at 254 nm (Figure 4.22). After desalting the total 
GDP amount in the samples was lower, but the amount of bound GDP did not decrease. 
Additional GDP that was in elution buffer was removed but the GDP bound to GPA1 
was not affected. The affinity purified and desalted GPA1 samples bound GDP with a 
ratio of ~0.7 mole GDP / mole protein (Figure 4.81 and Table 4.14). 
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Figure 4.23: DLS size distributions by intensity (A) and number (B) of fresh desalted 
pool, without additives. 
 
 DLS results showed that use of HiPrep™ 26/10 Desalting column for buffer 
exchange yielded smaller oligomers (diameter 8 nm and 30 nm) of GPA1 which were 
detected in plots of the size distribution both by intensity and by number (Figure 4.23). 
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Aggregation and more heterogenous solutions started to form during - 80 °C storage 
(data not shown). 
4.2.3 Affinity Purification with Detergents 
 Detergents were included in the lysis and purification buffers in order to increase 
the amount of solubilized GPA1 and to improve stability of the protein. The buffers 
used for GPA1 Ni-affinity purification are given in Chapter 3.2. Detergents used were 
Triton X-100 and Lubrol PX and characterization of detergent containing buffers by 
DLS measurements and UV spectra are given in APPENDIX K. The critical micelle 
concentration (cmc) for Triton X-100 is 0.25 mM, above this concentration detergent 
micelles form. Below the cmc, on the other hand, the detergent molecules cannot 
effectively dissolve membrane bound and/or lipid attached molecules. The cmc for 
Lubrol PX is 0.1 mM [119]. DLS analyses for both Triton X-100 and Lubrol PX 
showed that, below the cmc buffer solutions had heterogeneous particle size 
distributions but above cmc monodisperse solutions with particles of 8.5 nm diameter 
were observed (Figure K 2 - Figure K 9). One major drawback of using Triton X-100 in 
buffers is that the detergent absorbs at 280 nm, interfering with protein concentration 
estimations. This problem was not observed with Lubrol PX (Figure K 10 and Figure K 
11). Lysis efficiency, on the other hand, was better with Triton X-100. 
• Ni-Affinity with Triton X-100 
 Triton X-100 was added at a final concentration of 0.1 % (1.5 mM) and 0.02 % 
(0.3 mM) to lysis and purification buffers, respectively. Stepwise elution was done as 
described in previous section. This application resulted in the yield of the affinity step 
increasing to above 10 mg when compared with about 5 mg when no detergent was 
used from 300 ml P. pastoris cultures. It was also observed that the relative amount of 
the contaminating factors had decreased (Figure 4.24). The UV spectra of the Ni-
affinity purified pools were similar to that without detergent and the A254/A280 ratios 
were ~1.1. 
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Figure 4.24: 12% SDS-PAGE analysis of Ni-affinity (Triton X-100) fractions. 
Lane 1: Protein MW marker ®, lane 2: CL, lane 3: FT, lanes 4-7: wash 1-4, lanes 8-9: 
E1 and E2. Samples were prepared with 6X SDS loading dye. 
 
 The purification was repeated in the presence of AlF4
- (30 µM Al2 (SO4)3 and 10 
mM NaF), which in the presence of GDP, binds to GPA1 and mimics the GTPase 
transition state. Purity of the affinity pool was similar to that shown in Figure 4.24 (data 
not shown). 
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Figure 4.25: UV spectra of Ni-affinity pool (Triton X-100 and AlF4
-).  
 The A254 /A280 ratio for each elution was ~0.75. 
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Table 4.5: Absorbance values and concentration estimation for Ni-affinity elutions 
 Absorbance (AU) Concentration 
Total 
Volume Yield A254/A280 
Sample 254 nm 260 nm 280 nm mg/ml ml mg  
E1 1.52 1.67 1.98 1.80 10 18.06 0.76 
E2 0.33 0.38 0.45 0.41 11 4.52 0.73 
 
 The Ni-affinity purified GPA1 had a A254/A280 nm ratio <1, and comparison of 
Figure 4.15 and Figure 4.25 (Table 4.2 and Table 4.5) show that in the presence of AlF4
-
, this ratio is lower. Since the GDP content of the purification buffer was constant, the 
increase in absorbance ~280 nm (higher yield) results in the reduction of the ratio. 
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Figure 4.26: DLS size distributions by intensity (A) and volume (B) of Ni-affinity 
purified GPA1 (Triton X-100). 
 Two dominating types of particles with different sizes were observed in Ni-
affinity purified GPA1 solutions with detergents. Although DLS pattern of Triton X-
100 micelles show a peak corresponding to particles with 8.5 nm (APPENDIX K), the 
pattern observed in Figure 4.26 is likely to contain also the protein component with a 
diameter of 15 nm. Larger particles with a diameter 50 nm correspond to oligomeric 
forms of GPA1. 
 
• Buffer Exchange 
 Buffer exchange was done either using HiPrep 26/10 Desalting Column or by 
dialysis as was described in section 4.2.2 for samples without detergent. Protein volume 
B A 
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was reduced using concentrator units before or after buffer exchange depending on the 
down stream process. 
 
Desalting 
 A total of 12 mg GPA1 from the Ni-affinity pool was desalted against 50 mM Tris 
HCl, pH 8.0. Following desalting, the pool contained 5 mg GPA1 and was concentrated 
from 20 ml down to 2 ml.  
 
 
 
Figure 4.27: 12% SDS-PAGE analysis of Ni-affinity (Triton X-100) fractions. 
Lane 1: Protein MW marker ®, lane 2: Ni-affinity pool, lane 3: desalted pool, lane 
4: concentrator filtrate, lane 5: concentrated pool. Ni-affinity pool was loaded 2 
fold diluted. Samples were prepared with 2X SDS loading dye. 
 
Table 4.6: Absorbance values and concentration estimations for Ni-affinity fractions. 
  *calculated assuming all protein is GPA1. 
 Absorbance (AU) Concentration 
Total 
Volume Yield Molarity* A254/A280 
Sample 254 nm 260 nm 280 nm mg/ml ml mg µM  
Ni-affinity 
pool 1.16 1.22 1.03 0.67 17 11.45 14 1.12 
Desalted 
pool 0.17 0.20 0.24 0.22 22 4.96 4.5 0.71 
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 The recovery from the desalting column was only 50% (Figure 4.27 and Table 
4.6). The concentration of bound GDP was 11.5 µM GDP for ~4.5 µM GPA1, which 
corresponds to a ratio of 1 mole GDP /mole protein (calculations given in section 4.5.1). 
 
Dialysis 
 As illustrated in Figure 4.28 after dialysis the particles ~20 nm were absent, which 
may imply formation of PMC (protein micelle complex) during dialysis. The 
dominating particles had a size ~55 nm and 85 nm. The larger particles correspond to 
components of the dialysis buffer (data not shown). 
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Figure 4.28: DLS size distributions by intensity (A) and volume of Ni-affinity pool after 
dialysis. 
 
• Ni-Affinity with Lubrol PX 
 Lubrol PX was added at a final concentration of 1 % (17 mM) and 0.1 % (1.7 
mM) to the lysis and purification buffers, respectively. Figure 4.29 shows that protein 
eluted with the high molecular mass contaminants from the affinity matrix in a fashion 
similar to that observed when Triton X-100 was used as the detergent (Figure 4.24). 
 
A B 
 83 
 
 
Figure 4.29: 12% SDS-PAGE analysis of Ni-affinity (Lubrol-PX) fractions. 
Lane 1: Protein ladder ®, lane 2: CL, lane 3: FT, lanes 4-7: wash 1-4, lane 8: E1, lane 
10: E2, lane 11: E3. Samples were prepared with 6X SDS loading dye. 
 The protein concentration in elution fractions was determined from UV spectra. 
The total yield of protein was ~15 mg GPA1 purified from 500-700 ml of culture and 
A254/A280 ratios were about 0.9-1.0. 
 
 
Figure 4.30: Western analysis of Ni-affinity (Lubrol-PX) elution E2. 
Lanes 1-2: with BME, boiled and not boiled, lanes 3-6: without BME, boiled, not 
boiled, heated to 60° C for 30 minutes, overflow, lanes 7-8: E2 stored at +4°C, 
prepared without BME not boiled and boiled. Samples were prepared with 6X 
SDS loading dye with or without BME. Membrane was incubated with 1:2500 
tetra-his-HRP. 
 
 The Western blot analysis shown in Figure 4.30 revealed that the proteins with 
high molecular mass present in GPA1 elutions were actually oligomers of GPA1. These 
oligomers were absent in the samples prepared with BME but for samples prepared 
without BME and not exposed to high temperatures, the tetra-his antibody was bound to 
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oligomers. These results suggest that the oligomers were formed via intermolecular 
disulfide bridges. 
 Results of DLS measurements on the Ni-affinity preparations with Lubrol-PX 
were dominated by particles with 5.5 nm-8.5 nm diameter due to the detergent but also 
a small amount of particles with larger diameters (50 nm) were detected (Figure 4.31).  
 The Ni-affinity purified GPA1 was concentrated and the buffer was exchanged 
using either a concentrator unit or by dialysis. The DLS size distribution by intensity 
and volume for these samples indicated that besides particles of about 20 nm diameter 
the solutions also contained particles with 85 nm (Figure 4.32). 
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Figure 4.31: DLS size distributions by intensity (A) and volume (B) of concentrated Ni-
NTA pool. 
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Figure 4.32: DLS size distributions by intensity (A) and volume (B) of N-affinity pool 
after dialysis. 
 
 The purification was also repeated in the presence of AlF4
- and results were 
similar in terms of yields, protein homogeneity and the A254/A280 ratio (data not shown).  
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4.3 Anion Exchange 
 Anion exchange chromatography was performed on Ni-affinity purified GPA1 
using HiTrap QHP, 5 ml, columns (GE Healthcare). Purification was carried out using 
0-700 mM NaCl gradient in 50 mM Tris HCl, pH 8.0. The presence of different 
additives in Ni-affinity and their effect in separation during anion exchange are 
summarized below. The NaCl concentrations and elution volumes are given in Table 
4.7. 
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Table 4.7 Comparison of NaCl concentrations and elution volumes for anion exchange in the presence of different additives. 
dns:data not shown 
 aCl, mM 
Additive 
/Figure Peak 1 Peak 2 Peak 3 Peak 4 
 start end Start end start end start end 
None / 4.33 
106.5 
(6.8 ml) 
145.4 
(9.3 ml) 
153 
(9.8 ml) 
192 
(12.3 ml) 
207.6 
(13.3 ml) 
285.3 
(18.3 ml) 
293 
(18.8 ml) 
370.7 
(23.8 ml) 
Triton /dns 
114.1 
(5.4 ml) 
145.9 
(6.8 ml) 
167 
(7.8 ml) 
209.5 
(9.8 ml) 
230.7 
(10.8 ml) 
273.2 
(12.8 ml) 
294.4 
(13.8 ml) 
379.2 
(17.8 ml) 
Triton-AlF4
- 
/ 4.39 
103.7 
(5.4 ml) 
187.7 
(9.8 ml) 
206.7  
(10.8 ml) 
225.7 
(11.8 ml) 
235.2 
(12.3 ml) 
263.7 
(13.8 ml) 
301.7 
(15.8 ml) 
396.7 
(20. 8 
ml) 
Lubrol / 4.48 
91.2 
(4.3 ml) 
123 
(5.8 ml) 
133.6 
(6.3 ml) 
165.4 
(7.8 ml) 
207.8 
(9.8 ml) 
250.3 
(11.8 ml) 
282 
(13.3 ml) 
366.9 
(17.3 ml) 
Lubrol AlF4
- 
/ dns 
57 
(3 ml) 
95 
(5 ml) 
152 
(8 ml) 
209 
(11 ml) 
228 
(12 ml) 
304 
(16 ml) 
323 
(17 ml) 
418 
(22 ml) 
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4.3.1 Obtaining two biophysically different GPA1 pools 
 Separation of protein components after Ni-affinity preparations of GPA1 was 
investigated. The buffer of GPA1 was exchanged on a HiPrep™ 26/10 desalting column 
after affinity purification. The pool with a total of ~8 mg protein (in 31 ml), in buffer 50 
mM Tris HCl, pH 8.0, 20 µM GDP and 10 % glycerol, was loaded onto a 5 ml HiTrap 
Q HP column. The elution pattern of the Ni-affinity pool displayed four peaks as 
illustrated in Figure 4.33. SDS-PAGE analysis revealed that GPA1 eluted as the major 
component in peaks 3 and 4 (Figure 4.34) with about 95% homogeneity. The fractions 
of peak 3 and 4 were pooled separately (pool 3 and pool 4). Pools 3 and 4 were dialyzed 
against 20 mM HEPES, pH 8.0, 50 mM NaCl and 0.1 mM PMSF. After dialysis the 
samples were stored with 20 µM GDP, 10% glycerol at -80 ºC.  
 The absorbance values of peak 3 and peak 4 fractions were inconsistent with the 
SDS-PAGE results. On the chromatogram (Figure 4.33) the ratio of the area under the 
peak of pool 3 to pool 4 was about 4:1. Direct measurements made from the pools 
indicated the A280 to be about 2:1 (Table 4.8) and when equal sample volumes from 
peak 3 and peak 4 were loaded on the gel the proteins bands had similar intensity 
(Figure 4.34). This indicated that the absorbance of peak 3 at 280 nm could be mainly 
due to a component other than GPA1. 
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Figure 4.33: Elution of GPA1 from a HiTrap Q HP column with NaCl gradient. 
Linear gradient was applied with 0-700 mM NaCl in 50 mM Tris HCl, pH 8.0 over a 
volume of 25 ml with a flow rate of 5 ml/min. 0.5 ml fractions were collected. 
 
 
Figure 4.34: 12% SDS-PAGE analysis of anion exchange fractions. 
Lane 1: Protein MW marker ®, lanes 2-3: Ni-affinity elutions, E1-E2, lane 4: 
desalted pool, lanes 5-14: anion exchange fractions; lane 5: peak 1, lanes 6-7 peak 
2, lanes 8-10: peak 3, lanes 11-14: peak 4. 
 
Table 4.8: Absorbances and concentration estimates for pool 3 and 4. 
Measured immediately after dialysis and before addition of GDP and glycerol. 
 Absorbance (AU) Concentration 
Total 
Volume Yield 
sample 260nm 280nm mg/ml ml mg 
pool 3 0.127 0.93 1.344 2 2.689 
pool 4 0.38 0.41 0.346 5 1.733 
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 The monodispersity of the two-anion exchange pools were monitored by DLS 
before and after dialysis. 
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Figure 4.35: DLS size distributions by intensity (A) and number (B) of anion exchange 
pool 3 before dialysis. 
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Figure 4.36: DLS size distributions by intensity (A) and number (B) of anion exchange 
pool 4 before dialysis. 
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Figure 4.37: DLS size distribution by intensity (A) and number (B) for pool 3 after 
dialysis. 
Protein was stored at -80 ºC in 20 mM HEPES 50 mM NaCl, 20 µM GDP and 10% 
glycerol. 
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Figure 4.38: DLS size distribution by intensity (A) and number (B) for pool 4 after 
dialysis.  
Protein was stored at -80 ºC in 20 mM HEPES 50 mM NaCl, 20 µM GDP and 10% 
glycerol. 
 
 The particle size distributions of pool 3 and pool 4 indicate the presence of 
particles of different size (Figure 4.35 and Figure 4.36). Pool 3 contains larger 
oligomers with diameter 60 and 100 nm and yet the smallest particle size in the 
distribution is closer to that expected from monomers (10 nm). Pool 4 was composed of 
particles with sizes 30 nm and 10 nm. After dialysis and storage pool 3 molecules were 
in a homogenous but oligomeric form (100 nm) whereas the pool 4 molecules formed a 
more heterogeneous solution, with smaller sized oligomeric forms (40 and 70 nm) of 
GPA1 (Figure 4.37 and Figure 4.38). 
 
 
Figure 4.39: 12% SDS-PAGE and Silver stain analysis of anion exchange pools. 
Lane 1: Ni-affinity AD, lane 2: pool 3 BD, lane 3: pool 3 AD, lane 4: pool 4 BD, lane 5: 
pool 4 AD. Samples were prepared with 2X SDS loading dye. BD: before dialysis. AD: 
after dialysis. 
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 The purity of pool 3 and pool 4 were compared by silver staining. Pool 3 was 
highly pure, there was low amount of HMM forms, whereas pool 4 contained 
significant amount of aggregation and degradation products as shown in Figure 4.39. 
 
4.3.2 Anion Exchange, load with detergent 
 Anion exchange fractionation was carried out on GPA1, obtained from Ni-affinity 
purification in the presence of different detergents. Buffers used are given in Chapter 
3.2. 
1. Triton X-100 & AlF4
- 
 In exploratory purifications, GPA1 purified from Ni-affinity matrix with Trion X-
100 buffers was analyzed on the anion exchange column and results were similar to 
those obtained without detergent summarized above. As the last parameter to vary, 
AlF4
- was added to the detergent buffers and concentration of GDP was raised to 50 µM 
as a stabilizing factor. GPA1 was purified from Ni-affinity matrix in the presence of 
0.02% Triton X-100, 30 µM Al2 (SO4)3 and 10 mM NaF. Affinity purified protein was 
stored without buffer exchange at -20 ºC after the addition of 10 % glycerol. Before 
separation by anion exchange, samples were thawed, concentrated and dialyzed against 
50 mM Tris HCl pH 8.0, 1 mM DTT and 1 mM PMSF. GPA1 (20 mg in 11 ml) was 
loaded onto anion exchange column and protein eluted from the column with the profile 
in Figure 4.40. Fractions were pooled according to the result of SDS-PAGE analysis in 
Figure 4.41. Functional assays were done on GPA1 purified without AlF4
-. 
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Figure 4.40: Elution of GPA1 from a HiTrap Q HP column with NaCl gradient. 
Linear gradient was applied with 0-700 mM NaCl in 50 mM Tris HCl, pH 8.0 over a 
volume of 30 ml with a flow rate of 3 ml/min and 0.5 ml fractions were collected. 
 
 
 
Figure 4.41: 12% SDS-PAGE analysis of anion exchange fractions. 
Lane 1: Protein MW marker ®, lanes 2-3 : peak 1 top fractions and last fraction, lane 4: 
peak 2 first fraction, lane 5: peak 3 first fraction, lanes 6-7: peak 4 top and last fractions, 
lane 8: peak 5 top fraction. Samples were prepared with 6X SDS loading dye. 
 
 Fractions from peak 3 (NaCl from 235.2 to 263.7 mM, total of 2.6 ml) and peak 4 
(NaCl from 301.7 to 396.7 mM, total of 7.5) were pooled and dialyzed against 5 mM 
Tris HCl, pH 8.0, 5 mM NaCl, 1 mM DTT and 1 mM PMSF. Following dialysis pools 
were lyophilized for 20 hours; after flash freezing in liquid nitrogen and stored at room 
temperature. Samples were taken before lyophilization for UV and DLS analysis.  
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Table 4.9 Comparison of absorbance values of dialyzed pools 3, 4 and 5 
 Absorbance (AU) Concentration A254/A280 
 254 nm 260 nm 280 nm mg/ml  
pool 3 0.867 0.814 0.701 0.468 1.236 
pool 4 0.548 0.561 0.614 0.525 0.892 
pool 5 0.321 0.312 0.188 0.054 1.707 
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Figure 4.42: Comparison of UV spectra for pool 3, 4 and 5 (after dialysis). 
 The absorbance at ~254 nm is indicated with triangles. 
 
 The discrepancy between the 280 nm absorbance values and protein content of 
pools 3 and 4 is clear from the values given in Table 4.9 and the SDS-PAGE analysis 
shown in Figure 4.41. Pool 3 GPA1 had excess GDP with a high A254/A280 ratio, as 
compared to pool 4 GPA1. Pool 5 contained most unbound excess GDP and had very 
low protein content (Figure 4.42 and Table 4.9). 
 Pool 3 was highly aggregated after dialysis; there were no monomeric particles 
even in size distribution by number. Pool 4 contains particles with size ~15 nm (Figure 
4.43 and Figure 4.44). The particle size did not change upon storage for neither of the 
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pools (data not shown). The particles with sizes above 300 nm in the distribution by 
intensity are also present in the buffer (data not shown).  
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Figure 4.43: DLS size distributions by intensity (A), volume (B) and number (C) of 
fresh pool 3 in final dialysis buffer. 
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Figure 4.44: DLS size distributions by intensity (A) and volume (B) of fresh pool 4 in 
final dialysis buffer. 
 
 Lyophilized pool 3 and pool 4 proteins were resuspended in the final dialysis 
buffer in 10 fold-reduced volume compared to that before lyophilization. Samples were 
analyzed by SDS-PAGE /Silver stain, Figure 4.45, and western blotting, Figure 4.46, to 
investigate protein quality. DLS measurements were done on samples that were brought 
up to the original volume.  
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Figure 4.45: 12% SDS-PAGE analysis of anion exchange pools with Silver stain. 
Lane 1: Protein MW marker ®, lane 2: pool 3 AD, lane 3: pool 3 lyophilized, lane 4: 
pool 4 AD, lanes 5-6: pool 4 AD concentrated, lane 8: pool 4 lyophilized. Samples were 
prepared with 6X SDS loading dye with the indicated amount of protein. 
 
 
 
Figure 4.46: Western analysis of Ni-affinity and anion exchange fractions. 
Lanes 1-2: ni-nta pool 1 before and after concentrating, lanes 3-4: ni-nta pool 2, 
before and after concentrating lanes 5-6: pool BD and AD lanes 7-9: pool 3 BD, 
AD and lyophilized, lanes 10-12: pool 4 BD, AD and lyophilized. Samples in 
lanes 2,4, 5 and 6 were prepared with 6 µl, in lane 9 with 2 µl and in lane 10 with 
10 µl protein. Membrane was incubated with 1:2,000 tetra-his-HRP (Qiagen). 
 
 The Ni-affinity samples contained degradation products. In cases where GPA1 
was partially degraded in the Ni-affinity step, the anion exchange selectively eliminated 
the degradation products from pool 3 but not from pool 4. HMM aggregation products 
were detected in both pools by silver and antibody staining (Figure 4.45 and 45), but the 
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amount was significantly higher in pool 4. Both degradation and aggregation were 
pronounced upon lyophilization for pool 4 but not pool 3 GPA1, also verified by DLS. 
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Figure 4.47: DLS size distributions by intensity (A), volume (B) and number (C) of 
lyophilized and resuspended pool 3 in final dialysis buffer. 
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Figure 4.48: DLS size distributions by intensity (A), volume (B) and number (C) of 
lyophilized and resuspended pool 4 in final dialysis buffer. 
 Pool 3 samples were oligomeric, with the same particle size distribution as before 
lyophilization (Figure 4.47). Pool 4 was aggregated after lyophilization/resuspension 
with particle sizes shifted from ~15 nm to ~40 nm (Figure 4.48). 
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 In conclusion western blot detection and silver staining revealed that the 
oligomeric form, pool 3 GPA1 contains more intact/pure protein. DLS results showed 
that pool 3 GPA1 was more stable to lyophilization than pool 4 GPA1. 
 
2. Lubrol PX  
 The buffer of GPA1 purified by Ni-affinity in the presence of 0.02% Lubrol PX 
was exchanged by dialysis. About 6 mg GPA1 in 6 ml 50 mM Tris HCl, pH 8.0, 1 mM 
DTT and 1 mM PMSF buffer were loaded on the anion exchange column (Figure 4.49). 
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Figure 4.49: Elution of GPA1 from a HiTrap Q HP column with NaCl gradient. 
Linear gradient was applied with 0-700 mM NaCl in 50 mM Tris HCl, pH 8.0 over a 
volume of 25 ml with a flow rate of 3 ml/min. 0.5 ml fractions were collected. 
 
 Fractions from peaks 3 and 4 were pooled separately as described above and 
further analyzed by SDS-PAGE. Homogeneous GPA1 was eluted in both peaks 3 and 4 
(Figure 4.50). 
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Figure 4.50: 12% SDS-PAGE analysis of anion exchange pools.  
Lane 1: Prestained protein ladder ®, lane 2: Ni-affinity pool, lane 3: concentrated 
pool (10 fold diluted), lane 4: dialyzed pool, lane 5: peak 1 top fraction, lane 6: 
peak 2 top fraction, lane 7: peak 3 top fraction, lane 8: peak 4 top fraction, lane 9: 
peak 5 top fraction. Samples were prepared with 6X SDS loading dye. 
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Figure 4.51: UV-vis spectra of pool 3 and pool 4 GPA1 and corresponding filtrates.  
The signal at ~253 nm (triangle) in pool 3 corresponds to free nucleotide. 
 
 UV-vis spectra of the pools (Figure 4.51) revealed that pool 3 GPA1 had an 
A254/A280 ratio twice as high as pool 4 (0.98 and 0.56 repectively). The GDP content of 
GPA1 in the pools was determined as described in chapter 3.2 and the spectra of 
filtrates with GDP released from GPA1 are shown in Figure 4.51. Pool 3 contained high 
amounts of GDP, with a ratio of 1.4 mole GDP/ mole protein. Pool 4 was bound to 0.8 
mole GDP / mole protein (Table 4.14).  
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Figure 4.52: DLS size distributions by intensity (A) and number (B) of pool 3 GPA1. 
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Figure 4.53: DLS size distributions by intensity (A) and number (B) of pool 4 GPA1. 
 
 DLS analysis showed that pool 3 was composed of particles with a diameter ~9 
nm and pool 4 with ~15 nm (Figure 4.52 and Figure 4.53). These particles could be 
GPA1 with or without Lubrol micelles. The particles with size ~1000 nm are also 
present in the buffer (data not shown). The purification was repeated with GPA1 
affinity purified in the presence of 0.1% Lubrol PX, 30 µM Al2 (SO4)3 and 10 mM NaF 
and the separation was similar. The A254/A280 ratios of pool 3 and pool 4 were 0.69 and 
0.48 respectively; the value for pool 3 is lower than that obtained without AlF4
-. 
 
 In summary, there were two distinguishable GPA1 molecules after Ni-affinity 
purification, which could be resolved by anion exchange. The NaCl concentrations at 
which peak 3 and peak 4 GPA1 eluted were similar for different affinity purification 
conditions (Table 4.7) but the separation from contaminants was worse when Triton X-
100 was included in affinity step. These two forms were further analysed by CD, SAXS 
and nucleotide binding measurements and results are given in following sections.  
B A 
B A 
 100 
4.4 Size Exclusion Chromatography 
 After establishing the oligomeric nature of GPA1 obtained by Ni-affinity 
chromatography, gel filtration columns with different resolution range were used to 
analyse the different oligomers. The first trial was carried out using a HiLoad 16/60 
Superdex 75 pg column (GE Healthcare, 120 ml) which resolves proteins within the 
molecular masses between 3 kDa and 70 kDa. Here GPA1 purified from Ni-affinity was 
eluted in the void volume. Fractionation on Sephacryl S-300 (resolution range between 
10 kDa to 1500 kDa) and Sephacryl S-200 columns (resolution range between 5 kDa to 
250 kDa) were explored using different buffers (Table 4.10) as detailed below. 
Calibration curves for the columns with standard proteins are given in Appendix L. 
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Table 4.10: Purification Conditions for GPA1 Gel Filtration 
 Lysis Buffer Ni-Affinity, 10 X Desalting Gel filtration Buffer 
1 
50 mM Tris HCl, pH 8.0 
10 mM MgCl2, 1mM EDTA 
5% glycerol, EFPI, 2 mM PMSF 
0.1% Triton-X 100 
500 mM Tris-HCl 8.0, 3 M NaCl 
100 mM BME, 1 mM PMSF 
200 µM GDP,20 mM MgCl2 
200 mM  imidazole, 0.2 % Triton-X 100 
20 mM HEPES, pH 
8.0, 100 mM NaCl 
Buffer A:                              
20 mM HEPES, pH 8.0        
100 mM NaCl 
2 
                                                             
50 mM Tris HCl, 8.0 
10 mM MgCl2, 1 mM EDTA 
5% glycerol, EFPI, 2 mM PMSF 
0.1 % Triton-X 100 
50 µM  GDP 
500 mM TrisHCl, 8.0, 3 M NaCl 
100 mM BME, 2 mM PMSF 
500 µM  GDP, 50 mM MgCl2 
200 mM imidazole, 0.2% Triton-X 100       
50 mM Tris HCl,         
1mM DTT 
Buffer B:                              
50 mM Tris HCl, pH 8.0 
150 mM NaCl 
1 mM DTT, 5% glycerol 
50 µM  GDP 
3 
                                                             
50 mM Tris HCl, 8.0 
10 mM MgCl2, 1 mM EDTA 
5% glycerol, EFPI, 2 mM PMSF 
0.1 % Triton-X 100 
50 µM  GDP 
500 mM TrisHCl, 8.0, 3 M NaCl 
100 mM BME, 2mM PMSF 
500 µM GDP,50 mM MgCl2 
200 mM imidazole 
0.2% Triton-X 100 
300 µM Al2(SO4)3, 100 mM NaF N.A. 
Buffer C:                              
50 mM HEPES, pH 8.0 
150 mM NaCl 
1 mM DTT, 5% glycerol 
50 µM GDP, 5 mM 
MgCl2 
4 
50 mM Tris HCl, 8.0 
10 mM MgCl2, 1 mM EDTA 
5% glycerol, EFPI, 2 mM PMSF 
1% Lubrol-PX 
50 µM GDP 
500 mM TrisHCl, 8.0, 3 M NaCl 
100 mM BME, 2 mM PMSF 
500 µM GDP, 50 mM MgCl2 
200 mM imidazole 
1% Lubrol –PX 
300 µM Al2(SO4)3, 100 mM NaF N.A. 
Buffer D:                              
20 mM HEPES, pH 8.0 
150 mM NaCl 
1 mM DTT, 5% glycerol 
5 mM MgCl2 
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• Sephacryl S-300 HR 16/60, Buffer A 
 GPA1 affinity purified in the presence of Triton-X was desalted using a HiPrep™ 
26/10 desalting column against 20 mM HEPES, pH 8.0 , 100 mM NaCl buffer and 
stored at -20 ºC after addition of 20 µM GDP. A total of 5 mg protein was loaded onto 
the column after concentrating down to 2 ml. The DLS analysis (Figure 4.57) indicates 
that the protein loaded on the column was in oligomeric form with particles of diameter 
20 and 100 nm. 
 Protein eluted from the column in a complex pattern (Figure 4.54) and the 
molecular masses corresponding to the elution positions of different peaks are shown in 
Table 4.11. Top fractions from the peaks were analyzed by SDS-PAGE for 
homogeneity. As illustrated in Figure 4.55 all peaks contained mainly GPA1 apparently 
in different oligomeric forms. The UV spectra (Figure 4.56) confirmed the presence of 
aggregates for fractions eluted at earlier volumes. The oligomers were monitored by 
DLS (Figure 4.58-Figure 4.61) and in accordance with the elution pattern from the gel 
filtration column the smallest size particles were observed in peak 4, with size ~10 nm. 
The smallest particles with 8.5 nm may correspond to Triton X-100 micelles (Table 
4.11 and APPENDIX K) 
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Figure 4.54: Elution pattern of GPA1 from S-300 HR 16/60 column with Buffer A. 
      Flow rate was 0.3 ml/min and 0.5 ml fractions were collected. 
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Table 4.11 Molecular mass estimations for S-300 (Buffer A) peaks. 
Estimated from elution volumes and column calibration (Figure L 3). 
 Ve Range Molecular Mass, Da 
Diameter, 
nm (DLS) 
 ml ml Top Start End Top 
peak 1 34.43 32-36 607506 755565 527364 50 
peak 2 43.37 39-48 271600 4025430 179003 20 
peak 3 53.44 50-56 109713 149504 87102 8.5, 15 
peak 4 60 57-66 60799 79602 35398 8.5, 10 
 
 
 
Figure 4.55: 12% SDS-PAGE analysis of S-300 (Buffer A) fractions. 
Lane 1: Prestained protein ladder ®, lane 2: Ni-affinity concentrated pool, lane 3: 
concentrator filtrate, lanes 4-12 peak fractions at elution volumes. Lanes 4-5: peak 1 
fractions, 32 and 35 ml, lane 6: peak 2 fraction, 44 ml, lanes 7-8: peak 3 fractions, 51 
and 54 ml, lanes 9-12: Peak 4 fractions, 57, 60, 63 and 66 ml. Samples were prepared 
with 6X SDS loading dye. 
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Figure 4.56: Comparison of UV spectra of GPA1 eluted in different elution volumes. 
Peak 1 fractions differ significantly from the others and there was more aggregation in 
peak 2 than in peak 4 (Absorbance above 290 nm, shown with star). 
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Figure 4.57: DLS size distributions by intensity (A) and volume (B) of concentrated 
GPA1 (column load). 
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Figure 4.58: DLS size distributions by intensity (A) and volume (B) of peak 1 fraction 
32 ml. 
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Figure 4.59: DLS size distributions by intensity (A) and volume (B) of peak 2 fraction 
44 ml. 
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Figure 4.60: DLS size distributions by intensity (A) and number (B) of peak 3 fraction 
54 ml. 
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Figure 4.61: DLS size distributions by intensity (A) and volume (B) of peak 4 fraction 
60 ml. 
 
 In peak 4 GPA1 could be obtained with a molecular mass of ~60 kDa. The protein 
solution was not monodisperse as revealed by DLS. 
• Sephacryl S-300 HR 16/60, Buffer B  
 GPA1 affinity purified in the presence of Triton-X was desalted using a HiPrep™ 
26/10 desalting column with 50 mM TrisHCl, pH 8.0 and 1 mM DTT buffer and 50 µM 
GDP was added to the desalted pool. A total of 4.5 mg protein was loaded onto a 
Sephacryl S-300 HR 16/60 column after concentrating down to 2 ml. 
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Figure 4.62: Elution pattern of GPA1 from S-300 HR 16/60 column with Buffer B. 
Flow rate was 0.5 ml/min and 0.5 ml fractions were collected. 
 
Table 4.12 Molecular mass for S-300 (Buffer B) peak 2 fractions. 
Estimated from elution volumes and column calibration (Figure L 3).  
 Ve Range Molecular Mass, Da 
Diameter, 
nm 
 ml ml Top Start End Top 
peak 2 58 53-62 72748 114114 50746 10, 15, 60 
 
 
 
Figure 4.63: 12% SDS-PAGE analysis of S-300 HR 16/60 column peak 2 fractions. 
Lane 1: Protein MW marker ®, lanes 2-10: fractions eluted at the 53, 54, 55, 56, 57, 58, 
59 and 60 ml. Lane 9 is overflow of lane 8. Samples were prepared with 6X SDS 
loading dye. 
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Figure 4.64: UV-vis spectra of S-300 peak 2 fractions. 
 In the elution pattern of GPA1 from the Sephacryl S-300 column, there were two 
main peaks at 32 ml and at 58 ml (from 53 to 62 ml). The latter corresponded to a 
molecular mass of about 70 kDa (Figure 4.62 and Table 4.12). 
 SDS-PAGE analysis of the fractions of peak 2 (Figure 4.63) indicated that the 
dominating species in this peak was GPA1 but the degradation product could also be 
observed. DLS measurements showed that although GPA1 existed possibly in 
monomeric form (10 nm), higher order oligomers were also present with diameter 15 
nm and 60 nm (Figure 4.65 and Table 4.12). 
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Figure 4.65: DLS size distributions by intensity (A) and volume (B) of a S-300 peak 2 
pool. Samples was stored at -80 ºC. 
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• Sephacryl S-300 HR 16/60, Buffer C  
 GPA1, purified by Ni-affinity in the presence of Triton-X and AlF4
- was directly 
concentrated. The buffer exchange was done in the concentrator unit. A total of 23 mg 
GPA1 in 2 ml was loaded to the column. 
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Figure 4.66: Elution pattern of GPA1 from S-300 HR 16/60 column with Buffer C. 
Flow rate was 0.3 ml/min and 0.5 ml fractions were collected. 
 
Table 4.13 Molecular mass for S-300 peak 2 (Buffer C) fractions. 
Estimated from elution volumes and column calibration (Figure L 3). 
 Ve Range Molecular Mass, Da 
Diameter, 
nm 
 ml ml Top Start End Top 
peak 2 57 53-61 79602 114114 55527 8.5, 10, 85 
 
 The elution volume of second peak was 57 ml, which corresponds to a molecular 
mass range of ~55 kDa to 114 kDa (Figure 4.66 and Table 4.13). Fractions of peak 2 
(from 53 to 61 ml) were combined and the 10 ml protein pool was dialyzed against 
Buffer C. Free GDP and AlF4
- were removed by dialysis. SDS-PAGE analysis of 
selected fractions (Figure 4.67) from peak 2 showed that GPA1 was purified to about 
90% homogeneity. GPA1 yield was ~6 mg from 800 ml yeast culture.  
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Figure 4.67: 12% SDS-PAGE analysis of Ni-affinity and S-300 (Buffer C) fractions. 
Lane 1: Protein ladder ®, lane 2: FT, lanes 3-5: wash 1-3, lanes 6-8: Ni-affinity E1-E3, 
lane 9: Ni-affinity concentrated, lane 10: void fraction, lanes 11-13: peak 2 fractions, 
first, top and last, lane 15: S-300 pool BD. FT and wash samples were prepared with 2X 
SDS loading dye, others with 6X SDS-loading dye. 
 
 
  
Figure 4.68: Western analysis of S-300 eluted GPA1 before and after dialysis. 
Lane 1: Ni-affinity pool, lanes 2-3: S-300 pool BD, stored at +4 ºC and -80 ºC, lanes 4 
and 6: S-300 pool AD, at +4 ºC and -80 ºC, lane 5: 57 ml fraction, lane 7:80 ml fraction, 
lane 8: S-300 FT, lane 9: S-300 load. Samples were prepared with 6X SDS loading dye, 
except S-300 load with 2X SDS loading dye. Membrane was incubated with 1:4000 
anti-myc-HRP. A: Exposure time 1min, B: Exposure time 10 min. 
 
 Figure 4.68 obtained from western blot of the purified protein indicates that there 
was already a small amount of degradation at the affinity purification step which did not 
increase during dialysis. Depending on the assays in which the samples were used 
dialysis was employed to ensure removal of free additives.  
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Figure 4.69: DLS size distribution by intensity (A) and volume (B) of 57 ml (top) 
fraction stored at +4 ºC. 
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Figure 4.70: DLS size distribution by intensity (A) and volume (B) of 57.5 ml fraction 
stored at -80 ºC. 
 
 DLS measurements showed that the purified protein was composed of particles 
with size 8.5, 10 and 85 nm and was not affected by storing at 4 °C or -80 °C (Figure 
4.69 and Figure 4.70). 
 
• Sephacryl S-200 HR 16/60, Buffer D  
 GPA1, purified by Ni-affinity in the presence of Lubrol-PX was loaded to a S-200 
column but monomeric GPA1 did not elute from the column. In another trial AlF4
- was 
included in Ni-affinity purification and affinity elutions were stored until use at -20 ºC 
after addition of 20% glycerol. The pool was directly concentrated and the buffer was 
exchanged in the concentrator unit before loading 10 mg GPA1 in 2 ml onto a 
Sephacryl S-200 HR 16/60 column. 
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Figure 4.71: Elution pattern of GPA1 from S-200 HR 16/60 column with Buffer D. 
Flow rate was 0.5 ml/min and 0.5 ml fractions were collected. 
 
 
 
Figure 4.72: 12% SDS-PAGE analysis of S-200 (Buffer D) fractions. 
Lane 1: Protein MW marker ®, lane 2: Ni-affinity pool, lane 3: concentrated pool, lane 
5: void top fraction, lane 6: void middle fraction, lane 7: void last fraction, lane 8: 
fraction of 52 ml, lane 9: fraction of 60 ml, lane 10: fraction of 65 ml. Samples were 
prepared with 6X SDS loading dye. 
 Figure 4.71 illustrates that GPA1 was eluted in 2 different forms from S-200 
column. The first pool with a molecular mass above 250 kDa; eluted before the void 
volume. The particle diameters for void pool were 10, 20 and 60 nm (Figure 4.74). The 
elution volume of the second peak was not directly determined from elution pattern. 
The peak was between 50 and 70 ml of elution, but only the fractions between 50 and 
60 ml contained GPA1 (Figure 4.72) with a molecular mass range of 60-30 kDa 
(according to column calibration curve given in Figure L 6) and particle diameter of 10 
nm and 20 nm (Figure 4.75). The later fractions did not contain any protein but excess 
(free) GDP and / or detergent micelles in the sample may be the reason for the increased 
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absorbance at 280 nm. The GPA1 eluted at the column void volume had excess/free 
GDP shown with an increased absorbance above 254 nm, which was absent for the 
fractions eluted after 50 ml (  Figure 4.73). 
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  Figure 4.73: UV spectra of S 200 fractions.   
 
 GDP can be detected in void fractions by an increase above 254 nm (triangles). 
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Figure 4.74: DLS size distributions by intensity (A) and volume (B) of void top 
fraction. 
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Figure 4.75: DLS size distributions by intensity (A) and volume (B) of 52 ml fraction. 
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 In summary monomeric and homogenous GPA1 could not be obtained from 
Sephacryl columns, even the form with the smallest molecular mass and diameter 
contained oligomeric forms, albeit at lower amounts. 
 114 
 The purification scheme followed is given below. Protein obtained at different 
stages of purification step is numbered according to this scheme (e.g. stg. 3.2) for ease 
of following the functional/structural characterization results. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Affinity Purification 
 
3. Large Scale 
Ni-NTA Triton-X / Lubrol  
2. Large Scale 
Ni-NTA Agarose 
1.Small Scale: 
HisTrap™ HP, 5ml 
Buffer Exchange 
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2.1 Dialysis 
 
2.2.1  
Anion Exchange 
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3.1.1 
Anion Exchange 
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Gel Filtration 
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4.5 Functional Assays 
4.5.1 GDP Binding 
 GDP bound form of GPA1 was stabilized by using a purification buffer that 
contained minimum of 20 µM GDP in the Ni-affinity step and further GDP was added 
according to the subsequent procedure. The GPA1-GDP solutions, therefore, also 
contained excess unbound GDP. Buffer exchange using a desalting column helped to 
separate unbound GDP from GPA1 as detected by changes in the shape of absorbance 
spectra at around 254 nm. As can be seen from Figure 4.76 the buffer exchanged 
samples display less absorbance around this position. 
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Figure 4.76: Comparison of UV spectra of GPA1 (stg. 3---) and desalted pool (stg. 
3.2−). 
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 Absorbance ~254 nm was further investigated by measuring the desalted pool 
against buffer with or without GDP. The effect of free and bound GDP on the UV 
spectra of Ni-affinity purified –desalted GPA1 samples can be seen in Figure 4.77 (stg 
2.2) and Figure 4.78 (stg 3.2) for samples that were purified in the absence and presence 
of detergents respectively. The GDP peak at 254 nm can be readily seen when the 
measurement is carried out against the buffer without GDP, and is still visible when the 
measurement was against the GDP containing buffer. The bound GDP can thus be 
detected in samples coming from the affinity purification step.  
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Figure 4.77: Comparison of UV spectra of GPA1 (stg 2.2) measured against different 
buffers.  
GPA1 was stored in 20 µM GDP, 10 % glycerol in 50 mM TrisHCl, pH 8.0 and 
measured against buffer with (⋅-) and without () additives. 
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Figure 4.78: Comparison of UV spectra of GPA1 (stg. 3.2) measured against different 
buffers.  
Measured against buffer with (---) and without GDP (−).The spectrum of 30 µM GDP is 
also shown (-⋅-⋅-⋅). 
 
 Estimation of GDP amount bound to GPA1 was carried out by boiling GPA1 and 
measuring the GDP content of the filtrate as described in chapter 3.2. The calibration 
curve was obtained by measuring A254 values of solutions of GDP at different 
concentrations (Figure 4.79). 
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Figure 4.79: Dependence of absorbance at 254 nm on GDP concentration in 50 mM Tris 
HCl, pH 8.0. 
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Table 4.14: Estimation of GDP content of GPA1 at different stages of the purification. 
* the protein was not boiled so the amount of remaining GDP is calculated. 
  
Absorbance GDP GDP Content Protein GDP 
/Protein 
GPA1 
stage 
254 nm 
(AU) 
y = 78.838x 
+ 2.7711 
Added 
GDP 
Bound  
GDP 
concentration Mole/mole 
2.2 0.304 26.73 µM 20 µM 
6.73 µM /  
2.7 nmole 
0.18 mg/ml;      
3.74 nmole 0.72 
3.2 * 0.452 38.4 µM 50 µM 
11.59 µM / 
4.63 nmole 
0.22 mg/ml 
4.57 nmole  0.98 
3.1.1 
pool 3 0.236 21.37 µM - 
21.37 µM / 
8.55 nmole 
0.287 mg/ml   
5.96 nmole 1.42 
3.1.1 
pool 4 0.064 7.81 µM - 
7.81 µM / 
3.12 nmole  
0.183 mg/ml  
3.8 nmole 0.82 
 
 Filtrates containing the released GDP (Figure 4.81) displayed spectral features 
that were similar to that of GDP solutions (Figure 4.80). The GDP content of GPA1 
obtained in pool 3 of the anion exchange column was different from that of pool 4 
indicating that these two pools contain different forms of GPA1. The average value of 
bound GDP for pool 3 and for pool 4 is ~equal to that of affinity purified GPA1 (Table 
4.14).  
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Figure 4.80: The UV spectra of different concentrations of GDP in Tris buffer. 
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Figure 4.81: UV-Vis Spectra of GDP filtrates of GPA1 from stg. 2.2 and 3.2. 
 
4.5.2 GTP Binding 
 GTP-binding activity of GPA1 obtained at different stages of the purification 
procedure was investigated using [35S]GTPγS. GPA1 purified from Ni-affinity column 
without detergents (stg. 2.2) binds ~0.3 mole GTPγS / mole protein (± 0.067) and in the 
presence of 100 µM cold GTP this ratio is lowered to 0.06 (± 0.035) (Figure 4.82).  
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Figure 4.82: Dependence of [35S]GTPγS binding to GPA1 (stg. 2.2) concentration. 
 
 Pool 3 GPA1 (stg. 3.1.1, Triton X-100) binds ~0.3 mole GTPγS / mole protein, 
the presence of GTP was less competitive as compared to affinity purified GPA1 
(Figure 4.83). 
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Figure 4.83: Dependence of [35S]GTPγS binding  to pool 3 (stg. 3.1.1) concentration. 
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4.5.3 GTP Hydrolysis 
 GTP hydrolysis activity of GPA1 from different stages of the purification 
procedure was investigated using 32P-GTP and by measuring released 32P in the reaction 
mixture. The background level of radioactivity measured for buffers and protein 
samples was around 20-60 CPM. Data represent CPM data that was integrated for 5 
minutes. All experiments were performed with protein initially affinity purified in the 
presence of Triton X-100 (stg.3). 
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Figure 4.84:Dependence of released 32P on protein purity.  
0.14 nM 32P-GTP / assay was used. 32P release was measured after 30 minutes. 
 
 Figure 4.84 shows the specific activity of GPA1 which increases as the purity of 
GPA1 increased during purification. 
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Figure 4.85: Time course of GTPase activity of 290 nM pool 3 GPA1 (stg 3.1.1).  
0.167 nM  32P GTP / assay was used. The CPM value of last data was assumed 100 %. 
 
Table 4.15: CPM values of 290 nM pool 3 GPA1 (stg 3.1.1). 
0.167 nM  32P GTP / assay was used 
time(min) 0 2 9 12 15 33 45 80 
CPM 5042 5443 5392 7489 6569 11153 11407 15866 
 
 Figure 4.85 (and Table 4.15) shows that pool 3 GPA1 has GTPase activity and the 
hydrolyzed amount of Pi was increased as the incubation time of GPA1 with 32P GTP 
was increased. 
 
 Figure 4.86 (Table 4.16) and Figure 4.87 (Table 4.17 ) show that in the absence of 
Lubrol PX, pool 3 and pool 4 GPA1 had comparable GTPase activity. 
 
Table 4.16: CPM values of pool 3 GPA1 (stg. 3.1.1) as a function of concentration. 
1.67 nM 32P-GTP /assay were used. 32P release was measured after 60 minutes. 
GPA1 
(mM) 1.2 2.4 3.6 
CPM 295846.5 317417 326717.5 
stdev 4296.381 1303.198 7881.412 
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Figure 4.86: Concentration dependence of GTPase activity of pool 3 GPA1 (stg. 3.1.1). 
Assay buffer was prepared without Lubrol. 1.67 nM 32P-GTP /assay were used. 32P 
release was measured after 60 minutes. The higher CPM value of highest concentration 
was assumed 100 %. 
 
Table 4.17: CPM values of pool 4 GPA1 (stg. 3.1.1) as a function of concentration. 
1.67 nM 32P-GTP /assay were used. 32P release was measured after 60 minutes. 
GPA1 
(mM) 0.19 0.385 0.555 1.111 1.667 
CPM 177882.5 184775.5 250053 317030 311293.5 
 
GPA1 (mM)
0,0 0,2 0,4 0,6 0,8 1,0 1,2 1,4 1,6 1,8
%
 C
P
M
50
60
70
80
90
100
110
  
Figure 4.87: Concentration dependence of GTPase activity of pool 4 GPA1 (stg. 3.1.1). 
Assay buffer was prepared without Lubrol. 1.67 nM 32P-GTP /assay were used. 32P 
release was measured after 60 minutes. The CPM value of highest concentration was 
assumed to be 100 %. 
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Figure 4.88: Effect of detergent and MgCl2 on GTPase activity of pool 4 (stg. 3.1.1). 
The CPM value of 120 minutes was assumed to be 100 %. 400 nM GPA1 and 1.6 nM 
32P-GTP was used for each assay. Lubrol PX was not added to assays. 
 
 Figure 4.88 shows the MgCl2 dependency of GTPase acitivity of GPA1, in the 
absence of Mg+2 the released Pi amount is reduced 3 fold. The released Pi amount was 
increased ~3 fold when detergent (Triton X-100) was included in assay buffer. 
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Figure 4.89: Time course of GTPase activity of 70 nM GPA1 (stg 3.2.1). 
         1.67 nM  32P GTP / assay was used. 
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 Figure 4.89 shows that S-300 purified GPA1 has GTPase activity and the 
hydrolyzed amount of Pi was increased as the incubation time of GPA1 with 32P GTP 
was increased. 
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Figure 4.90: Concentration dependence of GTPase activity of GPA1 (stg. 3.2.1). 
1.6 nM of 32P-GTP was used per assay. 32P release was measured after 30 minutes. The 
CPM value of highest concentration was assumed 100 %. 
 
Table 4.18: CPM values of GPA1 (stg. 3.2.1) as a function of concentration. 
1.6 nM of 32P-GTP was used per assay. 32P release was measured after 30 minutes. 
GPA1 
(mM) 0.097 0.194 0.389 0.583 0.777 
CPM, 
average 286916.5 304968 310612 332313 355577 
st. dev. 29419.88 2706.098 3646.55 9359.972 42917.85 
 
 The GTPase activity of GPA1 purified from S-300 gel filtration column was 
slightly higher than those of anion exchange purified proteins (Figure 4.90 and Table 
4.18). 
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Figure 4.91 Effect of nucleotide competition on GTPase activity of GPA1 (stg.3.2.1). 
Nucleotides were added at a final concentration of 50 µM. A: percent B: CPM values. 
100 nM GPA1 and 3.3 nM 32P-GTP was used for each assay.32P release was measured 
after 60 minutes. 
 
 As shown in Figure 4.91, in the presence of GTPγS and GTP the hydrolyzed 32P 
amount was the same as that from the control sample with no protein. The raw data was 
used for analysis, since blank (total count) subtraction resulted in negative values in the 
presence of competitor nucleotides. The hydrolyzed Pi amount was reduced ~30 % in 
the presence of ATP, which was not expected. 
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Figure 4.92: Effects of receptor mimetics compound (MP) on GTPase activity of GPA1 
(stg. 3.2.1.).  
Assay was started 15 minutes after the addition of MP. 1.67 nM 32P-GTP and 200 nM 
(0.56 µg) GPA1 was added per assay. 32P release was measured after 60 minutes. 
B A 
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 The raw data was used for analysis, since blank (total count) subtraction resulted 
in negative values in the presence of competitor nucleotides. The addition of receptor 
mimetic compound, MP (100 µM) resulted in a slight increase in the amount of 
hydrolyzed Pi when the protein is bound to GDP or GTP. In the presence of GTPγS the 
receptor mimetic compound caused a slight decrease in GTPase activity of GPA1 
(Figure 4.92). 
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4.6 Biophysical Characterization 
4.6.1 Membrane Localization 
 Membrane fractions of P.pastoris cells were solubilized in order to investigate 
localization of GPA1. Figure 4.93 shows that GPA1 was detected in both soluble 
cytosolic and insoluble membrane fractions. The membrane fraction in lane 2 was from 
lysis without detergent and the smear pattern may indicate improper solubilization of 
the membrane bound proteins. The sample in lane 3 was from lysis in the presence of 
Triton-X 100. 
 
 
Figure 4.93: Western detection of GPA1 in membrane fractions of P.pastoris. 
Lane 1: Soluble lysate without detergent, lane 2: Membrane fraction after lysis without 
detergent, lane 3: membrane fraction after lysis with Triton X-100. Samples were 
prepared with 6X SDS loading dye. Membrane was incubated  with 1:2000 tetra-his-
HRP Exposure time was 10 min. 
  1            2             3 
GPA1 
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4.6.2 Interaction with AGB1/AGG2 Dimer 
 The effect of AGB1/AGG2 interaction on GPA1 was analyzed with SDS-PAGE 
followed by Western blot (Figure 4.94). GPA1 eluted in the void volume of S-200 (stg. 
3.2.1) was incubated with GTPγS or dimer before loading on SDS-polyacrylamide gel. 
Degradation occurred during room temperature incubation and presence of the dimer 
prevented this. GPA1 was aggregated and aggregates were visible even the sample was 
boiled before loading. Addition of dimer reversed the aggregation unlike addition of 
GTPγS. 
 
Figure 4.94: Western blot analysis of S-200 GPA1 (stg. 3.2.1, Lubrol-PX) fractions. 
Lane 1 GPA1 60 kDa, lanes 2-6: void fraction; Samples were incubated at room 
temperature for 30 minutes with lane 4: 5 µM GTPγS, lanes 5 and 6, equal volume of 
Gβγ. Samples were prepared with 6X SDS loading dye. Samples in lanes 3 to 6 were 
not boiled before loading. Membrane was incubated with 1:2000 tetra-his-HRP. 
 1     2      3      4     5     6   
GPA1 
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4.6.3 Analysis for presence of detergents 
• MR 
 
 GPA1 was purified in the presence of detergents at affinity step followed by either 
size exclusion or anion exchange chromatography. Proton NMR shifts of detergent and 
GPA1 solutions were compared in order to detect if the detergent co-purifed. 
 The spectra of samples labeled with deuterium were recorded after solvent (H2O) 
saturation. The shift at 4.8 ppm corresponds to the solvent (Figure 4.95) and the peaks 
before 4.8 ppm were not used for analysis. The chemical structures of buffer 
components and detergents are given in APPENDIX N. 
 
 
Figure 4.95: NMR spectrum for HND buffer (ppm values are given). 
 
 The proton shifts of Lubrol-PX hydrocarbon chain (CH3 (CH2)11) can be seen 
around 1.6 ppm (CH2), 1.3 ppm ((CH2)n) and 0.9 ppm (CH2CH3) (Figure 4.96). 
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Figure 4.96: NMR spectrum of HND buffer (A) and 0.1% Lubrol-PX in HND (B). 
    Signals below 3.4  ppm are shown. 
 
 The polyethylene glycol chain ((CH2CH2O)n) of Lubrol-PX was seen at ~3.7 ppm 
(Figure 4.97). The hydroxyl group shift is invisible due to solvent (water) saturation. 
 
 
Figure 4.97: NMR spectrum of HND buffer (A) and 0.1% Lubrol-PX in HND (B). 
        Signals above 3  ppm are shown. 
 In order to see if Lubrol-PX can be detected in the presence of a protein, BSA was 
prepared in HND with Lubrol-PX. The signature peaks verified the presence of Lubrol–
PX (Figure 4.98). 
B 
A 
B 
A 
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Figure 4.98: NMR spectrum of BSA in HND, with (A) or without (B) 0.1 % Lubrol. 
       BSA concentration 1.6 mg/ml. 
 
 The presence of Lubrol was shown for GPA1 (stg. 3.2.1, Lubrol-PX) purified 
from S-200 column in buffer HND (Figure 4.99). 
 
 
 
Figure 4.99: NMR spectrum of GPA1 (stg. 3.2.1) (A) and 0.1% Lubrol (B) in HND.  
Upper panel shows ppm between 0.5 to 2.2, lower panel shows 2.4 to 3.8 ppm. GPA1 
concentration was 1.4 mg/ml. 
B 
A 
B 
A 
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 The amount of Lubrol-PX was calculated by using HEPES (4-(2-hydroxyethy)-1 
piperazine-ethane sulfonic acid) ethyl proton shift as reference. The buffer 
concentration was constant (20 mM), so the integration value of the shift will be of 
equivalent value in either GPA1 or 0.1% Lubrol-PX solution. The proton shift of CH3  
(alkyl chain) of Lubrol-PX was selected for comparison and the amount in known 
concentration solution was calculated as a control (Figure 4.100). The ratio of 
integrations of two peaks (HEPES/Lubrol) is equal to their proton number X 
concentration ratio; 2 (CH2) X 20 mM/ 3 (CH3) X unknown and Lubrol concentration 
was found 1.67 mM. 
 
Figure 4.100: Calculation of Lubrol-PX concentration from NMR spectrum of 0.1% 
Lubrol-PX in HND. 
Peak integration at 3.8 ppm (2 protons) was used as a reference to calculate the 
concentration of Lubrol-PX from the integration value at 0.9 ppm (3 protons). HEPES 
concentration was 20 mM. 
 
 The Lubrol concentration in GPA1 (stg. 3.2.1) was estimated as described above 
and was found 1.87 mM (Figure 4.101). All of the Lubrol added to affinity purification 
buffer was co-eluted with GPA1 from gel filtration column. 
 134 
 
Figure 4.101: Calculation of Lubrol-PX concentration from NMR spectrum of GPA1.in 
HND. 
Calculations were done as described in Figure 4.100.  
 
 All of the proton shifts of Triton X-100 could not be identified in HND-GGM 
buffer, due to the presence of buffer signals. The significantly different protons shifts 
were at ~0.65 ppm (tert-butyl) and 1.65 ppm (CH2) from the alkyl chain of Triton X-
100 as shown in Figure 4.102 for 0.02 % Triton X-100. 
 
 
Figure 4.102 NMR spectrum of 0.02 % Triton X-100 (A) and HND-GGM (B). 
 
B 
A 
 135 
 Triton X-100 added at the affinity purification step did not co-purify with GPA1 
from anion exchange column as can be seen from the NMR spectra of pool 3 and Triton 
X-100 (Figure 4.103). 
 
 
 
Figure 4.103: NMR spectrum of GPA1 (stg. 3.1.1) (A) and 0.02% Triton X-100 
(B) in HND-GGM (B).  
Upper panel shows 0 to 1 ppm, lower panel shows 1.55 to 1.95 ppm. GPA1 
concentration was 0.1 mg/ml. 
 
• TCA stain  
 GPA1 purified from different stages were compared for the presence of detergent. 
Samples that were either purified in the presence of detergent or those that were 
incubated with detergents were run on 8% native polyacrylamide gel, followed by TCA 
staining [129].  
 
 
B 
A 
B 
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Figure 4.104: TCA stained 8% Native-PAGE analysis for detergents and GPA1. 
Lane 1: GPA1 stg.3.2 (Lubrol), lanes 2-4: pool 4 (stg.2.2.1) with Triton, with Lubrol 
and no detergent, lane 5: pool 3 (stg.3.1.1, Triton), lane 6: pool 3 (stg. 3.1.1, Lubrol), 
lanes 7-9: pool 3 (stg. 2.2.1) with triton, lubrol and no detergent, lane 10: Triton, lane 
11: Lubrol, lanes 12-14: GSTdmt with triton, lubrol and no detergent. Samples were 
prepared with 6X native loading dye. 
 
 Result in Figure 4.104 show that detergents Lubrol, 1.7 mM and Triton, 0.3 mM 
can be detected with TCA staining and GPA1 after affinity purification contained 
detergent if this was included in purification buffers. After anion exchange detergent 
was separated from GPA1, Lubrol or Triton did not co-elute from anion exchange 
column with GPA1. 
 The gel was washed in water overnight after TCA staining and stained with 
coomassie blue. The result (Figure 4.105) show that only lane 1 (affinity purified , stg. 
3.2) and lane 7 (pool 3, stg 3.1.1 Lubrol) samples can be seen with a smear pattern on 
the gel. The control (GSTdmt) samples, each 0.5 mg/ml, are in lanes 12-14. The 
samples were also analyzed on SDS-PAGE for protein quality and quantity (Figure 
4.106). 
 
 
 
 
 1         2  3   4  5 6    7   8   9 10 11 12 13 14 
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Figure 4.105: 8% Native-PAGE analysis of GPA1 from different stages.  
Lane numbering is identical to Figure 4.104. Samples were prepared with 6X native 
loading dye. 
 
 
 
Figure 4.106: 12% SDS-PAGE analysis of samples used in native gel (Figure 4.105).  
Lane 1: Protein MW marker ®, lane 2: pool 3 (stg. 2.2.1), lane 3: pool 3 (stg.3.1.1, 
Lubrol), lane 4: pool 3 (stg. 3.1.1, Triton), lane 5: pool 4 (stg.2.2.1), lane 6: GPA1 stg.3. 
(Lubrol), lane 7: GPA1 stg.3.2 (Lubrol), lanes 8-10: GSTdmt, no detergent, with Lubrol 
and with Triton. Samples were prepared with 6X SDS loading dye. 
 
4.6.4 MALDI-TOF MS 
 Matrix Assited Laser Desorption (MALDI) Time of Flight (TOF) mass 
spectrometry (MS) was done on pool 3 and pool 4 (stg. 2.2.1). 
 1       2  3   4  5 6  7   8   9 10 11      12 13 14 
 1    2      3       4      5     6    7      8       9    10 
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 Pool 3 MALDI-TOF MS resulted in fragments covering 86.72 % of GPA1 amino 
acid sequence (Figure 4.107).The resulting sequence is given in APPENDIX I. Some 
peptide fragments were not visible, including the 6 amino acid N-terminal region. 
According to the amino acid sequence of GPA1, the N-terminal peptide containing the 
C as Carbamidomethyl-cystein (GLLC*SR) should appear at 705.4 Da. This peptide 
was visible in pool 4, however not in pool 3. 
 Some of the peptides missing correspond to Gα conserved residues; a long 23 
amino acid region which contain the P-loop and GoLoco binding residues 
(GAGESGK), two amino acids in switch I (VR) and in switch II (RK) and six residues 
of putative receptor binding site (VFKIYR). Two plant Gα specific insertion regions 
were also not detected; LDYPR and SGEVYR. There were five undigested arginine and 
eleven lysine residues, including one in GDP/GTP binding site and three in putative 
receptor binding site. 
 
 
Figure 4.107: MALDI-TOF result and data analysis for pool 3 (stg. 2.2.1). 
 
 Pool 4 MALDI-TOF MS resulted in fragments covering 86.72 % of GPA1 amino 
acid sequence (Figure 4.108).The resulting sequence is given in APPENDIX I. The m/z 
for N-terminal peptide containing the C as Carbamidomethyl-cystein (GLLC*SR) was 
present at 705.4 Da, but was assigned manually. 
 For pool 4 again the missing fragments correspond to Gα conserved residues; but 
did not completely overlap to the missing fragments in pool 3. The long missing region 
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was 32 amino acids long (as compared to 23 for pool 3).The P-loop and GoLoco 
binding residues (GAGESGK), two amino acids in switch I (VR) and in switch II (RK) 
were missing as in pool 3. Only three residues of putative receptor binding site (VFK) 
were absent and unlike pool 3 all the lysines in this site were digested by trypsin. The 
two plant Gα specific insertion regions were also not detected SGEVYR and LDYPR, 
but following 3 residues were also absent (LTK) in pool 4. There were six undigested 
arginine and seven lysine residues. Lysine in GDP/GTP binding site besides all three in 
putative receptor binding site and another at position 329 were all accessible to tryptic 
digestion, unlike in pool 3 where they were all undigested. 
 
 
Figure 4.108: MALDI-TOF result and data analysis for pool 4 (stg. 2.2.1). 
 
 The peptide containing a palmitoylation at C4 should appear at 886.4 Da. This 
mass was not present in any of the two samples. The peptide containing a 
palmitoylation at C4 and a myristoylation at the N-terminus should appear at 1096.5 Da. 
This mass is also not visible in any of the two samples. According to these results, pool 
4 does not contain any lipid modifications attached to its N-terminus.  Since pool 3 N-
terminal 6 amino acid fragment was insible in MS, the absence / presence of lipid 
modifications can not be deduced. 
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4.7 Structural Characterization of GPA1 
4.7.1 Secondary Structure Analysis 
• Secondary Structure Comparison of GPA1 from different purification 
procedures 
 CD measurements were done mainly to investigate the quality of the purified 
protein. GPA1 is expected to have high helical content, hence the presence of α helical 
CD signature was followed throughout the purifications. Furthermore, the folding of 
proteins was also analyzed by inspecting the presence of ellipticity in the near-UV 
region of the CD spectrum. The CD spectra of buffers are given in APPENDIX M. 
• Affinity Purified GPA1: 
The protein storage conditions were optimized depending on near-UV spectrum signals.  
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Figure 4.109: Far (A) and Near-UV (B) spectra of GPA1 (stg.2.1). 
GPA1 was stored with different additives in 50 mM TrisHCl, pH 8.0 buffer as given. 
 
 GPA1 stored with GDP and glycerol has more signal is near-UV region, which 
may indicate all (more) aromatic amino acid residues are correctly folded giving rise to 
optical rotation (Figure 4.109). This may indicate that storage without glycerol damages 
the tertiary structure of the protein. θ208 nm/ θ222 nm are similar, 1.2 for GPA1 stored with 
GDP and glycerol, 1.17 stored with only GDP; and θ 222 nm value was -8857 and -8594 
respectively. The corresponding western blot results are given in Figure 4.20. 
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Figure 4.110: Far (A) and near –UV (B) spectra for GPA1 (stg.3.1, Triton X-100). 
     Sample was in buffer with 50 mM TrisHCl, 1mM DTT, 1mM PMSF. 
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 GPA1 Ni-affinity purified in the presence of Triton X-100 and dialyzed had an 
θ208 nm/ θ222 nm ratio of 1.16, similar to protein purified without detergent, but θ 222 nm 
value was -6788. In contrast, the near-UV spectral region is quite different, which may 
indicate that tertiary structure of GPA1 is different in the presence and absence of 
Triton X-100 (Figure 4.110). 
 
• Anion Exchange: 
 Anion exchange separated two biophysically different GPA1, pool 3 was more 
stable as shown by SDS-PAGE, Western and DLS analysis. CD measurements also 
support the view that pool 3 and pool 4 has different properties (Figure 4.111). 
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Figure 4.111: Far-UV (A) and Near-UV (B) CD spectra of pool 3 and pool 4 (stg.2.2.1). 
 
 The two different GPA1 pools (stg. 2.2.1) had different helical content as shown 
(Figure 4.111) by far-UV CD spectra and pool 3 showed more pronounced minima with 
θ208 nm/ θ222 nm of 1.27 as compared to 1.19 for pool 4. The values for θ222 nm was -4906 
for pool 3 and -4710 for pool 4. Furthermore the two proteins had different near-UV 
spectra which may imply that the environment of aromatic residues were different in 
B A 
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pool 3 and pool 4; the two proteins have different tertiary structures, but the signals are 
too weak to do more conclusions. 
 
wavelength (nm)
200 210 220 230 240
E
ll
ip
ti
ci
ty
 (
de
g 
cm
2  
dm
ol
-1
)
-10000
-8000
-6000
-4000
-2000
0
Pool 3 GPA1
Pool 4 GPA1
wavelength (nm)
250 260 270 280 290 300
E
ll
ip
ti
ci
ty
 (
de
g 
cm
2  
dm
ol
-1
)
-100
-50
0
50
100
150
Pool 3 GPA1
Pool 4 GPA1
 
Figure 4.112: Far-UV (A) and Near-UV (B) CD spectra of pool 3 and pool 4 (stg.3.1.1, 
Triton X-100).  
 
 The two different GPA1 pools (stg. 3.1.1 with Triton-X) had similar θ208 nm/ θ222 
nm ratio, 1.0 for pool 3 and 1.1 for pool 4. θ222 nm was -8211 for pool 3 and -8036 for 
pool 4. In contrast, the near-UV regions are different, pool 3 has more distinct bands 
(Figure 4.112). 
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Figure 4.113: Far-UV (A) and Near-UV (B) CD spectra of pool 3 and pool 4 (stg.3.1.1, 
Triton X-100 and AlF4
-). 
Samples were in buffer with5 mM Tris HCl, pH 8.0, 5 mM NaCl, 1 mM DTT and 1 
mM PMSF. 
 The two different GPA1 pools (stg. 3.1.1 with Triton X-100 / AlF4
-) had similar 
θ208 nm/ θ222 nm ratios, 1.15 for pool 3 and 1.16 for pool 4 but the θ222 nm values were 
different; -6892 for pool 3 and -4563 for pool 4. The near-UV regions are different. 
Pool 4 has a band around 265 nm, which is shifted to 260 nm in pool 3 (Figure 4.113).  
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Figure 4.114: Far-UV (A) and Near-UV (B) CD spectra of pool 3 and pool 4 (stg. 3.1.1, 
Lubrol-PX). 
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 The two different GPA1 pools (stg. 3.1.1 with Lubrol PX) had different θ208 nm/ 
θ222 nm ratios, 1.13 for pool 3 and 1.0 for pool 4. Pool 4 showed a more pronounced 
minimum with θ222 nm of -10350 as compared to θ222 nm of -8389 for pool 3. The 
ellipticity wavelengths are similar for pool 3 and pool 4 in the near-UV region of the 
spectra, with small difference in the intensity of bands (Figure 4.114).  
 The near-UV region in CD spectrum is a good indicator of tertiary structure of a 
protein and the presence of signals can be attributed to a folded protein. Near –UV 
region is sensitive to small conformational/ structural changes arising from protein 
environment. In summary the folding of aromatic resides/ intermolecular disulfides 
appear to be different in pool 3 and pool 4 GPA1, considering the observation that, 
independently of purification procedure, they had different near-UV spectra. 
 
 
• Change in helical content upon Receptor interaction 
 Secondary and tertiary structural changes that may occur upon addition of GTPγS 
to pool 3 GPA1 (stg. 3.1.1) were analyzed (Figure 4.115). The θ208 nm/ θ222 nm ratio was 
changed from 1.13 to 1.232 and θ222 nm was changed from -6867 to -8630 with the 
presence of GTPγS. In the near-UV CD region the 270 nm band was shifted to 265 nm 
and 285 nm band was shifted to 290 nm, which can be caused by the different 
environments of Tyr and Trp in the presence of GTPγS. It was shown that pool 3 GPA1 
can bind GTPγS (Figure 4.83), these results suggest that the structure of GPA1 is altered 
in the presence of different nucleotides. 
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Figure 4.115: Far-UV (A) and Near-UV (B) CD spectra for pool 3 with and without 
GTPγS and MgCl2. 
 
 One of the receptor interaction site on heterotrimeric G protein alpha subunits is 
their C-terminal helical region and this interaction results in a structural change. This 
was investigated by using receptor mimetic compounds, compound 48/80 (C48/80), 
mastoparan (MP) and Mas7 (highly active mastoparan analog). These compounds are 
known to interact with and activate mammalian G protein alpha subunits. Receptor 
mimetic compounds were added to GPA1 and CD spectra were recorded in order to see 
if any structural change occurred. MP and Mas7 are unstructured peptides and fold into 
a helical structure upon interaction with mammalian Gα [40]. 
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Figure 4.116: Ellipticity of pool 3 with and without C48/80. 
 
 In the presence of C48/80 the α helical signature bands at 208 nm and 222 nm 
were lost and  θ208 nm/ θ222 nm ratio was reduced to 0.45 from a value of 1.13 and θ222 nm 
was increased to -5200 from -6867 (Figure 4.116). 
 
wavelength (nm)
200 204 208 212 216 220 224 228 232 236 240 244 248
el
li
pt
ic
it
y 
(d
eg
 c
m
2  
dm
ol
 -1
)
-9000
-6000
-3000
0
3000
pool 3
pool 3 with MP , 100 µM
 
Figure 4.117: Ellipticity of pool 3 with and without 100 µM of MP. 
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 In the presence of MP the intensity of α helical signature bands at 208 nm and 
222 nm decreased and θ208 nm/ θ222 nm ratio was reduced to 0.33 from a value of 1.13 and 
θ222 nm was increased to -4242 (Figure 4.117). 
 
wavelength (nm)
200 204 208 212 216 220 224 228 232 236 240 244 248
el
li
pt
ic
it
y 
(d
eg
 c
m
2  
dm
ol
 -1
)
-9000
-6000
-3000
0
3000
pool 3
pool 3 with 100 µM Mas7  
 
Figure 4.118: Ellipticity for pool 3 with and without 100 µM Mas 7.  
 
 In the presence of Mas 7 the intensity of α helical signature bands at 208 nm and 
222 nm decreased and θ208 nm/ θ222 nm ratio was reduced to 0.38 from a value of 1.13 and 
θ222 nm was increased to -4148 (Figure 4.118). 
 The ellipticity increased upon addition of all three compounds, which may 
indicate that the α-helical content was decreased upon interaction with these receptor 
mimetic compounds. MP and Mas7 fold into a helical structure when interacting with 
GPA1. The subtracted curves show the change in pool 3 GPA1. 
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4.7.2 SAXS data analysis 
 SAXS data measurements were carried out on different GPA1 samples; affinity, 
anion exchange or gel filtration purified. Results are summarized below. 
 
1: Affinity purified GPA1 
 The protein was desalted and final buffer was 50 mM Tris HCl, pH 7.4, 0.3 M 
NaCl, 40 µM GDP and 2 mM MgCl2. Protein concentration was measured before 
SAXS data collection and was 1.22 mg/ml. 
 Affinity purification did not suffice to obtain pure and monodisperse recombinant 
GPA1. The intensity plot showed that the protein was aggregated and it was not 
possible to find a linear region for the Guinier estimation (data not shown).  
The intensity and Guinier plot for 4.36 mg/ml BSA are given in Figure 4.119. 
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Figure 4.119: Intensity plot (A) and Guinier plot (B) of BSA. 
The Guinier region was estimated with the AutoRg software [128]. 
 The Rg of BSA (3.05 nm) was calculated with sRg limits 0.71 - 1.295. The Rg 
can be converted to radius by multiplying with a factor of 1.29 for spherical particles. 
The radius of BSA estimated in this manner is 3.9 nm, but BSA (proteins) is (are) not an 
ideal sphere. Therefore, radius calculations should be done according to distance 
distribution function. 
R (nm)
0,5 1,5 2,5 3,5 4,5 5,5 6,5 7,5 8,5
P
 (
R
)
0
5
10
15
20
 
Figure 4.120: The distance distribution function of BSA.  
The R max was set to 9.0 nm and the Rg was 3.05 nm. 
 The distance distribution function for a homogeneous particle gives the 
probability of finding two volume elements of the particle separated by a distance R. 
The radius of BSA was estimated~3.5 nm from P(R) plot (Figure 4.120).  
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2: Anion Exchange Purified GPA1 (stg.2.2.1) 
 Pool 3 and pool 4 GPA1 were stored in 20 mM HEPES, pH 8.0 50 mM NaCl, 20 
µM GDP and 10% glycerol at -80 ºC and were transported to EMBL, Hamburg on dry 
ice. Since both samples contained 10% glycerol, dialysis was done against 50 mM 
HEPES pH 8.0 and 50 mM NaCl. Following dialysis samples were centrifuged using an 
airfuge (Beckman) and concentrations (Table 4.19) were measured using a nanodrop 
spectrometer (Thermo Scientific). Pool 4 GPA1 was significantly aggregated as judged 
from intensity plot and it was not possible to find a linear region for the Guinier 
estimation (data not shown). 
 
Table 4.19: Concentration estimations for pool 3 (stg.2.2.1). 
 Absorbance (AU) Concentration 
sample 260 nm 280 nm mg/ml 
pool 3 0.675 0.561 0.356 
pool 3 air 0.618 0.507 0.316 
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Figure 4.121: Intensity plot for anion exchange GPA1 pool 3.  
Data collected from the supernatant after airfuge centrifugation. 
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Figure 4.122: Guinier plot for anion exchange GPA1 pool 3. 
Data collected from the supernatant after airfuge centrifugation. The Guinier region was 
estimated with the AutoRg software. 
 
Table 4.20: Summary of SAXS measurements and MM estimations. 
    Auto RG MM,kDa 
sample concentration I(0)/c Rg points quality, % Expected calculated 
BSA 4.5 313.13 2.98 72 77 67   
pool 3 
air 0.3 282.12 3.66 40 58 48 60 
 
 Pool 3 sample was expected to have a higher molecular mass than that of GPA1 
and SAXS measurements verified this (Table 4.20 and Figure 4.121). Still the data was 
not sufficient for building a low resolution structural model. The DLS measurements 
before airfuge centrifugation showed a radius of 100 nm for pool 3 (Figure 4.37).  
 
 
 
 153 
3: Size exclusion purified GPA1 (stg. 3.2.1, Lubrol-PX)  
 GPA1 was purified from Sephacryl S-200 HR 16/60 (Buffer D) and samples were 
stored in 20 mM HEPES, pH 8.0, 150 mM NaCl, 1 mM DTT, 5% glycerol and 5 mM 
MgCl2 at 4 ºC and were transported to EMBL, Hamburg on ice. The S-200 fractions 
were pooled according to their elution volumes from column and 4 pools were obtained 
with the estimated MM (Table 4.21). Samples were stored at +4 ºC until measurement 
(3 days). 
 
Table 4.21: Molecular mass estimations from column calibration curve. 
 Ve MM, kDa 
pool 1 35.88 247.6 
pool 2 40.87 143.3 
pool 3 43.62 108.1 
pool 4 47.37 75.1 
 
 The buffer was exchanged to remove the glycerol in the samples using Vivaspin 
500, 30,000 MWCO (Sartorius) to 20 mM HEPES, pH 8.0, 150 mM NaCl and 1 mM 
DTT prior to SAXS data collection. Protein concentrations were measured using a 
Nanodrop spectrometer (Table 4.22). 
 
Table 4.22: Concentration estimations for GPA1 pools (stg. 3.2.1). 
 Absorbance (AU) A254/A280 
Concentration 
(Eqn 1)               (Eqn2) 
Sample 254 nm 260 nm 280 nm  mg/ml mg/ml 
pool 1 0.773 0.873 1.56 0.49 1.754 1.4 
pool 2 1.147 N.A 2.721 0.42 - 2.44 
pool 3 1.452 1.816 3.131 0.46 3.473 2.82 
pool 4 0.622 0.725 1.25 0.49 1.386 1.12 
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Figure 4.123: Comparison of scattering plots of GPA1 with different molecular masses. 
 
 The scattering plots verify the expected molecular mass difference within 
different pools of GPA1, pool 1 with the highest and pool 4 with the lowest I(0) value 
(Figure 4.123). 
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Figure 4.124: A: Scattering pattern of S-200 pool 1 GPA1 (two consecutive 
measurements). B: Guinier plot for pool 1 GPA1, sRg limits 0.732-1.297. 
 
 Figure 4.124 shows that there is no detectable radiation damage in the small angle 
region, since the scattering profiles overlay in the small angle region. 
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Figure 4.125: Scattering plot (A) and Guinier plot (B) for S-200 pool 2. sRg limits: 
0.808 to 1.202. 
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Figure 4.126: Scattering plot (A) and Guinier plot (B) for S-200 pool 3. sRg limits: 0.81-
1.297. 
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Figure 4.127: Scattering plot (A) and Guinier plot (B) for S-200 pool 4. sRg limits: 
0.867-1.302. 
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Figure 4.128: Scattering plot (A) and Guinier plot (B) of BSA (3.91 mg/ml). sRg limits 
0.597-1.255. 
 
Table 4.23: MM estimations from SAXS data of BSA and S-200 pools. 
    Auto RG MM, kDa Calculated 
Ratio 
MM 
sample mg/ml I(0)/c Rg (nm) points quality, % theoretical SAXS Column SAXS/the 
BSA 3.91 0.79 3.18 ±0 91 87 67 - -   
pool 1 1.14 2.97 7.44±0.02 34 94 48 252 247.6 5.247 
pool 2 2.44 2.13 5.98±0.03 37 88 48 181 143.3 3.763 
pool 3 2.82 1.57 5.43±0 40 87 48 133 108.1 2.774 
pool 4 1.12 1.35 4.98±0 39 83 48 114 75.1 2.385 
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Table 4.24: Comparison of Rg (Guinier), volume (Porod) and diameter (DLS).  
 Guninier Porod DLS 
Sample I(0)/c Rg (nm) I(0)/c Rg (nm) Ex.volume (nm) d (nm) 
pool 1 2.97 7.44 2.89 7.21 808.8 25 
pool 2 2.13 5.98 2.12 5.98 501.94 20 
pool 3 1.57 5.43 1.566 5.44 420 N.A. 
pool 4 1.35 4.98 1.36 4.98 342.35 15 
 
 The molecular mass estimations from SAXS data are given in Table 4.23. The 
intensity plots for all S-200 GPA1 samples (Figure 4.125 - Figure 4.127) were different 
from intensity plot of BSA (Figure 4.128). The plots were similar to those of protein-
micelle complex and/or multi domain protein complexes [130-132]. The molecular 
mass estimations support the presence dimers in case of pools 2, 3 and 4 and tetramers 
for pool 1 and possibly another component that increases the mass in solution. This may 
be Lubrol-PX in the purified protein as shown by NMR (Figure 4.99).  
 The average particles size estimations are given in Table 4.24, Rg values 
calculated from Guinier and Porod plot match. The Porod volume is the excluded 
volume of the hydrated particle which equals to four time of the volume for a hard 
sphere [133]. The estimated particle diameter using the values of the radius of gyration 
were in agreement with DLS measurements. The DLS measurements verify the 
presence of a nearly monodisperse solution with decreasing particle size according to 
elution volume (Figure 4.129-Figure 4.131). 
 
 158 
0
5
10
15
0.1 1 10 100 1000 10000
In
te
n
s
ity
 (
%
)
Size (d.nm)
Size Distribution by Intensity
Record 600: GPA1, 17112008 S 200 f 11 void Record 601: GPA1, 17112008 S 200 f 11 void
Record 602: GPA1, 17112008 S 200 f 11 void  
Figure 4.129: DLS size distributions by intensity of GPA1 pool 1 (stg.3.2.1). 
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Figure 4.130: DLS size distributions by intensity of GPA1 pool 2 (stg.3.2.1). 
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Figure 4.131:DLS size distributions by intensity (A) and volume (B) GPA1 pool 4 
(stg.3.2.1). 
 
 Model calculations to determine structures that would give rise to the observed 
SAXS patterns were carried out using rigid body modelling. The scattering expected 
from the crystal structure for mammalian Gα on GPA1 was fitted to the experimental 
scattering profile using SASREF and GPA1 was modeled as an oligomeric protein 
[132]. The crystal structure 1GFI [134] monomer was used as template with different 
subunit numbers. Data points from 35-1300 corresponding a S range to 0.1513-3.0630 
nm-1 portion of the pool 4 scattering curve was selected in analyses. P1 overall 
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symmetry was chosen with angular units for momentum transfer (S) given by 4πsin(θ)/λ 
(nm-1). Results of several are given in Table 4.25. 
 
Table 4.25: SASREF Parameters and error values. 
     Shift from the origin 
Model monomers 
fraction to 
fit 
Penalty 
of shift best chi values X Y Z 
g111e 5 1 0.00192 1.73 -0.09 0 0.01 
g111f 5 0.5 2.8477 1.28 79.28 -79.5 81.57 
g111g 4 0.5 3.97213 1.37 138.68 132.67 -13.92 
g111h 6 0.5 0.00047 1.25 0 0.02 -0.01 
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Figure 4.132: SASREF fit (g111e) to scattering curve. 
5 monomers of GFI were used to fit on the total scattering curve (fraction to fit selected 
1.0). Best chi value was 1.738 at the end of simulated annealing.  
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Figure 4.133: SASREF fit (g111h) to scattering curve. 
6 monomers of GFI were used to fit with fraction to fit 0.5. Best chi value was 1.256 at 
the end of simulated annealing. 
 
 As a result the models g111e (5 subunits, Figure 4.132) and g111h (6 subunits, 
Figure 4.133) are selected as the most reliable models (Figure 4.134). The two models 
were superimposed by using SUPCOMB (Automatic Superposition of High- and Low-
Resolution Structural Models) [135]. The resultant model (g111er) from the 
superimposition of g111e and g111h is given in Figure 4.135 and overlay with 
individuals models is given in Figure 4.136. The crystal structure of 1GFI and the 
corresponding unit cell is given in Figure 4.137 and Figure 4.138 respectively. 
 
 
Figure 4.134: SASREF models.g111e (A) and g111h (B). 
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Figure 4.135: SUPCOMB superimposed model, g111er 
 
 
Figure 4.136: Overlay of g111er (gray) with g111e (A) and g111h (B). 
 
 
Figure 4.137: Crystal structure of 1GFI (Galphai bound to GDP and AlF4
-). 
      A: space fill model, B: stick model, GDP- AlF4
- is shown. 
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Figure 4.138: Unit cell structure of 1GFI (Gi with GDP and AlF4
-). 
 
 
 In summary according to SAXS data, the molecular mass of GPA1 is more than 
the expected MM of a dimer. SASREF analyses with known structures, on the other 
hand, suggest the presence of a molecule with shape resembling a pentameric Gα 
protein. The presence of detergent micelles increases the size of the molecule.  
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4.8 Expression of AGB1 and AGG1 / 2 subunits 
 In order to establish the A. thaliana heterotrimer, AGB1 and AGG1/2 proteins 
were cloned and expressed in E.coli using pGEX-4T-2 (GE Healtcare) and pQE-80L 
(Qiagen) vectors. pGEX-4T-2 results in GST fusion form of the recombinant proteins, 
whereas pQE-80L introduces an N terminal his tag with additional RGS residues. GST-
AGB1, GST-AGG1, RGS-his-AGB1 and RGS-his-AGG2 sequences were verified and 
the results are given in APPENDIX F. There was one silent mutation in GST-AGB1 
sequence. 
4.8.1 Cloning into pGEX-4T-2 vector 
 The TAIR plasmids (Table 3.1) harboring the genes encoding AGB1 and AGG1 
were isolated from host E. coli DH10B and PIR1 cells respectively and used as 
templates in PCR amplification. AGB1 and AGG1 were PCR amplified using primers 
designed according to the PUBMED sequences (Gene ID: 829597 and 825517 
respectively) with EcoRI and XhoI restriction enzyme sites (Table 4.26).  
Table 4.26: Primers designed for cloning into pGEX-4T-2.  
 Restriction enzyme sites are underlined. 
Primers for AGB1   
Forward Primer BF2  5’-AAACCCGAATTCCCATGTCTGTCTCCGAGCTCA-3’ 
   
Reverse Primer BR2 5’-TTTGGGCTCGAGTCAAATCACTCTCCTGTGTCC-3’ 
Primers for AGG1   
Forward Primer  FG1E  5’ AAACCCGAATTCCCATGCGAGAGGAAACTGTGG-3’ 
Reverse Primer RG1X  5’-TTTGGGCTCGAGTCAAAGTATTAAGCATCTGCA-3’   
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Figure 4.139: 1% Agarose gel electrophoresis analysis of PCR amplification of AGB1 
and AGG1 fragments. 
Lane 1: 100bp DNA ladder Plus®, lanes 2-7: AGB1 fragments, lanes 8-13: AGG1 
fragments. Lanes 2 & 8: 61.3 ˚C, lanes 3 & 9: 62.6 ˚C lanes 4 & 10: 64˚C, lanes 5 & 11: 
65.6 ˚C, lanes 6 & 12: 67˚C, lanes 7 & 13: 68.4 ˚C. 
 As can be seen from Figure 4.139, AGB1 of size 1200 bp (lanes 2-7) and AGG1 of 
size 300 bp (lanes 8-13) fragments were amplified at all annealing temperatures tested. 
AGB1 fragment amplified at 65.5˚C and AGG1 fragment amplified at 65˚C were used 
for cloning. Purified PCR products and pGEX-4T-2 vector were digested with 
restriction enzymes EcoRI and XhoI. 
 
Figure 4.140: 1% Agarose gel electrophoresis analysis of restriction enzyme digestion 
for insertion into pGEX-4T-2. Lane 1: 100 bp. DNA Ladder Plus ®. 
 
 Restriction enzyme digested PCR products and the linear vector (Figure 4.140) 
were ligated and E.coli TOP10F’ cells were transformed with different amounts of the 
ligation mixtures as described in chapter 3.2. Positive clones were chosen from the 
colonies that grew on LB-amp plates and the presence of inserts was verified by colony 
3000 bp 
500 bp 
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PCR and restriction enzyme digestion. The constructs chosen for expression were 
labeled GST-AGB1 and GST-AGG1. 
 
 
Figure 4.141: 1% Agarose gel electrophoresis analysis of colony PCR for pGEX-4T-2 
constructs. 
Lanes 1-6: AGB1, lanes 7, 8, 10-16: AGG1, lane 9: 100 bp.DNA Ladder Plus ®. 
 Colony PCR results shown in Figure 4.141 display strong bands around 1200 bp 
for AGB1 (lane 2) and around 300 bp for AGG1  (lanes 7,11 and 16). 
 
Figure 4.142: 1% Agarose gel electrophoresis analysis of restriction enzyme digestion. 
Lanes 1 and 7: pGEX-4T-2, lane 2: pGEX-4T-2-AGB1, lanes 3 and 9: pGEX-4T-2 
EcoRI / XhoI, lane 4: pGEX-4T-2-AGB1-EcoRI / XhoI, lane 5: AGB1 control lane 6: 
O'GeneRuler Mix ®, lane 8: pGEX-4T-2-AGG1, lane 10: pGEX-4T-2-AGG1-EcoRI / 
XhoI, lane 11: AGG1 control. 
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 The selected clones were verified by restriction enzyme digestion (Figure 4.142). 
These plasmids, GST-AGB1 and GST-AGG1 were selected for sequencing and after 
verification they were used for expression studies. 
4.8.2 Cloning into pQE-80L vector 
 The TAIR plasmids (Table 3.1) harboring the genes encoding AGB1 and AGG2 
were isolated from host E. coli DH10B and PIR1 cells to be used as template in PCR. 
AGB1 and AGG2 were PCR amplified using primers designed according to the 
PUBMED sequences (Gene ID: 829597 and 825532 respectively) with BamHI and 
KpnI restriction enzyme sites (Table 4.27). In the forward primers start codon was not 
included in order to fuse the coding sequence with the RGS-His tag. 
Table 4.27: Primers designed for cloning into pQE-80L. 
 Restriction enzyme sites are underlined. 
Primers for AGB1   
Forward Primer AGB1F  5’-AAAAGGATCCTCTGTCTCCGAGCT-3’ 
   
Reverse Primer AGB1R 5’-:TCTGGTACCAATCACTCTCCTGTG-3’ 
Primers for AGG2   
Forward Primer  AGG2F  5’-AAAGGATCCGAAGCGGGTAGCT-3’’ 
Reverse Primer AGG2R  5’-AAAGGTACCAAGAATGGAGCAG-3’   
 
 
Figure 4.143: 1% Agarose gel electrophoresis analysis of PCR amplification of AGB1 
and AGG2 with primers designed for pQE-80L. 
1200 bp 
300 bp 
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 Results of PCR, shown in Figure 4.143, indicate amplification of fragments 
AGB1, 1200 bp and AGG2, 300 bp long. 
 Restriction enzyme digested PCR products and the linear vector were ligated and 
E.coli TOP10F’ cells were transformed with different amounts of the ligation mixtures. 
Positive clones were chosen from the colonies that grew on LB-amp plates and the 
presence of inserts was verified by colony PCR and restriction enzyme digestion.  
 
 
Figure 4.144: 1% Agarose gel electrophoresis analysis of colony PCR with AGB1 
primers. 
 
Figure 4.145: 1% Agarose gel electrophoresis analysis of colony PCR with AGG2 
primers. 
 
 The colonies 5, 6 and 8 contain the AGB1 gene (Figure 4.144) and all colonies 
except 18 and 20 contain the AGG2 gene (Figure 4.145). Plasmids were isolated from 
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the selected colonies harboring the inserted genes. Plasmids were double digested with 
the restriction enzymes BamHI and KpnI to verify the presence of the inserts. 
 
 
Figure 4.146: 1% Agarose gel electrophoresis analysis of restriction enzyme digestion 
of selected plasmids. Lane 5: O'GeneRuler Mix ®. 
 
 Colonies 5 and 6 contain the AGB1 gene. All colonies tested for AGG2 contained 
the gene. Plasmids from colony 6 and colony 16 (Figure 4.146) were sequenced and 
after verification they were used for expression studies. The constructs were named 
RGS-his-AGB1 and RGS-his-AGG2. 
4.8.3 Expression and Purification of AGB1 
a. GST-AGB1  
 GST-AGB1 was obtained in inclusion body fractions and different host strains 
(BL21 (DE3) and BL21 (DE3) RIPL) and induction parameters (Table 4.28) were 
investigated to solubilize the protein. The molecular mass of GST is 27 kDa and that of 
AGB1 is 41 kDa, so that the recombinant fusion protein is expected to have a molecular 
mass of 69 kDa. 
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Figure 4.147: 12% SDS-PAGE analysis of GST-AGB1 expression at 18 ° C. 
Induction was with 0.3 mM IPTG for 4 hours. Lane 1: Protein ladder ®, lanes 2 and 5: 
lysate, lanes 3 and 6: supernatant (UP), lanes 4 and 7: pellet (IP). Samples were 
prepared with 6X loading dye. 
 
Table 4.28 Expression of GST-AGB1 in inclusion body fractions at different induction 
parameters. UP: urea soluble, IP: urea insoluble. 
Host Temperature 
IPTG, 
mM Fraction 
BL21(DE3) 37 ºC 0.6 IP 
BL21(DE3) 37 ºC 0.5 IP 
BL21(DE3) 28 ºC 0.5 IP 
BL21(DE3) 18 ºC 0.5 
UP and 
IP 
BL21(DE3) 18 ºC 0.3 
UP and 
IP 
BL21(DE3)RIPL 29 ºC 0.5 UP/IP 
 
 GST-AGB1 was not in soluble fractions even under low temperature and low 
IPTG conditions (Figure 4.147). In order to obtain soluble protein pQE-80L expression 
system was investigated. 
 
 
 
1            2      3       4        5      6       7 
 GST      GST-AGB1 
50 kDa 
25 kDa 
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b. RGS-his-AGB1 
 RGS-his-AGB1 construct was introduced into TOP10 and Rosetta 2 (DE3) cells. 
TOP10 cells harboring the RGS-his-AGB1 construct were induced with 0.5 mM IPTG 
at 25 °C. The expected size of the recombinant protein is ~ 44 kDa. The expression was 
screened by RGS-his–HRP antibody binding after transfer to PVDF membranes. 
 
 
  
Figure 4.148: Western analysis of RGS-his-AGB1 expression.  
A: Lane 1: Prestained protein MW marker ®, lanes 3-6: samples induced with 0.5 mM 
IPTG, lanes 7-9: non-induced samples. B: Lane 1: Prestained protein MW marker ®, 
lane 2: RGS-his-AGB1, lanes 4-7: pQE-80 empty vector induced with 0.5 mM IPTG. 
Membranes were incubated with 1:2400 antibody in Qiagen reagent. 
 
 The Western blots in Figure 4.148 indicated that the recombinant protein was 
expressed in the soluble cytosolic fraction 2 hours after induction at 25 ºC. 
 Several different purification conditions, given in Table 4.29, were investigated to 
improve the yield and homogenity of purified recombinant proteins. The results show 
that RGS-his-AGB1 was co-eluted with a 60 kDa contaminant protein at ~200 mM 
imidazole. There was another co-purifying protein with a molecular mass ~43 kDa, this 
protein was separated from RGS-his-AGB1 when NaPO4 buffers were used. The yield 
of RGS-his-AGB1 was very low for all the expression and purification conditions 
investigated. 
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Table 4.29: Purification Conditions for RGS-his-AGB1 
  Buffers       
Prep /Culture Lysis Purification 
Affinity 
Media Gradient Result 
1: Tris pH 8.0         
/ 100 ml -5 h 
50 mM Tris HCl, pH 8.0,  
5 % glycerol, 10 mM MgCl2,  
2 mM PMSF , EFPI 
50 mM Tris HCl pH 8.0, 300 
mM NaCl, 10 mM BME, 0.1 
mM PMSF and 10 mM 
imidazole 
Ni-NTA 
Agarose 
N.A Eluted in 
flowthrough 
2: PBS pH 7.5       
/ 100 ml -20 h  
1X PBS pH 7.5,  
0.5 mM MgCl2, 5 % glycerol,  
1 mM DTT , EFPI 
Binding:Lysis Buffer, 
Wash: 5 mM imidazole in 
Lysis Buffer  
Ni-NTA 
Agarose 
N.A 150 and 200 
mM imidazole, 
very low 
amount. 
3: NaPO4 pH 
7.0    
/ 170 ml -5 h 
50 mM NaPO4, pH 7.0,  
150 mM NaCl, 10 mM MgCl2,  
5% glycerol, 2 mM PMSF, EFPI 
Binding:Lysis Buffer              
Wash: 10 mM imidazole in 
Lysis Buffer  
HisTrap  
HP, 5 ml 
10-400 mM 
imidazole, 6 CV 
200 mM 
imidazole,very 
low amount. 
4: NaPO4, pH 
elution                 
/ 500 ml - 5 h 
50 mM NaPO4, pH 7.0,  
150 mM NaCl, 10 mM MgCl2,  
2 mM PMSF, EFPI 
Binding:Lysis Buffer              
Wash: 30 mM imidazole in 
Lysis Buffer, pH 7.2  
HisTrap  
HP, 5 ml 
30-400 mM 
imidazole ( pH 
7.2 to 7.5),  
6 CV 
200 mM 
imidazole with 
60 kDa protein. 
43 kDa protein 
separated.  
5: NaPO4 pH 
7.0, Lubrol          
/ 500 ml - 5 h 
50 mM NaPO4, pH 7.0,  
150 mM NaCl, 10 mM MgCl2,  
2 mM PMSF, 1 mM EDTA,  
0.1 % Lubrol, EFPI 
Binding:Lysis Buffer              
Wash: 30 mM imidazole in 
Lysis Buffer,with 0.05% 
Lubrol, 1mM DTT and no 
EDTA  
HisTrap 
 HP, 5 ml 
30-400 mM 
imidazole, 6 CV 
200 mM 
imidazole with 
60 kDa protein. 
43 kDa protein 
separated 
6: Tris pH 8.9        
/ 600 ml - 5 h 
50 mM Tris HCl, pH 8.9,  
150 mM NaCl, 10 mM MgCl2,  
5% glycerol, 2 mM PMSF, EFPI 
Binding:Lysis Buffer              
Wash: 10 mM imidazole in 
Lysis Buffer  
HisTrap 
 HP, 5 ml 
10-400 mM 
imidazole, 6 CV 
200 mM 
imidazole with 
60 kDa and 43 
kDa protein 
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• Purification with aPO4 Buffer , pH elution 
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Figure 4.149: HisTrap HP column chromatogram of elution of RGS-his-AGB1 with 
linear imidazole and pH gradient.  
Imidazole gradient (- - -) and absorbance at 280 nm (−) are shown. 
 
 The linear gradient resulted in the separation of 3 main peaks (Figure 4.149), 
fractions of which were pooled and buffer exchanged either by dialysis or by desalting 
on a HiTrap desalting column using 50 mM NaPO4, pH 7.0, and 150 mM NaCl buffer. 
 
 
Figure 4.150: 12% SDS-PAGE analysis of HisTrap HP column fractions.  
Lane 1: Protein ladder ®, lane 2: CL, lanes 3-5: FT, lane 6: wash, lane 7: peak 1 first 
fraction, lane 8: pool 1, lane 9: pool 1 desalted, lane 10: pool 1 dialyzed. Proteins in 
lanes 2-6 were prepared with 3X, others were prepared with 6X loading dye. 
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Figure 4.151: 12% SDS-PAGE analysis of HisTrap HP column fractions.  
Lane 1: Prestained Protein ladder Plus ®, lane 2: peak 2 first fraction, lane 3: peak 2 
pool, lane 5: peak 2 last fraction, lane 6: desalted pool, lane 7: dialysed pool, lanes 8-9: 
peak 3 fractions. Samples were prepared with 6X loading dye. 
 
 The dominating protein in pool 1 had a molecular mass between 40-50 kDa 
(Figure 4.150) whereas the major component in pool 2 was in the range 55-70 kDa 
(Figure 4.151). There were two proteins with molecular masses ~43 kDa in pool 2. 
RGS-his-AGB1 was identified by Western blot with RGS-his-HRP antibody. 
 
 
Figure 4.152: Western analysis of HisTrap HP column fractions.  
Lane 1: Prestained protein ladder ®, lane 2: CL, lane 3: FT, lane 4: wash, lane 5: pool1, 
lane 7: pool 1 dialyzed, lane 8: pool 2, lane 9: pool 2 desalted, lane 10: pool 2 dialyzed. 
Membrane was incubated with 1:3000 RGS-his –HRP and film was exposed for 1 
minute. 
 
 The signal from antibody was seen only for pool 2 fractions after 1 min (Figure 
4.152) or 30 min exposure (data not shown). The dominant protein in pool 1 was 
probably another protein of similar molecular mass. 
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• Purification with Tris Buffer pH 8.9 
 
Figure 4.153 HisTrap HP column chromatogram of elution of RGS-his-AGB1 with a 
linear imidazole gradient.  
Imidazole gradient (green), absorbance at 280 nm (blue) and fraction numbers (red) are 
shown. 
 
 
 
Figure 4.154: 12% SDS-PAGE analysis of HisTrap HP column fractions.  
Lane 1: Protein MW marker ®, lane 2: CL, lanes 3-4: FT, lane 5: wash, lane 6: f51, lane 
7: f54, lane 8: f61, lane 9: f72. Samples were prepared with 6X loading dye. 
 
 60 kDa and ~43 kDa proteins co-eluted from HisTrap HP column (Figure 4.153 
and Figure 4.154). RGS-his-AGB1 was identified by Western blot with RGS-his-HRP 
antibody. 
 
 
 1      2        3     4     5      6      7        8       9     
35 kDa 
45 kDa 
 175 
 
 
Figure 4.155: Western analysis of HisTrap HP column fractions.  
Lane 1: CL, lanes 2-3: FT, lane 4: f55, lane5: f66. Membrane was incubated with 
1:2000 RGS-his-HRP and film was exposed for 1 min. 
 
 The RGS-his-AGB1 protein was purified from cells with Tris pH 8.9 buffer, but 
most of the protein was lost in flow-through fractions (Figure 4.155). The proteins with 
molecular masses of 60 and 43 kDa were blotted onto PVDF membranes for Edman 
degradation. The results are given in Appendix I. The 60 kDa protein is similar to 
GRoEL, a chaperone protein. The 43 kDa band contains two proteins; the dominant one 
is E.coli lac repressor protein. The ratio of RGS-his-AGB1 in the sample was not 
enough to assign amino acids. 
 As a final approach the RGS-his-AGB1 construct was introduced into Rosetta 2 
(DE3) cells which contain an extra plasmid that supply the tRNA for the rare codons in 
E.coli for Arg (AGG, AGA,CGG), Ile (AUA), Leu (CUA), Pro (CCC) and Gly (GGA). 
The transformed cells were grown at 29 °C until OD reached 0.8 and were induced with 
0.5 mM IPTG. The results in Figure 4.156 show that the expression of RGS-his-AGB1 
was still very low and decreased after prolonged induction. As a control the expression 
of RGS-his-AGG2 was also screened to compare the expression levels. 
 
1           2          3        4      5 
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Figure 4.156: Western analysis RGS-his-AGB1 expression from Rosetta 2 (DE3) cells. 
Lanes 1-7: RGS-his-AGB1 screen, lanes 1-4: samples induced with 0.5 mM IPTG, 
lanes 5-7: non-induced samples. Lanes 8-11: RGS-his-AGG2 screen, samples induced 
with 0.5 mM IPTG. Membranes were incubated with 1:2000 antibody in Qiagen 
reagent. Exposure time was 10 minutes. 
 
4.8.4 Expression and Purification of GST-AGG1 
 GST-AGG1 was obtained in inclusion body fractions of BL21 (DE3) cells and 
different induction parameters (Table 4.30) were investigated to solubilize the protein. 
The molecular mass of GST is 27 kDa and that of AGG1 is 12 kDa, so that the 
recombinant fusion protein is expected to have a molecular mass of 39 kDa. GST-
AGG1 was found in urea insoluble inclusion body fractions (pellet) for all conditions 
screened, including induction at 18 °C with 0.3 mM IPTG (Figure 4.157). 
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Figure 4.157: 12% SDS-PAGE analysis of GST-AGG1 expression at 18 °C. 
Induction was done with 0.5 mM (lanes 1-3) or 0.3 mM (lanes 5-7) for 24 hours. Lanes 
1 and 5: GST-AGG1 lysate, lanes 2 and 6: GST-AGG1 supernatant (UP), lanes 3 and 7: 
GST-AGG1 pellet (IP), lane 4: Protein ladder ®, 8: GST lysate. Samples were prepared 
with 6X loading dye. 
 
Table 4.30: Expression of GST-AGG1 in inclusion body fractions at different induction 
parameters. UP: urea soluble, IP: urea insoluble. 
Host Temperature 
IPTG, 
mM Fraction 
BL21(DE3) 37 ºC 0.6 IP 
BL21(DE3) 37 ºC 0.5 IP 
BL21(DE3) 28 ºC 0.5 IP 
BL21(DE3) 18 ºC 0.5 IP 
BL21(DE3) 18 ºC 0.3 IP 
 
4.8.5 Expression and Purification of RGS-his-AGG2 
 TOP10 cells harboring the RGS-his-AGG2 construct were induced with 0.5 mM 
IPTG 25 °C. The expected molecular mass of the recombinant protein is ~ 14 kDa. The 
expression was screened by RGS-his–HRP antibody binding after transfer to PVDF 
membranes. The recombinant protein was expressed in the soluble cytosolic fraction 
after 4 hours of induction at 25 ºC (Figure 4.158). 
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Figure 4.158: Western analysis of RGS-his-AGG2 expression at 25 °C. 
Lane 1: Prestained protein MW marker ®, lanes 2-5: samples induced with 0.5 
mM IPTG, Lanes 6-8: non-induced samples. The membrane was incubated with 
1:2400 RGS-his-HRP. 
 
 Several different purification conditions, as indicated in Table 4.31 were 
investigated to improve the yield and homogeneity of purified recombinant proteins. 
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Table 4.31: Purification conditions for RGS-his-AGG2 
  Buffers         
Prep/Culture Lysis Purification Affinity Media Gradient Flowrate Result 
1: PBS pH 7.5        
/ 100 ml - 20h  
PBS pH 7.5, 0.5 mM 
MgCl2, 5 % glycerol, 1 
mM DTT , EFPI 
Binding:Lysis Buffer                 
Wash: 5 mM imidazole in 
Lysis Buffer  
Ni-NTA 
Agarose 
N.A N.A Eluted pure at 250 mM, 
150 and 200 mM 
imidazole; low purity. 
2: PBS pH 7.5       
/ 100 ml - 5 h 
PBS pH 7.5, 0.5 mM 
MgCl2, 5 % glycerol, 1 
mM DTT , EFPI 
Binding:Lysis Buffer                 
Wash: 10 mM imidazole in 
Lysis Buffer  
HisTrap HP, 5 
ml 
10-1000 mM 
imidazole, 6 
CV 
3 ml/min binding  and 
wash, 
1 ml/min elution 
Eluted at the end of 
gradient; 1M imidazole 
with high purity. 
3: NaPO4, pH 
7.0              / 
200 ml - 5 h 
50 mM NaPO4, pH 7.0, 
150 mM NaCl, 2 mM 
MgCl2, EFPI 
Binding:Lysis Buffer                   
Wash: 100 mM imidazole 
in Lysis Buffer 
Ni-NTA 
Agarose 
N.A N.A Eluted with 400 mM 
imidazole, purity lower. 
4: Tris pH 7.5,    
/ 150 ml /-5 h 
50 mMTris HCl pH 7.5, 
150 mM NaCl, 0.5 mM 
MgCl2, 5 % glycerol, 1 
mM DTT, 2 mM PMSF, 
EFPI 
Binding: Lysis Buffer                 
Wash: 10 mM imidazole in 
Lysis Buffer  
HisTrap HP, 5 
ml 
10-1000 mM 
imidazole, 6 
CV 
3 ml/min binding  and  
wash, 
1 ml/min elution 
Eluted with ~500 mM 
imidazole, high purity. 
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• Purification with PBS Buffer pH 7.5 
 Cell lysate, flow-through, wash and elution fractions were analyzed both by 
coomassie staining and RGS-his-HRP antibody binding.  
 
 
Figure 4.159: 15% SDS-PAGE analysis of Ni-NTA RGS-his-AGG2 fractions. 
Lane 1: FT, lane 2-3: wash 1-2, lane 4: Prestained protein ladder ®, lane 5-8: 1 ml 
elutions with 100, 150, 200 and 250 mM imidazole respectively. Samples were prepared 
with 6X loading dye. 
 
 
 
 
Figure 4.160: Western analysis of Ni-NTA RGS-his-AGG2 fractions. 
Lanes 1-4: elution fractions; 1: 100 mM, 2: 150 mM, 3: 200 mM and 4: 250 mM 
respectively. Membrane was incubated with 1:3000 RGS-his-HRP. 
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 High purity protein was obtained with 250 mM imidazole (Figure 4.159). In the 
western blot there are high molecular mass proteins/complexes that give a significant 
signal (Figure 4.160). 
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Figure 4.161: DLS size distributions by intensity of RGS-his-AGG2 (A) and (B) PBS 
buffer. 
 The DLS measurements (Figure 4.161) were not conclusive since the buffer itself 
contains particles with similar size to those observed in the protein solution. 
• Purification with aPO4 Buffer pH 7.0 
 
Figure 4.162: 15% SDS-PAGE analysis of batch purification RGS-his-AGG2 fractions. 
Lane 1: CL, lane 2: FT, lanes 3-5: wash, lanes 6-7:400 mM imidazole elutions 1 and 2, 
lane 10: protein ladder ®. Samples in lanes 1-5 were prepared with 2X; others were 
prepared with 6X loading dye. 
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Table 4.32: Absorbance values and concentration estimations for RGS-his-AGG2  
 Absorbance (AU) cocnentration 
Sample 260 nm 280 nm mg/ml 
RGS-his-AGG2 E1 1.02 0.63 0.5355 
RGS-his-AGG2 E2 0.54 0.35 0.2975 
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Figure 4.163: UV spectra of RGS-his-AGG2.  
 The samples were eluted with 5 ml imidazole buffer. The absorbance of proteins 
at 280 nm was measured (Figure 4.163 and Table 4.32) and concentrations were 
calculated with a theoretical extinction coefficient of 0.85. The total protein in E1 was 
2.6 mg and 1.5 mg in E2. The total yield was ~4 mg protein / 200 ml culture. The 
protein purity was lower in NaPO4 buffer than with PBS. The particle diameter was 
found ~10 nm by DLS measurements (Figure 4.164). 
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Figure 4.164: DLS size distributions by volume of RGS-his-AGG2 (elution 2). 
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• Purification with Tris Buffer pH 7.5; Column Purification 
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Figure 4.165: HisTrap HP chromatogram of RGS-his-AGG2 elution with a linear 
imidazole gradient.  
Imidazole gradient (- - -) and absorbance at 280 nm (−) are shown. 
 
 
Figure 4.166: 15% SDS-PAGE analysis of RGS-his-AGG2 fractions. 
Lane 1: Prestained protein ladder Plus ®, lane 2: RGS-his-AGB1 sample, lane 3: CL, 
lane 5: FT, lane 6: wash, lane 7: peak 1 fraction lanes 8-10: peak 2 fractions, first, top 
and last. Samples in lanes 3, 5 and 6 were prepared with 2X; others were prepared with 
6X loading dye. 
 
 Pure RGS-his-AGG2 was eluted with ~500 mM imidazole (Figure 4.165 and 
Figure 4.166) and fractions were pooled and dialyzed against 50 mM Tris HCl, pH 8.9, 
150 mM NaCl, 1 mM PMSF. After dialysis the absorbance value at 280 nm was 0.261 
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(Figure 4.167) and concentration was 0.22 mg/ml. The total yield was 1.33 mg /150 ml 
culture. 
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Figure 4.167: UV spectra of RGS-his-AGG2.  
 
 The pool was further characterized by DLS, and the size distribution was similar 
to that in PBS. Unlike PBS there was no contribution from the buffer to the size 
distribution (Figure 4.168). 
 
0
20
40
60
80
100
0.1 1 10 100 1000 10000
In
te
n
s
ity
 (
%
)
Size (d.nm)
Size Distribution by Intensity
Record 570: AGG2 11.11 pool AD Record 571: AGG2 11.11 pool AD
Record 572: AGG2 11.11 pool AD  
Figure 4.168: DLS size distributions by intensity of RGS-his-AGG2 after dialysis. 
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4.8.6 Dimerization 
 Attempts to produce AGB1 and AGG1/2 dimers in vitro were carried out on 
purified proteins in buffer NaPO4, pH 7.0 purified from prep number 3 (Table 4.29) and 
prep 2 (Table 4.31) respectively. The proteins were concentrated and the buffer was 
exchanged to NaPO4, pH 7.0 using an Amicon YM-3 kDa Centricon unit.  
 Equal volumes of each protein (without taking into account concentration 
differences) were combined and equlibriated at room temperature for 2 hours before 
storing at -20 ºC. The presence of dimers was monitored by loading a non-denatured 
sample onto SDS-polyacrylamide gels together with boiled samples in denaturing 
loading dye. The non-denatured sample was prepared with 6X native loading dye and 
was not boiled. 
 
Figure 4.169: Western analysis of complexes of RGS-his-AGB1 and RGS-his-AGG2. 
Lane 1:RGS-his-AGB1, desalted Ni-NTA fraction, lanes 3-5: RGS-his-AGG2, Ni-NTA 
elution, concentrated and desalted, lane 8: dimer with 6X SDS loading dye, lane 9: 
dimer with 6X native loading dye. Membrane incubated with 1:2000 RGS-his HRP. 
 
 A comparison of the bands in western blot analysis shown in Figure 4.169 lanes 8 
and 9 reveals the presence of large molecular mass components in the non-denatured 
sample (lane 9). This experiment was repeated with RGS-his-AGB1 and RGS-his-
AGG2 samples from different purifications and the same result was obtained (data not 
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shown). The large molecular mass components seen only in non-denatured protein 
mixtures show that the two subunits can form complexes. 
 The intensity of RGS-his-AGB1 and RGS-his-AGG2 bands are lower in non-
denatured sample as compared to denatured sample. In the denatured sample (lane 8) 
the discrepancy between the concentrations of the beta and the gamma subunits is 
clearly seen.  
 In the non denatured samples 4 bands are observed. Band 4 corresponds to 
monomeric form of RGS-his-AGG2 and band 3 is observed also in the gamma subunit 
samples in lanes 3-5. Band 2 migrates to a position that is slightly above that observed 
for RGS-his-AGB1 and is likely to represent the dimer. Band 1 may represent 
complexes with varying gamma subunit content. Note that a band corresponding to 
RGS-his-AGB1 is missing and band 4 is significantly weaker than the corresponding 
band in lane 8. 
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CHAPTER 5 
5 DISCUSSIO 
 The structures of the plant G-protein heterotrimer or the individual subunits are 
not yet known, unlike the mammalian heterotrimer, which is both biochemically and 
structurally well characterized. 
 Sequence homologies show that plant heterotrimeric G proteins contain the 
functional domains present in mammalian counterparts and models generated based on 
sequence alignments point to a very similar structure. 
 Mammalian Gα was mainly produced using E.coli or insect cells, or was directly 
isolated from native tissue. Chimeric or N-terminus truncated proteins were produced in 
some cases to increase expression levels and solubility [14]. The general purification 
procedure for E.coli produced mammalian Gα involved DEAE ion exchange, phenyl 
sepharose hydrophobic interaction chromatography, followed by Q Sepharose anion 
exchange and/or gel filtration [136]. His-tagged recombinant Gα was purified using a 
nickel affinity purification followed by a anion exchange chromatography procedure 
[56]. Our initial plan for purification of GPA1 from P.pastoris followed a similar line. 
 Gβ and Gγ subunits were either isolated from tissue or recombinantly produced 
from insect cells [26] or by in vitro translation [25]. Gβ was shown to be unstable in the 
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absence of Gγ. Separately produced proteins were shown to dimerize, co-
expression/translation is not necessary for dimerization [25] 
 We have been working on recombinant protein production mainly for structural 
analysis which requires highly purified and monodisperse protein at high concentration. 
 Protein quality is affected by main factors, including ionic strength and pH of the 
environment, the stability of the buffer system used, storage conditions and freeze-thaw 
cycles, and presence of ligands or other proteins. The stability of the recombinant 
proteins can be modified by changing any of these parameters. Well-defined and 
reproducible methods must be developed to analyse these changes. 
 There are several possible outcomes if the correct parameters are not applied; the 
most important ones are degradation and aggregation. Western transfer can detect 
degradation if there are availiable antibodies against different sites of the protein. 
Aggregation can be detected by native polyacrylamide gels and also with uv-vis 
spectrophotometry and dynamic light scattering measurements. 
 Following initial purification trials, it was shown that the purification results differ 
from those of mammalian Gα expressed in E.coli with the above mentioned parameters. 
The purification procedure was optimized in detail as discussed below. 
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5.1 Purification of GPA1 
 The present study is, to our knowledge, the first report in the literature on 
expression of GPA1 in a eukaryotic expression system for purification and biophysical 
characterization of the recombinant protein. The GPA1 gene was introduced into the 
genome of P.pastoris with a C-terminal his tag and recombinant protein expression was 
optimized with respect to cell viability and protein amount. In order to improve the 
amount of protein methanol addition time was optimized and cells were harvested at the 
48th hour of induction, methanol was supplemented at 6th and 24th hours during 
induction. GPA1 could be synthesized satisfactorily in the P. pastoris system, however, 
the level of protein expression was not reproducible which is an observation made also 
by others for other proteins [137, 138]. Similarly, the effect of proteolytic enzymes was 
also variable despite the use of protease inhibitors. 
 The initial step of purification involved isolation of the recombinant GPA1 from 
the cell lysate by nickel affinity chromatography. The best results were obtained using a 
Ni-NTA agarose matrix for batch purification. GPA1 was eluted with 300 mM 
imidazole in elution buffers. GPA1 co-purified with contaminating proteins of mass 
~90, ~80 and ~40 kDa. (Figure 4.14) The 40 kDa protein appears to be a common 
contaminant of nickel affinity purification from P.pastoris [139]. The 90 kDa protein 
was later shown to be an oligomeric form of GPA1 that formed via intermolecular 
disulfide bridges (Figure 4.30). 
 The heterogeneity in affinity purified GPA1 preparations was also shown by DLS 
measurements (Figure 4.17). Removal of imidazole by desalting increased the sample 
homogeneity but resulted in protein loss (Table 4.6). Therefore dialysis was performed 
routinely. Following buffer exchange, GPA1 was found to be stable when stored with 
GDP and glycerol. The affinity elution buffer supplemented with glycerol was the 
optimum condition for storage (Figure 4.20). Affinity purified GPA1 was stored at -20 
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°C with 10 % glycerol and buffer exchange was done immediately before further 
purification steps. 
 The initial protein characterization was done by monitoring the UV spectrum, 
which indicated the presence of GDP in the protein solutions. For protein concentration 
calculations an equation which took into account the presence of nucleotides was 
therefore used [124]. Excess GDP was added to affinity purification buffers to stabilize 
GDP - GPA1. Excess nucleotide resulted in a broad peak extending between 250 and 
290 nm (Figure 4.15). After desalting, the excess nucleotide was removed, and the 
spectrum was dominated by a peak at 280 nm (Figure 4.22). The measurements of 
GPA1 desalted pool against a buffer without GDP still displayed a hump at 254 nm, 
which verified the presence of bound GDP (Figure 4.77). 
 Detergents were included in lysis and purification buffers in order to increase the 
amount of solubilized GPA1 and to improve protein stability. The effect of Triton X-
100 and Lubrol-PX were screened. These two detergents have high aggregation 
numbers and therefore result in micelles with high molecular mass. Both detergents 
were shown to effectively solubilize and stabilize membrane integrated proteins without 
severely affecting protein activity [119]. Furthermore, Lubrol-PX is a routinely used 
detergent in Gα activity assays in order to mimic the physiological environment of the 
protein [126]. In the presence of Triton X-100 lysis efficiency was better, but the phenyl 
group of the detergent molecule interfered with the UV measurements (Figure K 10). 
Further addition of AlF4
- increased the amount and purity of GPA1 at the nickel affinity 
step. A similar observation was made by Willard and Siderovski in their work on 
purification of 6his-GPA1 from E.coli [107]. 
 Both detergents formed micelles with diameter ~8.5 nm as shown by DLS (Figure 
K 5 and Figure K 8). GPA1 purified in the presence of Triton X-100 showed 2 different 
distributions of particles with diameters 15 and 50 nm (Figure 4.26), which may 
correspond to protein detergent complexes and/or their higher oligomeric forms. 
Dialysis resulted in further oligomerization of smaller particles (Figure 4.28). GPA1 
affinity purified with Lubrol-PX formed relatively smaller particles, again with 
diameters increasing after dialysis (Figure 4.32). 
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 Affinity purified GPA1 was found to bind ~0.72 mole GDP/mole protein and 1 
mole GDP/mole protein, respectively in the absence and presence of Lubrol-PX (Table 
4.14). GTP binding was analyzed with radioactive GTPγS and was found to be 0.3 mole 
GTPγS/ mole protein (Figure 4.82). 
 The helical content of affinity purified GPA1 was verified by far-UV CD spectra. 
The near-UV region in CD spectrum of Triton X-100 (±AlF4
-) purified GPA1 had more 
distinct signals (Figure 4.110) compared to those purified with Lubrol-PX, where the 
signal/noise ratio was lower. This may be attributed to the stronger stabilizing effect of 
Triton X-100. CD was previously used by McCusker and Robinson to determine the 
quality of refolded Gα from inclusion bodies from E.coli [140]. These authors show that 
the features observed in the near-UV CD spectrum can serve as indicators of proper 
folding. Comparison of the signals between 260-280 nm with the control Gαi [140] 
indicated that GPA1 produced from P.pastoris was folded correctly (Figure 4.109 and 
Figure 4.110). Similarly Mannelli et. al. [41] also used CD to verify quality of 
secondary structure of nickel affinity purifed Gαo/i  
 Anion exchange chromatography resulted in separation of two different forms of 
GPA1, designated as pool 3 and pool 4 (Figure 4.33). Anion exchange pool 3 GPA1 
was pure and free of degradation products that were formed during lysis/ affinity 
purification (Figure 4.39). Pool 3 GPA1 was composed of large molecules with 
diameter ~100 nm (Figure 4.37).) and this oligomeric form was stable upon storage or 
lyophilization (Figure 4.47 and Figure 4.45). It was also resistant to degradation or 
further aggregation (Figure 4.46).  
 Pool 3 was shown by CD measurements to possess both secondary α helical and 
tertiary structure. In the presence of GTPγS the θ222nm and θ208 nm values were lower as 
compared to those of the GDP bound form (Figure 4.115). This may indicate a structure 
similar to Gαi. Gαi has a random coil N-teminus in GDP form and upon GTP binding 
this becomes buried in the protein, resulting in a better defined structure with a higher 
α-helical content [20].  
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 Interaction with receptor mimetic compounds was also shown by CD 
measurements. Previously, Tanaka et.al. had used N-terminal histag fusion Gαi from 
E.coli and reported that the interaction with receptor mimetic compounds is dependent 
on C-terminus by using N-terminus truncated forms [40]. Upon interaction with the 
receptor the C-terminal helical region may form a coiled-coil loosing its α-helical 
structure. This in turn will lead to a decrease in helical content and an increase in 
ellipticity values, as observed for pool 3 GPA1 in the presence of C48/80, MP and Mas7 
(Figure 4.116 to Figure 4.118). 
 In contrast, pool 4 GPA1 was a heterogenous solution containing the degradation 
products mentioned above (Figure 4.39) and was prone to both degradation and 
aggregation (Figure 4.46). Pool 4 GPA1 had GTP hydrolysis activity (Figure 4.87) in 
experiments done on fresh protein preparations but the functional stability was not 
determined. 
 The two forms of the protein had different GDP content as analysed by 
spectrophotometric measurements of both protein and filtrate. UV spectra showed that 
pool 3 GPA1 had higher amount of GDP as compared to pool 4 GPA1; 1.4 mole 
GDP/mole protein and 0.8 mole GDP/mole protein, respectively (Table 4.14). Pool 3 
GPA1 had slightly higher GTPase activity than pool 4, when Lubrol-PX was used in 
assay buffers (Figure 4.84). In contrast, both pools had comparable activity when 
detergent was not included in assay buffers (Table 4.16 and Table 4.17). 
 The environment of aromatic residues, as deduced from near-UV CD spectra, of 
pool 4 GPA1 was different from those in pool 3, indicating a difference in their 
conformation (Figure 4.111-Figure 4.114). 
 MALDI-TOF-MS results further supported different conformations because the 
trypsin digestion patterns of pool 3 and pool 4 GPA1 were different (Figure 4.107 and 
Figure 4.108). The lysine residues in GDP/GTP binding and putative receptor 
interaction sites were protected in pool 3 but were digested in pool 4 (APPENDIX I). 
Pool 4 did not contain any lipid modifications as deduced from the detected mass of the 
N-terminal fragments. On the other hand, pool 3 GPA1 N-terminal 6 amino acid 
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fragment (GLLCSR) was not detected at all. This can be due to its absence in the 
original sample or the high hydrophobicity of this region (with the lipid modifications 
both present) which may prevent this fragment from flying.  
 The MYR predictor (a server for myristoylation site detection) and CSS Palm 2.0 
(a server that detects palmitoylation targets) both predicted GLLCSR peptide as a 
potential myristoylation (Glycine) and palmitoylation (Cysteine) target (APPENDIX J). 
 In the case of mammalian Gα, a myristoylation deficient form of Gαi was shown 
to be localized in the cytosol [42], a palmitoylation mutant form of myristoylated Gαo 
was found in cytsosol in high amounts [45] and dual lipidated Gαo forms GTPγS non-
reversible oligomers [46]. In plants in vivo studies with fluorescent labeled proteins 
indicate that GPA1 is localized to PM [99] and mutations in the G2, C5 and G2C5 
residues resulted in distribution of GPA1 to both cytosol and PM [95]. Following these, 
our data indirectly supports the presence of the lipid modifications. The evidence are; 
membrane affinity of GPA1 (Figure 4.93), increased yield upon addition of detergents 
during affinity purification and a more stable GPA1 oligomer in pool 3. 
 Size exclusion chromatography was performed in order to separate the monomeric 
form of GPA1 from oligomers and to determine the molecular mass of the oligomers. 
According to our results purified GPA1 appeared in different oligomeric forms with 
masses between 50 kDa and 600 kDa. DLS measurements showed particles with a 
diameter of 10 nm for the lowest molecular mass fractions (Figure 4.131). 
 Results of size exclusion chromatography may be interpreted in terms of 
separation of monomer-oligomer mixtures with different equilibrium constants. 
Separation of the lowest molecular mass form was only achieved if the protein was 
purified with GDP- AlF4
- in the affinity purification step. Thus the presence of AlF4
- 
which is commonly used during Gα  purifications [21], appears to shift the equilibrium 
in favor of monomers. 
 Anion exchange pools (pool 3 and pool 4) and the low molecular mass GPA1 
obtained by gel filtration had GTP hydrolysis activity as shown by the release of 
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radioactive phosphate from 32P-GTP. The specific activity was shown to increase with 
higher protein purity (Figure 4.84). The presence of MgCl2 was essential for hydrolysis 
and additionally the presence of detergent resulted in a further increase in the amount of 
hydrolyzed Pi (Figure 4.88). S-300 purified GPA1 had a slightly higher GTP hydrolysis 
activity than pool 4 GPA1 (Figure 4.90). The presence of GTP or GTPγS inhibited 
radioactive Pi release, indicating competition (Figure 4.91). In the GDP or GTP bound 
state the presence of receptor mimetic compound MP resulted in an enhanced GTPase 
activity, whereas the activity decreased for the GTPγS bound form (Figure 4.92).  
 Recombinant expression of GPA1 from E.coli was investigated previously. Wise 
et al., produced protein by co-transforming a plasmid carrying the E.coli rare arginine 
codons. The protein was purified from an anion exchange column with yields of 1-2 
mg/L culture [76]. Willard and Siderovski cloned GPA1 in fusion with an N-terminal 
his tag and purified it by Ni-affinity followed by gel filtration using a 26/60 S-200 HR 
column. The yield of protein expression and purification as well as the elution volume 
from the column indicating the apparent mass of the purified protein was not reported 
[107]. Wang et al., also report purification of his tagged GPA1 using Ni-NTA agarose 
[99]. In GTP binding studies of recombinant GPA1, Wise et al., [76] found a ratio of 0.3 
mole GTP/mole protein. In another study, Johnston et al. [77] reports a significantly 
different ratio of 0.9 mole GTP/mole protein using the purification procedure of Willard 
and Siderovski [107]. In this last study, the recombinant GPA1 was suggested to be 
GTP bound most of the time and to have a very low hydrolysis rate, suggesting that in 
contrast to the mammalian Gα, GTP form of GPA1 is more abundant in the cell. The 
rate determining step in GTP hydrolysis was shown to be GDP release for mammalian 
Gα [38]. Wang et. al. report GTP binding activity but refrain from quantifying of the 
binding ratio. 
 Results of Wise et. al. and Johnston et al., should be interpreted cautiously due to 
complete lack of protein characterization. Our work shows that recombinantly 
expressed GPA1 is likely to be a heterogenous mixture contaning different forms of the 
protein. These forms differ in stability, oligomeric state and GDP content. Lack of 
quantification of GTP/GDP binding activity by Wang et al., may also be due to the 
heterogeneity of the protein produced in E.coli. 
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 Our results show that, during gel filtration GPA1 co-purified with detergents, 
when these were used in the affinity step. Proton NMR data analysis verified the 
presence of Lubrol-PX (Figure 4.99), and the molarity was found to be nearly equal to 
the added amount during affinity (Figure 4.101). Detergents added during affinity 
purification of other membrane integrated/TM proteins were shown to co-elute and 
were not separated even after extensive dialysis [131]. After anion exchange separation, 
neither of the GPA1 pools contained detergent, as shown by TCA stain (Figure 4.104). 
The absence of Triton X-100 was also verified by proton NMR spectra (Figure 4.103). 
 Small angle solution X-ray scattering experiments performed on affinity purified 
GPA1 showed the presence of a heterogeneous and aggregated protein pool, verifying 
the particle size distribution found in DLS measurements. Pool 3 GPA1 scattering data 
was better but it was still low quality, the molecular mass of the protein after airfuge 
centrifugation was estimated as 60 kDa, with a radius of gyration of 3.66 nm (Table 
4.20). Data collected from S-200 column purified GPA1 pools, each with different 
molecular mass, resulted in intensity plots similar to those protein-micelle solutions 
(Figure 4.123). The lowest molecular mass fraction from gel filtration eluted at a mass 
corresponding to ~75 kDa and SAXS measurements gave a molecular mass of ~100 
kDa for the same sample. This corresponds to ~2.5 fold of the theoretical molecular 
mass of GPA1 (Table 4.23). The calculated particle diameter using the Guinier 
approximation were in agreement with DLS measurements (Table 4.24). Attempts were 
made to model this oligomeric form of GPA1-Lubrol using a rigid body approach [132]. 
The high-resolution crystal structure for Gαi-GDPAlF4 [19] was used to estimate GPA1 
oligomeric state. A pentameric form that protein would fit the low angle region of 
GPA1 scattering plot within acceptable limits (Figure 4.132 and Figure 4.133). 
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5.2 Expression and Purification of AGB1, AGG1 and AGG2 
 AGB1 and AGG1 were expressed from pGEX-4T-2 vector as N-terminus GST 
fusions from BL21(DE)3 cells. Both proteins were produced in inclusion body fractions 
and attempts to solubilize the proteins failed even at very low temperature and IPTG 
concentrations (Figure 4.147 and Figure 4.157). 
 GST-AGB1 was found in the urea soluble pellet only when cells were grown at 18 
°C and induced with 0.3 mM IPTG. GST-AGG1 was always produced in the urea 
insoluble fractions. 
 A low copy and cis-repressed expression vector, pQE-80L was chosen to obtain 
soluble protein. Recombinant AGB1 and AGG2 were expressed as an N-terminal fusion 
with RGSHHHHHH amino acids. Cloning of AGG1 using pQE-80L expression system 
was not investigated. 
 RGS-his-AGB1 was produced in very low amounts from both TOP10 and Rosetta 
2 (DE) 3 cells. Affinity purification trials resulted in co-purification together with a 
contaminant protein of similar molecular mass (Figure 4.150 and Figure 4.152). This 
protein was identified as Lac repressor expressed from the vector itself (APPENDIX I). 
Cells expressing RGS-his-AGB1 were producing high levels of a 60 kDa protein 
(Figure 4.151), which was identified as E. coli chaperone GRoEL ((APPENDIX I). 
Both contaminants were expressed predominantly from cells carrying pQE-80L-AGB1 
and not from pQE-80L-AGG2. Considering the high numbers of rare E.coli codons in 
the AGB1 gene sequence, expression from Rosetta 2 (DE3) cells was investigated, but 
the amount of recombinant protein obtained from these cells was still very low (Figure 
4.156). The folding process/rate of AGB1 may be energetically unfavorable and slow; 
resulting in co-expression of the chaperone. Furthermore the co-expression of lac 
repressor may indicate that the AGB1 which is produced is toxic. 
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 Solubilization of GST-AGB1 from inclusion bodies and renaturation of the 
protein was not investigated, since we do not have a direct assay to control refolding 
into the native structure. 
 Cells harboring GST-AGG1 or RGS-his-AGG2 constructs grew to lower plateau 
levels than cell expressing AGB1 under all conditions tested (Appendix H). This can be 
due to the high expression levels of both Gγ subunits or leaky expression that may lead 
to toxicity. 
 RGS-his-AGG2 was produced from TOP10 cells in soluble fractions in moderate 
amount. The yield after affinity purification was approximately 1-4 mg per 150 ml 
culture. The highest purity protein was obtained with, Tris pH 7.5 buffer (Figure 4.166), 
but Na-PO4 buffer pH 7.0 and PBS pH 7.5 also resulted in separation from 
contaminants. According to UV spectrophotometry and DLS measurements (Figure 
4.163 and Figure 4.164), the affinity purification was optimized with Na-PO4 buffer. 
The particle diameter of RGS-his-AGG2 in solution obtained by DLS is approximately 
10 nm ie, much larger than expected for a 14 kDa protein. This can be due to the 
presence of contaminants in the affinity purified protein (Figure 4.162), but the amounts 
were very low as compared to AGG2. As the mammalian Gγ are unstructured and very 
elongated when not in complex with Gβ, our results suggests that this is also the case 
for plant Gγ. 
 Further optimization of RGS-his-AGG2 purification was not pursued considering 
the experimental difficulties of both purifying and characterizing this small molecular 
mass and probably unstructured protein. Furthermore the structural and functional effect 
of plant Gγ will be interesting when it is complexed with Gβ. 
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5.2.1 Dimerization 
 The formation of Gβγ dimer was analyzed by Western detection using RGS-his-
AGB1 and RGS-his-AGG2. Large molecular mass components, that do not match to 
size of either protein alone, were detected only for the non-denatured protein mixtures 
and were absent from samples loaded in SDS-sample buffer. Furthermore bands 
corresponding to individual proteins were weaker in the non denatured sample (Figure 
4.169). These results show that the two subunits can form complexes. 
5.3 Heterotrimer Formation 
 The interaction of GPA1 with AGB1/AGG2 dimer was shown by Western 
detection. The presence of dimer reversed the aggregation that was already present in 
higher molecular mass form (stg. 3.2.1) and furthermore protected GPA1 from 
degradation (Figure 4.94). 
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CHAPTER 6 
6 COCLUSIOS 
 The general aim of the work presented in this thesis was to investigate the 
structure of Arabidopsis heterotrimeric G proteins. To achieve this goal the Arabidopsis 
subunits were heterologously expressed. Purification schemes were developed, purified 
proteins were characterized and the structure of the alpha subunit was investigated by 
SAXS. 
 Recombinant GPA1 expression in P.pastoris and recombinant expression of 
AGB1, AGG1 and AGG2 in E.coli was achieved. His-tagged recombinant proteins 
could be purified from host organisms with variable yields. GPA1 was affinity purified 
with yields of 10-20 mg/L from P.pastoris. This is to our knowledge the first report of 
production of a plant Gα from an eukaryotic expression system. GPA1 was shown to 
bind GTP with a ratio of 0.3 mole GTP/ mole protein. 
 AGG2 was purified from small scale cultures with yields of about 1-4 mg per 150 
ml from E.coli. AGB1 yield was very low for all the conditions explored. This is to our 
knowledge the first study in the literature where plant Gβ subunit recombinant 
expression was shown. This work can provide a basis for future studies where co-
expression of AGB1 with AGG1/2 will be investigated to increase the yield. 
Dimerization of AGB1 and AGG2 and heterotrimer formation was detected by western 
blots. 
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 This is to our knowledge the first study in the literature where protein quality, 
homogeinity and oligomerization state have been systematically addressed for plant Gα 
proteins. Affinity purified GPA1 was shown to be heterogenous and two biophysically 
distinct forms (pool 3 and pool 4) were separated by anion exchange chromatography. 
Pool 3 appeared to be an oligomeric (as determined by DLS) stable form, whose folding 
was confirmed by CD measurements and had higher GDP content as shown by UV-
spectrophotometry. Pool 3 was bound to 1.4 mole GDP/ mole protein, whereas this ratio 
was 0.8 mole GDP/mole protein in pool 4. Pool 3 showed higher GTP hydrolysis 
activity in comparison to pool 4. Patterns of near-UV CD and trypsin digestion for mass 
spectrometry analysis indicated different conformations in the two pools. In future work 
kinetic parameters for GTPase activity should be determined to provide insight into 
activtation of the heterotrimer and signaling mechanism in plants. 
 Membrane localization, higher yield in the presence of detergents and a stable 
oligomeric form of purified GPA1 point to the presence of lipid modifications. Further 
work is required to clarify the presence/absence of lipid modifications and in order to 
perform structural comparisons with mammalian Gα. 
 Gel filtration in the presence of detergent resulted in the separation of different 
oligomeric forms of GPA1. The lowest molecular mass form was stabilized by AlF4
-. 
GPA1 was co-purified with the added amount of detergent as determined by proton 
NMR. 
 SAXS data of the lowest molecular mass and monodisperse form indicated 
protein-micelle structures in the solution. Rigid body models were compatible with 
oligomers of GPA1 resembling pentameric Gαi. Solution neutron scattering should be 
performed in order to gain more information about GPA1 conformation in the protein-
micelle complex. 
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APPEDIX A 
CHEMICALS 
(in alphabetical order) 
ame of Chemical  Supplier Company   Catalog umber 
Acetic Acid    Riedel-de Haén, Germany  27225 
Acrylamide/Bis-acrylamide   Sigma, Germany    A3699 
      Biorad Inc., USA   161-0158 
Agar-agar     Merck, Germany    101614 
Agarose low EO    Applichem, Germany   A2114 
Aluminum Sulfate    Fluka, Switzerland   60060 
Ammonium persulfate    Carlo-Erba, Italy    420627 
Ampicillin     Sigma, Germany    A9518 
Biotin     CALBIOCHEM, Germany  2031 
β-galactosidase    Sigma, Germany    G-2531 
Bromophenol blue sodium salt Applichem, Germany   A3640 
Chloroform    Merck, Germany    102431 
Complete EDTA-free    Roche, Germany    11 873 580 001 
Protease Inhibitor Cocktail Tablets 
Coomassie Brilliant Blue  Merck, Germany    115444 
Deuterium Oxide    Cambirdge Isotope    DLM-4-25 
      Laboratories Inc., USA 
Distilled water, sterile, MilliQ Millipore, France 
Filtered 
DTT      Fluka, Switzerland   43815 
EDTA     Riedel-de Haén, Germany  27248 
Ethanol     Riedel-de Haén, Germany  32221 
Ethidium Bromide   Merck, Germany    OCO28942 
D-(+) Glucose    Sigma, Germany    G-7021 
GDP      Sigma, Germany    G7127 
Glycerol     Riedel-de Haén, Germany  15523 
Glycine     Amresco, USA    0167 
GTP      Sigma, Germany    G8877 
GTPγS     Sigma, Germany    G8634 
HCl      Merck, Germany    100314 
HEPES     Fluka, Switzerland   54461 
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L-Histidine     Applichem, Germany   A3719 
Imidazole     Sigma, Germany    I0250 
IPTG      Promega, Germany   V39517 
Isopropanol    Riedel-de Haén, Germany  24137 
Kanamycin     Sigma, Germany    K4000.102 
KCl      Fluka, Switzerland   60129 
KH2PO4     Riedel-de Haén, Germany  04243 
KOH      Riedel-de Haén, Germany  06005 
Liquid nitrogen    Karbogaz, Turkey 
Lithium chloride    Fluka, Switzerland   62478 
(anhydrous) 
Lubrol PX     MP Biomedicals, France  195299 
Luria Agar     Sigma,Germany    L-3147 
(Miller’s LB Agar) 
Luria Broth    Sigma, Germany    L-3022 
(Lennox L Broth) 
2-Mercaptoethanol   Sigma, Germany  ,  M370-1 
Methanol     Riedel-de Haén, Germany  24229 
NaCl      Riedel-de Haén, Germany  13423 
NaF      Sigma, USA    201154 
NaO2C2H3.3H2O    Riedel-de Haén, Germany  25022 
NaOH     Merck, Germany    106462 
NaPO4H2     Riedel-de Haén, Germany  04269 
Peptone     Applichem, Germany   A2208 
Phenol     Applichem, Germany   A1153 
Phenol/chloroform   Applichem, Germany   A0889 
/isoamylalkohol 
PMSF     Amresco, USA    0754 
Sodium Dodecyl Sulphate  Sigma, Germany    L-4390 
D(-) Sorbitol    Applichem, Germany   A2222 
TEMED     Sigma, Germany    T-7029 
TritonR X-100    Applichem, Germany   A1388 
Tris      Fluka, Switzerland   93349 
Tween® 20     Merck, Germany    822184 
Yeast Extract    Applichem,Germany   A1552 
Yeast Nitrogen Base   Sigma, Germany    Y0626 
(with ammonium sulfate without amino acids) 
Zeocin     Invitrogen, Germany   R250 
32P-GTP (3000 Ci/mmol)  Izotop, Hungary    SCP-302 
35S-GTPγS (1000 Ci/mmol)  GE Healthcare, UK   SJ1320 
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APPEDIX B 
MOLECULAR BIOLOGY KITS 
(in alphabetical order) 
Name of Kit     Supplier Company  Catalog Number 
ECL Western Blotting Substrate  Pierce Protein Research Products 32109 
       Thermo Scientific, USA 
Quiaquick® PCR Purification Kit (250) Qiagen, Germany   28106 
Quiaquick® Gel extraction Kit (250) Qiagen, Germany   28706 
Quiaprep® Spin Miniprep Kit (250)          Qiagen, Germany                             27106 
QIAGEN® Plasmid Midi Kit (100)  Qiagen, Germany   12145 
RGS-His HRP Conjugate Kit  Qiagen, Germany   34450 
Silver Stain Kit     BIO-RAD, USA    161-046 
Tetra-His HRP Conjugate Kit  Qiagen, Germany    34470  
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APPEDIX C 
OTHERS 
(in alphabetical order) 
NAME      Supplier Company  Catalog Number 
BamHI      Fermentas, Germany   #ER0051 
BL21(DE3)     Stratagene, USA    200131 
CL-XPosure Film    Pierce Protein Research Products 34093 
       Thermo Scientific, USA 
CYROBANK MIXED COLOURS  MAST GROUP Ltd, UK  Cyro/M 
EcoRI      Fermentas, Germany   #ER0271 
Glass beads 0.5 mm d    Biospec Products,Inc, USA.  11079105 
HiPrep 16/60 Sephacryl S-200 HR  GE Healthcare, Sweden  17-1166-01 
HiPrep 16/60 Sephacryl S-300 HR  GE Healthcare, Sweden  17-1167-01 
HiPrep 26/10 Desalting Column  GE Healthcare, Sweden  17-5087-01 
HisTrap HP, 5 ml    GE Healthcare, Sweden  17-5248-02 
HiTrap Desalting, 5 ml    GE Healthcare, Sweden  17-1408-01 
HiTrap Q HP, 5 ml    GE Healthcare, Sweden  17-1154-01 
Hybond-P membrane (PVDF)  GE Healthcare, Sweden  RPN2020F 
KpnI       Fermentas,  Germany   #ER0521 
Lamda DNA/HindIII    Fermentas,  Germany   #SM0123 
(Agarose gel photograph and MW values of bands are provided below) 
Mass Ruler DNA Ladder,Mix  Fermentas, Germany   #SM0403 
(Agarose gel photograph and MW values of bands are provided below) 
MF™ Nitrocellulose Membrane Filters Millipore, Ireland  HAWPO2500 
0.45 µM HA 
Myc tag antibody (HRP)   abcam, UK     ab1326 
Ni-NTA Agarose     Qiagen, Germany   30230 
O'GeneRuler™ 100 bp    Fermentas, Germany   #SM1143 
O'GeneRuler™ 100 bp Plus   Fermentas, Germany   #SM1153 
O'GeneRuler™ Mix    Fermentas, Germany   #SM1173 
Protein MW Marker    Fermentas, Germany   #SM0431 
(gel photograph and MW values of bands are provided below) 
Prestained Protein MW Marker  Fermentas,Germany   #SM0441 
(gel photograph and MW values of bands are provided below) 
PageRuler™ Improved Prestained Protein Ladder Fermentas, Germany #SM0671 
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PageRuler™ Plus Prestained Protein Ladder Fermentas, Germany  #SM1811 
PageRuler™ Unstained Protein Ladder Fermentas, Germany    #SM0661 
Cellu•Sep T3; Nominal MWCO: 12,000-14,000 Bioron, Germany  O-1230-25 
Regenerated Cellulose Tubular Membrane 
Shrimp Alkaline Phosphatase  Fermentas, Germany   #EF0511 
Super loop, 50 ml, 4M Pa   GE Healtcare    18-1113-82 
T4 DNA Ligase     Promega, Germany   M180B 
Taq DNA polymerase    Fermentas, Germany   #EP0401 
TOP10      Invitrogen, Germany   Supplied      
                                                                                               with TOPO® TA Cloning Kit  
TOP10F’      Invitrogen, Germany     Supplied with 
              EasySelectTM Pichia Expression Kit 
Ultima Gold XR Scintillation Liquid Packard, USA    6013119 
Ultracel YM-30 membrane   Millipore, USA    4306 
Vivaspin 20, 30,000 MWCO   Sartorius, Germany   VS2022 
Vivaspin 500, 10,000 MWCO  Sartorius, Germany   VS0101 
Vivaspin 500, 30,000 MWCO  Sartorius, Germany   VS0121 
Zirconia/Silica beads, 0.5 mm  Biospec Products,Inc, USA  11079105z 
XhoI       Fermentas,  Germany   #ER0691 
 
O'GeneRuler™ 100 bp  100 bp.DNA Ladder Plus O'GeneRuler™ Mix  
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Protein MW Marker    Prestained Protein Molecular Weight Marker 
 
 
PageRuler™ Prestained Protein Ladder  PageRuler™ Unstained Protein Ladder  
 Plus     
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APPEDIX D 
EQUIPMET 
AKTA Prime  GE Healthcare, UK 
Autoclave:  Hirayama, Hiclave HV-110, JAPAN 
Balance:  Sartorius, BP211D, GERMANY 
   Sartorius, BP221S, GERMANY 
   Sartorius, BP610, GERMANY 
   Schimadzu, Libror EB-3200 HU, JAPAN 
Bead Beater   Biospec Products,Inc, USA  
Blot Module  X Cell II ™ Blot Module, Novex, USA 
CD Spectropolarimeter  JASCO J-810 , USA 
Centrifuge:  Eppendorf, 5415C, GERMANY 
   Eppendorf, 5415D, GERMANY 
   Eppendorf, 5415R, GERMANY 
   Kendro Lab. Prod., Heraeus Multifuge 3L, GERMANY 
   Hitachi, Sorvall RC5C Plus, USA 
   Hitachi, Sorvall Discovery 100 SE, USA 
Deepfreeze:   -70o C, Kendro Lab. Prod., Heraeus Hfu486 , GERMANY 
   -20o C, Bosch, TÜRKĐYE 
Distilled Water:  Millipore, Elix-S, FRANCE 
   Millipore, MilliQ Academic, FRANCE 
Electrophoresis:  Biogen Inc., USA 
   Biorad Inc., USA 
   X Cell SureLock ™ Electrophoresis Cell, Novex USA 
680 Microplate Reader  BIO-RAD, Japan 
Gel Documentation:  UVITEC, UVIdoc Gel Documentation System, UK 
   Biorad, UV-Transilluminator 2000, USA 
Ice Machine:  Scotsman Inc., AF20, USA 
Incubator:  Memmert, Modell 300, GERMANY 
   Memmert, Modell 600, GERMANY 
Laminar Flow:  Kendro Lab. Prod., Heraeus, HeraSafe HS12, GERMANY 
Magnetic Stirrer:  VELP Scientifica, ARE Heating Magnetic Stirrer, ITALY 
   VELP Scientifica, Microstirrer, ITALY 
Microliter Pipette:  Gilson, Pipetman, FRANCE 
   Mettler Toledo, Volumate, USA 
Microwave Oven:  Bosch, TÜRKĐYE 
Nano-ZS-DLS  Malvern Ins. UK 
Unity Inova 500 MHz NMR Varian, Inc. USA 
pH meter:  WTW, pH540 GLP MultiCal®, GERMANY 
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Power Supply:  Biorad, PowerPac 300, USA 
   Wealtec, Elite 300, USA 
Refrigerator:  +4o C, Bosch, TÜRKĐYE 
TRI-CARB 2900 TR Liquid Scintillation Analyzer Packard, USA 
Shaker:  Forma Scientific, Orbital Shaker 4520, USA 
   GFL, Shaker 3011, USA 
   New Brunswick Sci., Innova™ 4330, USA 
Sonicator  Vibracell 75043, Bioblock Scientific,FRANCE 
Spectrophotometer:  Schimadzu, UV-1208, JAPAN 
   Schimadzu, UV-3150, JAPAN 
Speed Vacuum:  Savant, Speed Vac® Plus Sc100A, USA 
   Savant, Refrigerated Vapor Trap RVT 400, USA 
Thermocycler:  Eppendorf, Mastercycler Gradient, GERMANY 
Vacuum:  Heto, MasterJet Sue 300Q, DENMARK 
Water bath:  Huber, Polystat cc1, GERMANY 
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APPEDIX E 
VECTOR MAPS 
E.1 Vector map of pPICZC  
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Multiple cloning site of pPICZC 
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E.2 Vector map of pGEX-4T-2 
 
Multiple cloning site of pGEX-4T-2 
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E.3 Vector map of pQE-80L 
 
 pQE vectors for N-terminal 6xHis tag constructs. PT5: T5 promoter,lac O: lac 
operator, RBS: ribosome-binding site, ATG: start codon, 6xHis: 6xHis tag sequence, 
MCS: multiple cloning site with restriction sites indicated, Stop Codons: stop codons 
in all three reading frames, Col E1: Col E1 origin of replication, Ampicillin: ampicillin 
resistance gene, lacIq, lacIq repressor gene. 
Multiple cloning site of pQE-80L 
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APPEDIX F 
SEQUECIG RESULTS 
F.1 Sequencing results of GPA1 and pPICZC+GPA1-2 construct, with EcoRI and XhoI 
restriction enzyme sites at 5’ and 3’ sites, respectively. Alignment starts at the EcoRI 
site and ends at the stop codon of polyhistidine tag of pPICZC. 
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F.2 Sequencing results of AGB1 and pGEX-4T-2 AGB1 construct   
Alignment starts from the EcoRI multiple cloning site of the vector and ends at the stop 
codon of the AGB1 gene. 
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F.3 Sequencing results of AGB1 and pQE-80L AGB1 construct 
Sequencing results of forward sequencing primer (QE Type III/IV) and reverse 
sequencing primer. Alignment starts at RGS-6xhis tag and ends at the stop codon  of 
pQE-80L coding frame. 
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F.4 Sequencing results of AGG1 and pGEX-4T-2 -AGG1 construct. 
Alignment starts from the forward sequencing primer and ends at the reverse 
sequencing primer of pGEX-4T-2 vector. 
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F.5 Sequencing results of AGG2 and pQE-80L -AGG2 construct 
Sequencing results of forward sequencing primer (QE Type III/IV) and reverse 
sequencing primer( QE terminator) were combined. Alignment starts at RGS-6xhis tag 
and ends at the stop codon  of pQE-80L coding frame. 
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APPEDIX G 
COSTRUCTS 
G.1 pPICZC+GPA1 
 
G.2 pQE-80L -AGB1 
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G.3 pQE-80L AGG2 
  
G.4 pGEX-4T-2-AGB1 
    
 
G.5 pGEX-4T-2 -AGG1 
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APPEDIX H 
IDUCTIO DATA 
 Different strains of Escherichia coli harboring pGEX-4T-2 or pQE-80L constructs 
were grown with the given conditions. The cells were analyzed for protein expression, 
as given in Chapter 4.8. 
1. BL21(DE3) 
BL21(DE3) Induction, 37 oC
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Figure H 1: Growth curves of GST-AGB1 and GST-AGG1 harboring BL21(DE3) cells 
grown at 37 ºC, in LB-amp. 0.5 mM IPTG was given at t=0 to cells. 
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Figure H 2: Growth curves of GST, GST-AGB1 and GST-AGG1 harboring BL21(DE3) 
cells grown at 28 ºC, in LB-amp. 0.5 mM IPTG was given at t=0 to cells. 
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Figure H 3: Growth curves of GST and GST-AGB1 harboring BL21(DE3) cells grown 
at 18 ºC, in LB-amp. 0.3 or 0.5 mM IPTG was given at t=0 for induced cells. 
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BL21(DE3) Induction, 18 oC : GST-AGG1
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Figure H 4: Growth curves of GST and GST-AGG1 harboring BL21(DE3) cells grown 
at 18 ºC, in LB-amp. 0.3 or 0.5 mM IPTG was given at t=0 for induced cells. 
 
2. BL21(DE3)RIPL 
BL21(DE3) RIPL Induction: GST-AGB1
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Figure H 5: Growth curves of GST and GST-AGB1 harboring BL21(DE3)RIPL cells 
grown at 29 ºC, in LB-amp. 0.5 mM IPTG was given at t=2.5 for induced cells. 
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BL21(DE3) RIPL Induction: GST-AGG1
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Figure H 6: Growth curves of GST and GST-AGG1 harboring BL21(DE3)RIPL cells 
grown at 29 ºC, in LB-amp. 0.5 mM IPTG was given at t=2.5 for induced cells. 
 
3. TOP10 
TOP10 Induction: RGS-his-AGB1
time (h)
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Figure H 7: Growth curves of pQE-80L without insert or RGS-his-AGB1 harboring 
TOP10 cells grown at 25 ºC, in LB-amp. 0.5 mM IPTG was given at t=2 for induced 
cells. 
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TOP10 Induction: RGS-his-AGG2
time (h)
0 5 10 15 20 25
O
D
60
0 
(a
rb
it
ra
ry
 u
ni
ts
)
0
1
2
3
pQE-80L  Induction
RGS-his-AGG2  Induction
RGS-his-AGG2  
 
Figure H 8: Growth curves of pQE-80L without insert or RGS-his-AGG2 harboring 
TOP10 cells grown at 25 ºC, in LB-amp. 0.5 mM IPTG was given at t=2 for induced 
cells. 
 
4. Rosetta 2 (DE3) 
 
Rosetta 2 (DE3) Induction: RGS-his-AGB1 and RGS-his-AGG2
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Figure H 9: Growth curves of pQE-80L with RGS-his-AGB1 or RGS-his-AGG2 
harboring Rosetta 2 (DE3) cells grown at 29 ºC, in LB-amp. 0.5 mM IPTG was given at 
t=1.5 for induced cells. 
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APPEDIX I 
Amino Acid Sequencing Results and Expected Sequences 
A. GPA1-his-myc 
• Theoretical Sequence: 
MGLLCSRSRHHTEDTDENTQAAEIERRIEQEAKAEKHIRKLLLLGAGESGKSTIF
KQIKLLFQTGFDEGELKSYVPVIHANVYQTIKLLHDGTKEFAQNETDSAKYMLS
SESIAIGEKLSEIGGRLDYPRLTKDIAEGIETLWKDPAIQETCARGNELQVPDCTK
YLMENLKRLSDINYIPTKEDVLYARVRTTGVVEIQFSPVGENKKSGEVYRLFDV
GGQRNERRKWIHLFEGVTAVIFCAAISEYDQTLFEDEQKNRMMETKELFDWVL
KQPCFEKTSFMLFLNKFDIFEKKVLDVPLNVCEWFRDYQPVSSGKQEIEHAYEF
VKKKFEELYYQNTAPDRVDRVFKIYRTTALDQKLVKKTFKLVDETLRRRNLLE
AGLLLEPRRPPAYVEQKLISEEDLNSAVDHHHHHH 
• Edman Sequencing Result: 
(G/X)LLXS 
 The sequencing results (Figure I 1) verified the presence of expected 4 amino 
acids. The first glycine was co eluted with an unknown peak, which could be from the 
blotting buffer or a modification. At position 4 there is only an unknown peak possibly 
a modified amino acid, e.g. cysteine. Cysteine is destroyed during Edman degradation, 
so normally it is reduced and carboxamidomethylated before sequencing to get a stable 
derivative. If it is modified by a fatty acid, it would elute very late or not at all from the 
reversed-phase HPLC column.  
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Figure I 1: N-terminus amino acid sequencing results for GPA1 (stg. 3.2.1). 
 
• MALDI-TOF Result: 
 The below amino acid sequence was deduced from fragments of pool 3 GPA1. 
Six amino acid N-terminus fragments could not be assigned to any m/z (mass/ charge). 
The R/K residues that were not digested by trypsin are highlighted; the unassigned 
amino acids are underlined, covering 13.28 % of the total sequence. 30% of the 
sequence was unmatched according to TOPLAB, 17.15% of the sequence was assigned 
using EXPASY Peptide Mass Server (http://www.expasy.ch/tools/peptide-mass.html) 
using the m/z values. 
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SRHHTEDTDENTQAAEIERRIEQEAKAEKHIRKLLLLGAGESGKSTIFKQIKLLF
QTGFDEGELKSYVPVIHANVYQTIKLLHDGTKEFAQNETDSAKYMLSSESIAIG
EKLSEIGGRLDYPRLTKDIAEGIETLWKDPAIQETCARGNELQVPDCTKYLMEN
LKRLSDINYIPTKEDVLYARVRTTGVVEIQFSPVGENKKSGEVYRLFDVGGQRN
ERRKWIHLFEGVTAVIFCAAISEYDQTLFEDEQKNRMMETKELFDWVLKQPCF
EKTSFMLFLNKFDIFEKKVLDVPLNVCEWFRDYQPVSSGKQEIEHAYEFVKKKF
EELYYQNTAPDRVDRVFKIYRTTALDQKLVKKTFKLVDETLRRRNLLEAGLLL
EPRRPPAYVEQKLISEEDLNSAVDHHHHHH 
 
 The below amino acid sequence was deduced from fragments of pool 4 GPA1. N-
terminus fragments were assigned correctly. The R/K residues that were not digested by 
trypsin are highlighted; the unassigned amino acids are underlined, covering 13.3 % of 
the total sequence. 28% of the sequence was unmatched according to TOPLAB, 15.25% 
of the sequence was assigned using EXPASY Peptide Mass Server 
(http://www.expasy.ch/tools/peptide-mass.html) using the m/z values.  
GLLCSRSRHHTEDTDENTQAAEIERRIEQEAKAEKHIRKLLLLGAGESGKSTIFK
QIKLLFQTGFDEGELKSYVPVIHANVYQTIKLLHDGTKEFAQNETDSAKYMLSS
ESIAIGEKLSEIGGRLDYPRLTKDIAEGIETLWKDPAIQETCARGNELQVPDCTK
YLMENLKRLSDINYIPTKEDVLYARVRTTGVVEIQFSPVGENKKSGEVYRLFDV
GGQRNERRKWIHLFEGVTAVIFCAAISEYDQTLFEDEQKNRMMETKELFDWVL
KQPCFEKTSFMLFLNKFDIFEKKVLDVPLNVCEWFRDYQPVSSGKQEIEHAYEF
VKKKFEELYYQNTAPDRVDRVFKIYRTTALDQKLVKKTFKLVDETLRRRNLLE
AGLLLEPRRPPAYVEQKLISEEDLNSAVDHHHHHH 
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B. RGS-his-AGB1 
• Theoretical Sequence: 
MRGSHHHHHHGSSVSELKERHAVATETVNNLRDQLRQRRLQLLDTDVARYSA
AQGRTRVSFGATDLVCCRTLQGHTGKVYSLDWTPERNRIVSASQDGRLIVWNA
LTSQKTHAIKLPCAWVMTCAFSPNGQSVACGGLDSVCSIFSLSSTADKDGTVPV
SRMLTGHRGYVSCCQYVPNEDAHLITSSGDQTCILWDVTTGLKTSVFGGEFQS
GHTADVLSVSISGSNPNWFISGSCDSTARLWDTRAASRAVRTFHGHEGDVNTV
KFFPDGYRFGTGSDDGTCRLYDIRTGHQLQVYQPHGDGENGPVTSIAFSVSGRL
LFAGYASNNTCYVWDTLLGEVVLDLGLQQDSHRNRISCLGLSADGSALCTGS
WDSNLKIWAFGGHRRVIGTPGRPAAKLN 
• Sequencing Result: 
 Sample gave a sequence of 15 amino acids, but it contained no His-Tag. The 
database search identified the main sequence as Lac repressor (E.coli, cloning vector). 
There were traces of minor sequences visible, but not enough for identification. 
 
C. The 60 kDa protein co-purified with RGS-his AGB1 
 
N-terminal sequence AAKDV 
 Although 5 amino acid residues were not enough to directly identify the protein, 
this sequence is highly conserved within 60 kDa chaperonin groEL protein family. 
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D. RGS-his-AGG2 
• Theoretical Sequence: 
MRGSHHHHHHGSEAGSSNSSGQLSGRVVDTRGKHRIQAELKRLEQEARFLEEE
LEQLEKMDNASASCKEFLDSVDSKPDPLLPETTGPVNATWDQWFEGPKEAKRC
GCSILGTPGRPAAKLN 
• Sequencing Result: 
 The sequence following the 6 histidines is clearly GSEAE, although there is a 
high lag of the many consecutive histidines and the minor sequence which seems to 
have an additional F at the N-terminus. 
Major sequence: MRGSHHHHHHGSEAE 
Minor sequence: FMRGSHHHHHHGSEA 
 
Figure I 2: N-terminus amino acid sequencing results for RGS-his-AGG2, 14 kDa band. 
 The 15th residue of RGS-his-AGG2 is supposed to be a G, but the sequencing 
results is an E. When the chromatogram is analyzed carefully the signal for G is also 
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increasing at position 15, but the dominating signal is from E, but could be the 
remainder from E at position 13, while G would possibly increase in cycle 16 and 17, 
but sample was not sequenced that far.  
 
Figure I 3: The chromatogram of 15th amino acid residue of RGS-his-AGG2  
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APPEDIX J 
 GPA1-myc-his recombinant protein myristoylation was predicted using NMT - 
The MYR Predictor (http://mendel.imp.ac.at/myristate/SUPLpredictor.htm). Results are 
given below, server predicts the first glycine as a myristoylation site. 
Prediction of potential Myristoylation by NMT (predicted myristoylation site 
highlighted): 
MGLLCSRSRH HTEDTDENTQ AAEIERRIEQ EAKAEKHIRK LLLLGAGESG KSTIFKQIKL  
LFQTGFDEGE LKSYVPVIHA NVYQTIKLLH DGTKEFAQNE TDSAKYMLSS ESIAIGEKLS  
EIGGRLDYPR LTKDIAEGIE TLWKDPAIQE TCARGNELQV PDCTKYLMEN LKRLSDINYI  
PTKEDVLYAR VRTTGVVEIQ FSPVGENKKS GEVYRLFDVG GQRNERRKWI HLFEGVTAVI  
FCAAISEYDQ TLFEDEQKNR MMETKELFDW VLKQPCFEKT SFMLFLNKFD IFEKKVLDVP  
LNVCEWFRDY QPVSSGKQEI EHAYEFVKKK FEELYYQNTA PDRVDRVFKI YRTTALDQKL  
VKKTFKLVDE TLRRRNLLEA GLLLEPRRPP AYVEQKLISE EDLNSAVDHH HHHH        
 
 
 
GLLCSRSRHHTEDTDE 
| 
2 (Position in sequence) 
Figure J 1: 'RELIABLE' myristoylation site predicted, Sequence of the predicted 
myristoylation signal. Overall score:  0.092. Probability of false positive prediction:  
4.66e-03. Parameter set: EUKARYOTA (without FUNGI) plus VIRUSES. All glycines 
investigated. 
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 GPA1-myc-his recombinant protein palmitoylation was predicted using CSS-
Palm 2.0 Online Server  (http://csspalm.biocuckoo.org/online.php ). Server predicts that 
the cysteine in GLLCSRS motif is a palmitoylation site. 
 
Figure J 2: Palmitoylation site predicted using CSS-Palm 2.0 Online Server. 
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APPEDIX K 
Lubrol PX and Triton X-100 Characterization 
 Triton X-100 and Lubrol-PX were used at different concentrations. The Triton X-
100 concentration was 1.5 mM in the lysis buffer and 0.3 mM in the purification buffer. 
The critical micelle concentration (cmc) for Triton X-100 is 0.25 mM and 0.1 mM for 
Lubrol PX [119]. Different concentrations of the detergents were prepared in 50 mM 
Tris, pH 8.0 and 150 mM NaCl. The DLS analysis showed that, below the cmc the 
solution was heterogeneous but that a homogenous solution with particle diameter 8.5 
nm started to form above the cmc for both Triton X-100 (Figure K 2 - Figure K 6) and 
Lubrol PX (Figure K 7 - Figure K 9). 
 One major drawback of using Triton-X in buffers is that the detergent itself 
absorbs at 280 nm, thus interfering with protein concentration estimations. It was not 
possible to measure the absorbance of 6 mM (0.4 %) and higher concentrations of 
Triton X-100 (Figure K 10). Lubrol PX, on the other hand, does not have a significant 
absorbance around 260 and 280 nm even at very high concentrations (Figure K 11).  
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Figure K 1: DLS size distributions by intensity (A) and number (B) of 50 mM Tris, pH 
8.0 and 150 mM NaCl. 
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Figure K 2: DLS size distributions by intensity (A) and number (B) of 0.012 % (0.2 
mM) Triton X-100. 
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Figure K 3: DLS size distributions by intensity (A) and number (B) of 0.015 % (0.25 
mM) Triton X-100. 
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Figure K 4: DLS size distributions by intensity (A) and number (B) of 0.02 % (0.3 mM) 
Triton X-100. 
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Figure K 5: DLS size distributions by intensity (A), volume (B) and number (C) of 0.1 
% (1.5 mM) Triton X-100. 
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Figure K 6: DLS size distributions by intensity (A), volume (B) and number (C) of 1 % 
(15 mM) Triton X-100. 
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Figure K 7: DLS size distributions by intensity (A), volume (B) and number (C) of 
0.0004 % (0.006 mM) Lubrol PX. 
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Figure K 8: DLS size distributions by intensity (A), volume (B) and number (C) of 0.1 
% (1.7 mM) Lubrol PX. 
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Figure K 9: DLS size distributions by intensity (A), volume (B) and number (C) of 1 % 
(17 mM) Lubrol PX. 
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Figure K 10: UV spectra of different concentrations of Triton X-100. A: below the cmc 
and low concentrations above the cmc, B: High concentrations above the cmc. 
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Figure K 11: UV-spectra of different concentrations of Lubrol PX. 
 
 CD spectrra were recorded for TND buffer, 0.02 % Triton X-100 and 0.1 % 
Lubrol-PX in TND Buffer.  After buffer subtraction the milidegree values were plotted 
(Figure K 12).  
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Figure K 12 CD spectra of 0.02 % Triton X-100 and 0.1 % Lubrol-PX in TND buffer, 
A: Far-UV region, B: Near –UV region. 
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APPEDIX L 
SIZE EXCLUSIO COLUM CALIBRATIOS 
• HiPrep 16/60 Sephacryl S-300 High Resolution Calibration Results 
 Standards (Table L1) were prepared in 50 mM Phosphate Buffer pH 7.2, 150 mM 
NaCl and 200 µl from each 4 mg/ml solution were combined. Sample was centrifuged 
and 0.5 ml sample was loaded to S-300 column. Column was run with 50 mM 
Phosphate Buffer pH 7.2, 150 mM NaCl at 0.5 ml/min and 1 ml fractions were collected 
(Figure L1). 
 Void volume of column was calculated from a separate run with 0.5 ml of 1mg/ml 
bluedextran 2000 in 50 mM phosphate 150 mM NaCl pH 8.0 buffer at 0.5 ml/min. The 
void volume of the column was found 32 ml. Column volume is 120 ml and Kav was 
calculated from Kav= (Ve-Vo)/(Vc-Vo); Vo (column void volume), Vc (geometric 
column volume) and Ve (elution volume). 
 
Table L 1: Standards used in column calibration. 
 
 
 
 
 
 
 
Standards MW (Da) Sample amount (mg/mL) 
Ribonuclease A 13700 4 
Carbonic anhydrase 29000 4 
Ovalbumin 43000 4 
BSA 67000 4 
B-galactosidase 118000 4 
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Figure L 1: Elution of standards from S-300 column. 
 
 
Figure L 2: 12% SDS-PAGE analysis of fractions eluted from S-300 column. Lane 1: 
column load, lanes 2-11:elution volume; lane 2: 57.5, lane 3: 58.5, lane 4: 61.5, lane 5: 
64.5, lane 6: 67.5, lane 7: 69.5, lane 8: 72.5, lane 9: 74.5, lane 10: 77.5, lane 11: 81.5, 
lane 12: Prestained protein ladder Plus ®. Samples were prepared with 6X SDS loading 
dye. 
 
 The standarts eluted at the indicated volumes in Table L2 and proteins were 
analyzed by SDS-PAGE (Figure L2). The 118 kDa protein B-galactosidase is not 
present even in column load, so there was a problem with protein stock. 
 
1       2    3   4   5   6    7   8  9 10 11 12 
35 kDa 
55 kDa 
27 kDa 
15 kDa 
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Table L 2 S-300 column calibration results and calculations.  Experimental Log MW 
calculated from calibration curve equation (Figure L3). 
  Range Ve   Theoretical Experimental 
  ml ml Kav MW Log MW Log MW MM 
BSA 57-61 59 0.306 67000 4.826 4.826 66.988 
ovalbumin 61-66 63 0.35 43000 4.633 4.674 47.206 
CA 67-74 70 0.43 29000 4.462 4.399 25.061 
RNaseA 75-81 78 0.5 13700 4.137 4.158 14.387 
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Figure L 3: S-300 column calibration curve 
 
• HiPrep 16/60 Sephacryl S-200 High Resolution Calibration Results 
 Standards (Table L3) were prepared in Buffer D (Table 4.10) and 200 µl from 
each 4 mg/ml solution were combined. Sample was centrifuged and 0.5 ml sample was 
loaded to S-300 column. Column was run with Buffer D at 0.5 ml/min and 1 ml 
fractions were collected (Figure L4). 
 Void volume of column was calculated from a separate run with 0.5 ml of 1 
mg/ml bluedextran 2000 Buffer D at 0.5 ml/min. The void volume of the column was 
found 32 ml.  
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 Column volume is 120 ml and Kav was calculated from Kav= (Ve-Vo)/(Vc-Vo); 
Vo (column void volume), Vc (geometric column volume) and Ve (elution volume). 
 
Table L 3 Standards used in column calibration. 
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Figure L 4: Elution of standards from S-200 column 
 
 
Standards MW (Da) Sample amount (mg/mL) 
Aprotinin 6 500 3 
Ribonuclease A 13 700 3 
Carbonic anhydrase 29 000 3 
Ovalbumin 43 000 4 
Conalbumin 75 000 3 
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Figure L 5: 12% SDS-PAGE analysis of fractions eluted from S-200 column. Lane 1: 
Protein ladder ®,  lane 2: column load, lane 3: overflow, lane 4: 48 ml, lane 5: overflow, 
lane 6: 49 ml, lane 7: 51 ml, lane 8:52 ml, lane9: 54 ml, lane 10: 58 ml, lane11: 60 ml, 
lane12: 67 ml, lane 13: 70 ml, lane 14: 72 ml, lane 15: 92 ml. 
 
 The standarts eluted at the indicated volumes in Table L4 and proteins were 
analyzed by SDS-PAGE (Figure L5). 
 
Table L 4: S-200 column calibration results and calculations.  Experimental Log MW 
calculated from calibration curve equation (Figure L6). 
  Range Ve   Theoretical Experimental 
  ml ml Kav MW Log MW Log MW MM 
Conalbumin 
46-49 48 0.1818 75000 4.875 4.850 70831 
Ovalbumin 51-54 52.2 0.2295 43000 4.633 4.688 48752 
CA 58-63 60.2 0.3205 29000 4.462 4.416 26061 
RNaseA 67-72 69.7 0.4284 13700 4.137 4.155 14288 
Aprotinin 89-98 92.2 0.6841 6500 3.813 3.812 6486 
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Figure L 6: S-200 column calibration curve 
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APPEDIX M 
CD SPECTRA OF BUFFERS 
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Figure M 1: CD raw data for buffers 
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Figure M 2: CD raw data for C48/80, A: spectrum of C48/80 used in assays. B: C48/80 
with noisy spectrum. The receptor mimetics compound was tested for noisy spectra 
before assays.  
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APPEDIX  
CHEMICAL STRUCTURES 
 
1. HEPES: [4-(2-hydroxyethyl)-1-piperazineethanesulfonic acid, C8H18[N2O4S]; 
amount in HND; 20 mM  
 
 
 
2. DTT: dithiothreitol; amount in HND; 1 mM 
 
 
3. Lubrol-PX, used 1.7 mM (0.1 %) in affinity purification buffer 
CH3 (CH2)11-O-(CH2CH2O)9-H 
4. Triton X-100, used 0.3  mM (0.02 %) in affinity purification buffer 
General structure for Octylphenoxypolyethoxyethanol is given below, x denotes the 
length of polyoxyethylene chain. Triton X-100 has on average 9-10 ethylene oxide units 
 
